≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Adrenocortical insufficiency

DOID EFO Endpoint Browser PheWeb

E4_ADDISON

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E27.1, E27.2, E27.3#, E27.4
  • Hospital discharge: ICD-9 — 2554
  • Hospital discharge: ICD-8 — 2551
  • Cause of death: ICD-10 — E27.1, E27.2, E27.3#, E27.4
  • Cause of death: ICD-9 — 2554
  • Cause of death: ICD-8 — 2551
  • KELA reimbursements: KELA codes — 105

3 out of 7 registries used, show all original rules.

1477

4. Check minimum number of events

None

1477

5. Include endpoints

None

1477

6. Filter based on genotype QC (FinnGen only)

1433

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7708 4664 2983
Only index persons 6408 3987 2421
Unadjusted period prevalence (%)
Whole population 0.11 0.13 0.08
Only index persons 0.13 0.15 0.09
Median age at first event (years)
Whole population 52.50 53.53 50.87
Only index persons 52.56 53.14 51.61

-FinnGen-

Key figures

All Female Male
Number of individuals 1433 948 485
Unadjusted period prevalence (%) 0.30 0.34 0.22
Median age at first event (years) 56.16 53.52 61.31

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1477
Matched controls
14770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
6413.1
307.7
462
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
6192.8
307.7
451
*
H02AA02
ATC
fludrocortisone; oral
160.7
307.7
364
30
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
307.7
407
*
H02AB09
ATC
hydrocortisone; systemic
917.9
307.7
1252
89
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
6319.1
307.7
719
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
7.9
203.7
317
491
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
12.3
203.0
214
200
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
69.8
201.7
110
17
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
9.0
169.3
226
290
J45.9
ICD-10 Finland
Asthma, unspecified
4.6
168.7
589
1874
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.3
168.5
838
3449
R03BB04
ATC
tiotropium bromide; inhalant
5.6
154.5
351
781
E27.2
ICD-10 Finland
Addisonian crisis
+∞
153.9
145
*
J46
ICD-10 Finland
Status asthmaticus
11.1
152.5
170
171
H02AB06
ATC
prednisolone; systemic
4.3
151.0
1046
5296
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.3
150.8
567
1883
E23.03
ICD-10 Finland
Lack of ACTH
+∞
147.4
139
*
R03AK08
ATC
formoterol and beclometasone; inhalant
7.5
139.8
218
333
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.1
136.9
532
1791
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
133.0
997
5153
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.1
131.7
325
770
H03AA01
ATC
levothyroxine sodium; systemic
3.8
130.4
613
2338
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.9
129.8
342
855
R03DC03
ATC
montelukast; oral
4.0
125.1
481
1594
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.6
124.4
683
2863
C03CA01
ATC
furosemide; systemic
3.5
120.5
643
2637
J45.1
ICD-10 Finland
Nonallergic asthma
5.4
117.7
264
573
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.0
109.4
396
1246
R50.9
ICD-10 Finland
Fever, unspecified
3.8
109.0
428
1424
J45.8
ICD-10 Finland
Mixed asthma
8.5
108.3
147
190
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.4
108.0
589
2417
M05BA04
ATC
alendronic acid; oral
5.0
106.7
262
612
R03AC12
ATC
salmeterol; inhalant
6.9
106.5
176
284
R11
ICD-10 Finland
Nausea and vomiting
4.5
102.0
290
761
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
101.2
96
*
L04AX01
ATC
azathioprine; systemic
6.7
99.7
170
283
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
39.7
99.6
61
16
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
33.4
99.5
64
20
R03DA04
ATC
theophylline; systemic, rectal
6.3
97.9
176
309
R53
ICD-10 Finland
Malaise and fatigue
3.1
93.5
586
2570
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
92.6
356
1155
A41.9
ICD-10 Finland
Sepsis, unspecified
7.4
92.4
140
205
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
9.4
90.8
112
128
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
90.3
422
1551
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
89.2
395
1402
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.6
88.5
355
1182
XG474
NOMESCO Finland
Exhalation nntrogen oxide
7.7
86.6
127
179
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
86.1
337
1102
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.0
84.6
276
796
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.5
84.1
356
1224
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
83.1
79
*
N02AA05
ATC
oxycodone; systemic
3.2
81.9
414
1585
J01MA14
ATC
moxifloxacin; systemic
4.1
81.9
255
710
WZC30
NOMESCO Finland
Teaching
3.3
80.7
397
1494
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.3
79.8
172
356
R06.0
ICD-10 Finland
Dyspnoea
2.8
79.0
587
2776
R03DC01
ATC
zafirlukast; oral
11.4
78.9
84
78
R96
ICPC
Asthma
3.8
78.4
279
852
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
78.2
483
2067
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
78.2
216
549
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
77.8
214
542
H02AB04
ATC
methylprednisolone; systemic
3.4
77.5
345
1219
UJF32
NOMESCO Finland
Coloscopy
2.9
77.5
544
2493
A07AA02
ATC
nystatin; oral
5.0
76.9
181
404
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
7.7
75.8
110
153
J01MA12
ATC
levofloxacin; systemic
3.1
75.7
405
1594
R03BA08
ATC
ciclesonide; inhalant
3.9
75.5
258
765
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
74.0
156
316
R03BA05
ATC
fluticasone; inhalant
3.0
73.7
426
1749
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
73.7
311
1060
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
72.5
498
2243
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
33.1
69.8
45
14
R03AC13
ATC
formoterol; inhalant
4.9
69.8
165
369
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
68.9
263
838
H02AB07
ATC
prednisone; oral
3.3
68.7
319
1149
J45
ICD-10 Finland
Asthma
3.5
68.6
280
931
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
68.3
299
1039
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.9
68.1
128
233
M05BX04
ATC
denosumab; parenteral
4.5
68.0
181
445
N03AX16
ATC
[U] pregabalin
2.8
67.1
482
2208
N03AX12
ATC
[U] gabapentin; oral
3.0
66.9
370
1473
R03BA01
ATC
beclometasone; inhalant
3.2
66.6
323
1192
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.7
65.8
166
391
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.3
65.6
141
290
M81.9
ICD-10 Finland
Osteoporosis, unspecified
5.2
64.8
143
301
S97
ICPC
Chronic ulcer skin
4.4
64.8
175
435
N02AX02
ATC
tramadol; systemic, rectal
2.5
63.2
773
4534
J01MA02
ATC
ciprofloxacin; systemic
2.5
62.9
697
3906
M81.4
ICD-10 Finland
Drug-induced osteoporosis
22.6
62.5
46
21
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
15.4
62.5
55
37
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
62.4
474
2220
N06AX21
ATC
duloxetine; oral
3.1
62.1
303
1119
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
61.9
707
4008
AA1AD
NOMESCO Finland
CT of head and brain
2.6
61.8
554
2809
A10AB05
ATC
insulin aspart; parenteral
3.9
61.0
196
553
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.7
59.8
116
217
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.5
59.2
119
230
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
+∞
58.7
56
*
SPAT1254
SPAT
Administration of medicine
3.0
58.2
317
1243
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
10.6
57.6
64
63
L04AX03
ATC
methotrexate; systemic
3.4
57.5
242
815
318
Kela drug reimbursment
Teriparatide
204.7
57.4
59
*
SPAT1262
SPAT
Handing over of treatment supplies
2.8
57.0
344
1424
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
56.6
231
763
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
56.1
458
2205
H05AA02
ATC
teriparatide; parenteral
568.8
56.0
55
*
104
Kela drug reimbursment
Thyroid insufficiency
3.9
55.8
183
523
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
12.1
55.2
56
48
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
5.8
54.6
104
191
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
54.3
260
945
ZX120
NOMESCO Finland
Intravenous
3.4
54.2
223
739
A01AB09
ATC
miconazole; local oral
3.5
53.8
209
668
J01FF01
ATC
clindamycin; systemic
2.4
53.1
517
2688
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.5
52.9
107
208
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
52.6
674
3941
25510
ICD-8 Finland
Diseases of adrenal glands, Adrenal cortical hypofunction
+∞
52.4
50
*
E27.9
ICD-10 Finland
Disorder of adrenal gland, unspecified
+∞
52.4
50
*
A02BC05
ATC
esomeprazole; systemic
2.3
52.2
725
4379
C03DA01
ATC
spironolactone; oral
3.1
52.1
257
948
R02
ICPC
Shortness of breath/dyspnoea
2.9
51.7
301
1217
E0000UV, ,
ATC
2.3
51.4
751
4624
A02BC02
ATC
pantoprazole; systemic
2.5
51.2
1127
8245
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.1
50.7
252
933
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
11.2
50.6
54
50
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
7.7
50.3
72
98
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.4
49.7
196
631
L04AA06
ATC
mycophenolic acid; systemic
8.1
49.2
67
86
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.9
49.0
113
246
L28
ICPC
Limited function/disability (L)
2.6
48.8
373
1725
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
48.3
194
632
N06AA09
ATC
amitriptyline; systemic
3.1
47.5
219
775
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
47.2
149
413
R03BB01
ATC
ipratropium bromide; inhalant
5.1
47.2
103
214
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.3
47.0
199
669
E87.6
ICD-10 Finland
Hypokalaemia
4.7
46.2
113
258
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.0
46.2
83
144
R03AC02
ATC
salbutamol; inhalant
2.2
46.1
952
6625
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
45.9
400
1958
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
45.9
238
900
SPAT1263
SPAT
Sampling
2.2
45.6
710
4418
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
45.5
242
927
A02BC01
ATC
omeprazole; systemic
2.3
44.9
487
2617
A06AD11
ATC
lactulose; oral
2.7
44.9
284
1192
WX892
NOMESCO Finland
Monitored bed care
3.4
44.9
174
553
JN4AD
NOMESCO Finland
Body CT examination
2.9
44.9
241
928
A07AA09
ATC
vancomycin; oral
8.9
44.6
56
65
A02BA02
ATC
ranitidine; systemic
2.5
44.3
359
1697
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
44.3
213
771
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
44.2
683
4222
A12AA04
ATC
calcium carbonate; oral
10.8
43.9
48
46
N03AE01
ATC
clonazepam; systemic
3.9
43.8
140
391
A07EA06
ATC
budesonide; oral, local oral
4.5
43.8
111
261
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.6
43.7
153
455
A46
ICD-10 Finland
Erysipelas
2.7
43.6
280
1183
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.5
43.2
109
255
E27.0
ICD-10 Finland
Other adrenocortical overactivity
+∞
42.9
41
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
7.6
42.6
61
83
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.2
42.4
185
632
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
42.2
311
1404
SPAT1255
SPAT
Intravenous administration of medicine
3.6
41.9
149
447
C07AB07
ATC
bisoprolol; oral
2.1
41.6
773
5087
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.3
41.5
112
276
J47
ICD-10 Finland
Bronchiectasis
6.8
41.5
66
101
R06AE07
ATC
cetirizine; oral
2.1
41.4
758
4956
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
41.4
356
1723
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
41.2
193
687
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.2
40.9
116
297
SPAT1229
SPAT
Assessment of need for aid
3.4
40.6
161
518
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.8
40.3
130
365
R60.0
ICD-10 Finland
Localized oedema
2.7
40.0
254
1064
M79.7
ICD-10 Finland
Fibromyalgia
4.3
39.9
106
258
R52.2
ICD-10 Finland
Other chronic pain
4.2
39.9
113
289
TQW80
NOMESCO Finland
Local dermatologic skincare
5.4
39.8
81
158
SPAT1153
SPAT
Removal of sutures
2.1
39.4
535
3113
GD1AD
NOMESCO Finland
Thorax CT examination
3.4
39.0
148
463
SPAT1301
SPAT
No procedures
2.1
38.8
529
3080
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
+∞
38.7
37
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
38.7
481
2703
N06AX16
ATC
venlafaxine; oral
2.5
38.7
297
1362
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
38.6
141
430
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.7
38.6
131
381
ZYC01
NOMESCO Finland
Remote contact by phone
3.4
38.4
151
483
E87.5
ICD-10 Finland
Hyperkalaemia
6.9
38.4
60
90
J02AC01
ATC
fluconazole; systemic
2.0
38.4
685
4399
SPAT1260
SPAT
Consultation of another employee
2.4
38.2
329
1587
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.3
38.2
104
258
S18
ICPC
Laceration/cut
2.0
38.1
780
5257
R51.80
ICD-10 Finland
Headache
2.4
37.8
325
1567
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
37.7
36
*
R03BA02
ATC
budesonide; inhalant
2.3
37.6
350
1745
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
37.6
204
786
N05BA04
ATC
oxazepam; oral
2.1
37.3
465
2610
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
37.3
725
4786
R01AD01
ATC
beclometasone; nasal
2.4
37.2
302
1418
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
37.1
446
2466
A11CC03
ATC
alfacalcidol; systemic
6.4
37.0
62
100
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.1
36.9
105
269
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.6
36.9
90
205
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.9
36.8
199
765
R03AK07
ATC
formoterol and budesonide; inhalant
2.2
36.8
401
2133
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.8
36.7
201
778
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
36.5
867
6120
N05CF01
ATC
zopiclone; oral
2.1
36.5
540
3227
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.6
36.4
59
92
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
36.4
254
1111
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.1
36.4
79
163
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.7
36.4
230
959
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.2
36.3
99
246
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
36.2
350
1771
XG410
NOMESCO Finland
Flow-volume spirometry
4.2
36.2
100
251
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
36.2
191
725
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
36.1
694
4547
B01AB05
ATC
enoxaparin; parenteral
2.1
35.9
529
3151
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.5
35.8
134
415
R03AK11
ATC
formoterol and fluticasone; inhalant
4.9
35.6
80
170
P01BA02
ATC
hydroxychloroquine; oral
2.9
35.5
179
662
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.1
35.4
504
2961
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.8
35.3
114
320
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.9
35.3
64
112
A10AC01
ATC
insulin (human); parenteral
3.1
35.1
159
553
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
8.2
35.1
47
59
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
6.3
35.1
60
99
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
35.0
299
1433
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
34.9
155
533
E86
ICD-10 Finland
Volume depletion
5.3
34.9
72
142
L01BA01
ATC
methotrexate; systemic
4.3
34.9
93
227
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.5
34.8
87
202
H04AA01
ATC
glucagon; nasal, parenteral
5.5
34.7
68
128
M05BA07
ATC
risedronic acid; oral
4.8
34.6
80
174
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
34.5
33
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
34.4
514
3067
R03AC03
ATC
terbutaline; inhalant
2.4
34.3
270
1246
H26.3
ICD-10 Finland
Drug-induced cataract
13.0
34.1
33
26
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
7.7
34.1
48
64
N05BA01
ATC
diazepam; systemic, rectal
2.5
33.6
247
1104
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
33.6
176
664
R60.9
ICD-10 Finland
Oedema, unspecified
3.4
33.6
130
411
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.0
33.5
74
155
2554A
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[MORBUS ADDISON PRIMARIUS]
+∞
33.5
32
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
33.4
703
4711
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
33.3
114
333
L04AD01
ATC
ciclosporin; systemic
6.1
33.1
58
98
N06AX11
ATC
mirtazapine; oral
2.0
33.0
579
3644
L04AA13
ATC
[U] leflunomide
5.1
32.9
70
142
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.1
32.8
92
233
ZXD05
NOMESCO Finland
Urgent procedure
2.0
32.5
496
2970
TGC00
NOMESCO Finland
Bronchial lavation
5.0
32.5
72
151
G47.3
ICD-10 Finland
Sleep apnoea
2.1
32.4
395
2179
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
32.4
102
281
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.0
32.4
152
539
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.8
32.3
75
164
R01AD08
ATC
fluticasone; nasal
2.0
32.2
488
2915
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.9
32.0
161
594
SPAT1325
SPAT
Vaccination
2.0
31.8
537
3327
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.3
31.8
85
208
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
31.7
470
2782
ZX114
NOMESCO Finland
Intramuscular
6.7
31.7
51
79
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.6
31.6
77
175
J01FA06
ATC
roxithromycin; oral
1.9
31.2
643
4250
49300
ICD-8 Finland
Asthma, bronchiale
5.3
31.1
64
126
N03AX09
ATC
lamotrigine; oral
3.4
31.0
118
369
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
31.0
146
519
B03BA03
ATC
hydroxocobalamin; parenteral
3.5
30.8
113
345
ZXA10
NOMESCO Finland
Bilateral
2.2
30.7
318
1644
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
30.5
205
876
SPAT1310
SPAT
Counselling related to known health issue
2.0
30.5
514
3173
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
30.4
73
164
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.1
30.3
137
475
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
+∞
30.3
29
*
L95
ICPC
Osteoporosis
3.7
30.3
99
280
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
30.2
191
793
N02BF01
ATC
gabapentin; oral
2.5
30.1
212
926
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
5.0
30.0
65
134
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.7
29.9
56
101
R4180
NOMESCO Finland
Podiatric therapy
7.1
29.8
45
65
A04
ICPC
Weakness/tiredness general
2.2
29.7
294
1489
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.8
29.7
93
255
A02BC03
ATC
lansoprazole; oral
2.0
29.7
471
2842
NF1AA
NOMESCO Finland
Hip X-ray examination
2.7
29.5
176
709
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
29.5
81
202
C01CA24
ATC
epinephrine; parenteral
2.9
29.5
147
539
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
29.4
242
1135
L04AA01
ATC
[U] ciclosporin
7.6
29.4
42
57
WX213
NOMESCO Finland
Lower leg blockade
10.2
29.2
33
33
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
29.1
225
1025
M05BB03
ATC
alendronic acid and colecalciferol; oral
5.4
29.0
58
111
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.9
29.0
64
134
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.7
28.9
54
97
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.8
28.9
90
246
SPAT1312
SPAT
General health counselling
1.9
28.8
512
3205
C10AC01
ATC
colestyramine; oral
4.3
28.7
75
180
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
28.5
177
727
127
Kela drug reimbursment
Transplant complication
7.5
28.5
41
56
R60.1
ICD-10 Finland
Generalized oedema
9.4
28.3
34
37
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
28.3
125
428
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.5
28.1
99
294
A07EC01
ATC
sulfasalazine; oral, rectal
2.7
28.0
159
624
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
28.0
464
2832
R5140
NOMESCO Finland
Monitoring the use of the aid
2.4
27.6
208
936
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.7
27.6
91
259
J01DB01
ATC
cefalexin; oral
2.3
27.4
1258
10606
Z3231
NOMESCO Finland
Registered nurse
1.9
27.3
442
2672
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.8
27.3
147
561
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.3
27.3
110
356
WW200
NOMESCO Finland
Immunization
4.6
27.3
65
145
TAB00
NOMESCO Finland
Lumbar puncture
3.3
27.2
106
336
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
26.9
254
1258
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.0
26.9
123
429
N02BF02
ATC
pregabalin; oral
2.8
26.9
144
548
BCA30
NOMESCO Finland
Unilateral adrenalectomy
142.6
26.7
28
*
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
10.2
26.5
30
30
JN4BD
NOMESCO Finland
Extensive body CT
2.5
26.5
180
771
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.1
26.4
116
395
M48.0
ICD-10 Finland
Spinal stenosis
2.3
26.4
220
1034
M54.5
ICD-10 Finland
Low back pain
1.8
26.4
608
4102
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4.4
26.2
67
158
B37.08
ICD-10 Finland
Other candidal stomatitis
8.5
26.2
34
41
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
26.2
393
2312
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.8
26.1
59
126
J01FA09
ATC
clarithromycin; systemic
1.9
26.0
508
3254
OAB50, ,
SPAT
2.6
26.0
160
654
WZC00, ,
SPAT
2.2
25.9
265
1355
A10AE05
ATC
insulin detemir; parenteral
3.1
25.9
111
373
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
25.8
434
2649
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.3
25.8
67
160
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
4.2
25.8
70
173
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
25.7
682
4788
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
25.7
114
391
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.5
25.5
89
263
J32.4
ICD-10 Finland
Chronic pansinusitis
5.7
25.5
48
87
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
25.3
132
495
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
51.0
25.3
30
6
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
25.2
496
3178
SPAT1211
SPAT
Application of soft bandage
2.6
25.2
164
688
R06AE09
ATC
levocetirizine; oral
2.2
25.2
257
1311
N05AH04
ATC
quetiapine; oral
2.1
25.2
306
1668
E27.8
ICD-10 Finland
Other specified disorders of adrenal gland
+∞
25.1
24
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.5
24.9
61
139
D07AC01
ATC
betamethasone; topical
1.8
24.8
570
3824
N02AC04
ATC
dextropropoxyphene; oral
3.9
24.8
75
201
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
24.6
182
810
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
28.1
24.5
33
12
XQ800
NOMESCO Finland
Prick test
2.6
24.5
152
623
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.8
24.4
55
117
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.7
24.4
79
222
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
24.3
358
2085
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
24.2
228
1125
L04AB01
ATC
etanercept; parenteral
5.6
24.2
46
84
A07EC02
ATC
mesalazine; oral, rectal
3.0
24.2
112
393
E000001, ,
ATC
2.0
24.1
330
1874
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
24.0
262
1370
H01AC01
ATC
somatropin; parenteral
+∞
24.0
23
*
A28
ICPC
Limited function/disability NOS
2.1
24.0
286
1546
UJF92
NOMESCO Finland
Capsular endoscopy
4.7
24.0
56
123
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
4.0
23.9
68
174
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
23.8
317
1782
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
7.5
23.8
34
46
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
23.7
187
856
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.4
23.6
39
62
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
23.6
162
697
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
23.5
604
4169
A04AA01
ATC
ondansetron; systemic, rectal
2.5
23.5
163
704
A01
ICPC
Pain general/multiple sites
2.3
23.5
194
906
N30.0
ICD-10 Finland
Acute cystitis
2.0
23.5
302
1677
WX725
NOMESCO Finland
Noninvasive ventilation
2.9
23.4
114
412
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.8
23.4
73
200
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
23.2
70
187
N06AB04
ATC
citalopram; systemic
1.9
23.1
336
1945
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
23.0
219
1085
106
Kela drug reimbursment
Hypoparathyroidism
+∞
23.0
22
*
M01AH01
ATC
celecoxib; oral
2.0
22.9
286
1569
E000002, ,
ATC
2.3
22.9
188
875
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
66.1
22.9
26
*
N03AX14
ATC
levetiracetam; systemic
4.0
22.8
66
171
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
5.9
22.8
41
71
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
22.7
132
523
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
22.6
243
1261
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
22.6
199
954
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
22.6
76
219
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.0
22.5
103
359
R52.9
ICD-10 Finland
Pain, unspecified
2.3
22.5
190
896
R55
ICD-10 Finland
Syncope and collapse
2.3
22.5
187
876
A01AB04
ATC
amphotericin B; local oral
3.2
22.4
93
306
R4190
NOMESCO Finland
Nutritional therapy
3.2
22.4
93
306
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.1
22.4
47
94
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.0
22.4
65
169
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.3
22.3
88
281
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.5
22.2
149
633
K50.1
ICD-10 Finland
Crohn disease of large intestine
6.7
22.2
35
53
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
22.2
541
3665
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.4
22.2
56
131
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
22.2
126
494
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
3.5
22.1
77
227
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
22.1
119
454
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
3.6
22.0
75
218
M13.9
ICD-10 Finland
Arthritis, unspecified
2.5
22.0
142
593
Z94.0
ICD-10 Finland
Kidney transplant status
8.6
21.9
28
33
E24.8
ICD-10 Finland
Other Cushing syndrome
+∞
21.9
21
*
WVA30, ,
SPAT
2.7
21.9
123
479
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.5
21.7
42
78
A10AB04
ATC
insulin lispro; parenteral
3.7
21.7
71
201
C07AB02
ATC
metoprolol; systemic
1.9
21.6
303
1728
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
21.6
173
797
WX882
NOMESCO Finland
High dependency care
3.8
21.5
67
183
N05CD07
ATC
temazepam; oral
2.3
21.5
187
891
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
21.5
142
599
TK800
NOMESCO Finland
Hemodialysis
5.4
21.4
42
79
J01AA02
ATC
doxycycline; systemic
1.9
21.4
1150
9653
N03AG01
ATC
valproic acid; systemic, rectal
2.7
21.4
119
461
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
21.4
238
1251
WX402
NOMESCO Finland
General anaesthesia
1.9
21.3
367
2237
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
21.3
470
3087
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.7
21.3
501
3352
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
21.3
214
1082
ZXE00
NOMESCO Finland
One hour or less
1.7
21.1
587
4109
A03FA02
ATC
cisapride; oral, rectal
2.6
21.1
129
524
T89
ICPC
Diabetes insulin dependent
3.2
21.1
86
280
M79.6
ICD-10 Finland
Pain in limb
1.7
21.1
692
5063
P01AB01
ATC
metronidazole; oral, rectal
1.7
21.1
621
4415
WX002
NOMESCO Finland
Sedation and analgesia
1.9
21.0
303
1743
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.0
20.9
37
63
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
20.9
175
821
102
Kela drug reimbursment
Diabetes insipidus
+∞
20.9
20
*
E25.00
ICD-10 Finland
Congenital salt-losing adrenal hyperplasia
+∞
20.9
20
*
WZA10
NOMESCO Finland
Extensive medical or dental certificate
5.3
20.9
42
81
C08CA01
ATC
amlodipine; oral
1.7
20.9
550
3792
J01FA10
ATC
azithromycin; systemic
1.7
20.9
872
6794
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.9
20.8
32
47
A10AE04
ATC
insulin glargine; parenteral
2.4
20.8
161
730
D07AA02
ATC
hydrocortisone; topical
2.1
20.7
238
1265
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.9
20.7
46
97
E23.05
ICD-10 Finland
Lack of TSH
212.9
20.6
21
*
X58
ICD-10 Finland
Exposure to other specified factors
2.0
20.6
247
1332
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
20.6
306
1777
M35.7
ICD-10 Finland
Hypermobility syndrome
5.2
20.6
42
82
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
6.6
20.5
33
51
SPAT1097
SPAT
Recording of ECG
2.1
20.5
225
1175
B01AB10
ATC
tinzaparin; parenteral
2.2
20.5
192
943
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.0
20.5
93
323
M70.6
ICD-10 Finland
Trochanteric bursitis
2.0
20.4
237
1263
J01FA15
ATC
telithromycin; oral
2.3
20.4
171
802
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
20.3
382
2389
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.8
20.1
448
2941
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.5
20.0
39
73
E83.50
ICD-10 Finland
Hypercalcemia
6.9
20.0
31
46
A12BA01
ATC
potassium chloride; oral
3.4
20.0
72
217
Z01.9
ICD-10 Finland
Special examination, unspecified
2.6
20.0
119
477
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.1
20.0
30
43
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
6.2
19.9
34
56
ZX112
NOMESCO Finland
Subcutaneous
4.1
19.9
55
138
EBA10
NOMESCO Finland
Operative extraction of tooth
2.1
19.9
207
1059
E31.00
ICD-10 Finland
APECED syndrome
+∞
19.8
19
*
E25.01
ICD-10 Finland
Congenital adrenal hyperplasia
+∞
19.8
19
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.6
19.8
66
189
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.1
19.8
86
291
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.1
19.8
42
85
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
19.8
90
313
Z71.8
ICD-10 Finland
Other specified counselling
1.7
19.7
539
3739
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
19.7
126
523
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
19.7
366
2278
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.5
19.6
69
205
UDM02
NOMESCO Finland
Sinoscopy
4.0
19.6
56
144
UKC02
NOMESCO Finland
Cystoscopy
2.0
19.6
230
1230
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
6.9
19.6
30
44
SAA04
NOMESCO Finland
Special examination of mouth
2.8
19.5
104
394
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.7
19.5
113
447
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.8
19.5
44
94
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
19.5
352
2171
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.8
19.4
60
163
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
19.3
174
840
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
19.3
167
793
N03AX11
ATC
topiramate; oral
3.8
19.3
60
164
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
19.3
389
2478
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.7
19.2
45
99
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.5
19.2
67
198
L04AB04
ATC
adalimumab; parenteral
3.9
19.1
57
151
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
7.0
19.1
29
42
R01AD09
ATC
mometasone; nasal
1.6
19.1
703
5256
H26.2
ICD-10 Finland
Complicated cataract
5.6
18.9
36
66
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.9
18.9
34
59
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.7
18.8
108
425
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
18.8
218
1159
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
18.8
417
2725
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
+∞
18.8
18
*
A07DA03
ATC
loperamide; oral
3.5
18.8
66
196
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
7.8
18.7
26
34
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.4
18.7
137
606
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
18.6
287
1681
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.3
18.6
71
222
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
192.3
18.6
19
*
L17
ICPC
Foot/toe symptom/complaint
1.7
18.5
479
3265
R01AD05
ATC
budesonide; nasal
2.4
18.4
139
623
Z00.0
ICD-10 Finland
General medical examination
1.8
18.4
307
1844
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.8
18.4
93
343
J01EA01
ATC
trimethoprim; systemic
1.7
18.3
403
2624
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.3
18.3
69
214
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.9
18.3
25
32
R06AX26
ATC
fexofenadine; oral
2.4
18.3
131
573
T99
ICPC
Endocr/metab/nutrit disease other
4.7
18.3
42
91
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
7.2
18.3
27
38
WX723
NOMESCO Finland
CPAP therapy
2.9
18.2
88
316
N30.9
ICD-10 Finland
Cystitis, unspecified
2.5
18.2
121
512
WVA20, ,
SPAT
3.0
18.2
80
273
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
18.1
133
589
R13
ICD-10 Finland
Dysphagia
2.4
18.1
127
551
B01AA03
ATC
warfarin; systemic
1.9
18.0
249
1407
B80
ICPC
Iron deficiency anaemia
3.7
18.0
57
158
L88
ICPC
Rheumatoid/seropositive arthritis
3.0
17.9
81
281
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.9
17.8
39
81
J01CA04
ATC
amoxicillin; systemic
1.8
17.8
1217
10587
E22.1
ICD-10 Finland
Hyperprolactinaemia
67.4
17.7
20
*
E27
ICD-10 Finland
Other disorders of adrenal gland
+∞
17.7
17
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.2
17.7
36
70
N06AB05
ATC
paroxetine; oral
2.6
17.7
108
438
SPAT1216
SPAT
Assessment of functional ability
1.9
17.6
234
1303
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.7
17.6
41
90
R06AX13
ATC
loratadine; oral
1.9
17.5
247
1403
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
17.5
142
656
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
17.5
312
1910
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
7.9
17.4
24
31
R03BC03
ATC
nedocromil; inhalant
2.4
17.4
122
528
T78.4
ICD-10 Finland
Allergy, unspecified
2.8
17.4
89
330
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.4
17.4
63
191
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.6
17.3
41
91
N06AA10
ATC
nortriptyline; systemic
3.9
17.3
51
134
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
17.2
66
207
N02BE01
ATC
paracetamol; systemic, rectal
2.1
17.2
1319
11815
RD210, ,
NOMESCO Finland
4.8
17.1
38
80
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
17.1
777
6053
107
Kela drug reimbursment
Pernicious anaemia
4.7
17.1
39
84
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.5
17.0
113
477
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
17.0
150
717
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.6
17.0
57
164
E000003, ,
ATC
2.9
17.0
83
300
G43.3
ICD-10 Finland
Complicated migraine
4.3
17.0
44
105
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.9
17.0
79
278
L03
ICPC
Low back symptom/complaint
1.7
17.0
464
3192
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
17.0
330
2070
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
25.9
16.9
23
9
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.5
16.9
106
436
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.5
16.9
41
93
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.7
16.9
53
146
B81
ICPC
Anaemia vit B12/folate deficiency
3.1
16.8
70
231
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
16.8
133
608
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.2
16.8
69
226
R42
ICD-10 Finland
Dizziness and giddiness
1.7
16.8
354
2271
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
16.8
165
824
V03AE01
ATC
polystyrene sulfonate; oral
6.3
16.8
28
45
A10AB01
ATC
insulin (human); parenteral
3.2
16.7
66
211
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
16.7
16
*
A02BA03
ATC
famotidine; systemic
3.3
16.7
63
196
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.8
16.7
88
332
SPAT1104
SPAT
Monitoring of emergency patient
2.5
16.6
105
433
A07EA02
ATC
hydrocortisone; rectal
4.0
16.6
47
120
K07.60
ICD-10 Finland
Snapping jaw
2.6
16.6
101
409
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
7.4
16.6
24
33
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.7
16.5
89
339
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.9
16.5
48
125
WX730
NOMESCO Finland
Conventional respirator
5.2
16.5
34
67
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
16.5
132
606
J96.1
ICD-10 Finland
Chronic respiratory failure
4.3
16.5
42
99
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
18.1
16.5
25
14
A03
ICPC
Fever
1.8
16.5
278
1670
ZY010
NOMESCO Finland
Hospital outpatient
2.6
16.5
98
393
K59.1
ICD-10 Finland
Functional diarrhoea
2.5
16.4
106
442
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
16.4
140
661
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.9
16.3
48
126
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.1
16.3
69
230
XKD00
NOMESCO Finland
Uroflowmetry
2.0
16.3
194
1039
J96.0
ICD-10 Finland
Acute respiratory failure
5.3
16.3
33
64
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
16.3
332
2107
A41.8
ICD-10 Finland
Other specified sepsis
4.3
16.3
42
100
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
16.3
125
564
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.0
16.2
75
263
D07AB08
ATC
desonide; topical
2.1
16.2
176
913
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.5
16.2
55
160
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
4.2
16.1
43
105
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
7.2
16.1
24
34
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
16.1
228
1295
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
16.1
444
3054
A55
ICPC
General and Unspecified, Local injection/infiltration
5.7
16.1
30
54
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
16.0
173
894
G44.2
ICD-10 Finland
Tension-type headache
1.9
16.0
230
1312
UDC00
NOMESCO Finland
Ear microscopy
2.3
16.0
126
575
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
15.9
231
1323
R52.1
ICD-10 Finland
Chronic intractable pain
5.8
15.9
29
51
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
5.8
15.9
29
51
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.2
15.9
62
197
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.1
15.9
151
744
-50
ICPC
Medication/prescr/renewal
2.9
15.9
76
272
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.6
15.9
93
370
M01CB01
ATC
sodium aurothiomalate; parenteral
5.3
15.8
32
62
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.8
15.8
80
295
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
5.5
15.8
30
55
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.5
15.8
30
55
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
33.8
15.7
20
6
B03XA02
ATC
darbepoetin alfa; parenteral
4.1
15.7
43
107
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.9
15.7
47
125
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.3
15.7
60
188
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.7
15.7
36
78
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.2
15.7
42
103
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
15.7
193
1046
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.1
15.6
27
45
M25.5
ICD-10 Finland
Pain in joint
1.6
15.6
516
3706
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
15.6
116
516
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
86.0
15.6
17
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.3
15.6
60
189
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
22.3
15.6
22
10
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
15.5
275
1674
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.1
15.5
42
104
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.9
15.5
34
71
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
15.5
137
656
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.5
15.4
100
418
120
Kela drug reimbursment
Hypogammaglobulinaemia
38.5
15.4
19
5
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.8
15.4
47
127
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
6.8
15.3
24
36
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
4.1
15.3
42
105
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.6
15.3
29
53
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.4
15.2
111
489
E66.8
ICD-10 Finland
Other obesity
2.4
15.2
104
445
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
15.2
89
354
D02AE01
ATC
carbamide; topical
2.4
15.2
111
490
I95.9
ICD-10 Finland
Hypotension, unspecified
4.3
15.1
39
93
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.3
15.0
25
40
R41.0
ICD-10 Finland
Disorientation, unspecified
3.3
15.0
58
183
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.7
15.0
34
73
N06AB10
ATC
escitalopram; oral
1.7
15.0
318
2037
L04AD02
ATC
tacrolimus; systemic
6.6
14.9
24
37
ZX198
NOMESCO Finland
Other local administration
6.6
14.9
24
37
A03CA02
ATC
clidinium and psycholeptics; oral
2.6
14.9
90
363
L86
ICPC
Back syndrome with radiating pain
2.4
14.9
109
481
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.5
14.9
51
149
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
14.8
170
898
K65.0
ICD-10 Finland
Acute peritonitis
6.0
14.8
26
44
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
14.8
66
227
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.5
14.8
36
82
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
14.8
127
601
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.2
14.7
39
95
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.0
14.6
41
104
OAB72
NOMESCO Finland
Weight control and weight loss guidance
5.7
14.6
27
48
M04AA01
ATC
allopurinol; systemic
2.0
14.6
173
924
E23.08
ICD-10 Finland
Hypopituitarism
+∞
14.6
14
*
E24.2
ICD-10 Finland
Drug-induced Cushing syndrome
+∞
14.6
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
14.6
63
213
J30.3
ICD-10 Finland
Other allergic rhinitis
2.7
14.5
77
291
NDG76
NOMESCO Finland
Fusion of DIP joint
5.9
14.5
26
45
L01XX23
ATC
mitotane; oral
151.4
14.5
15
*
A02BX02
ATC
sucralfate; oral
3.0
14.5
66
230
N05BE01
ATC
buspirone; oral
3.3
14.5
55
172
-44
ICPC
Preventive immunization/medic
2.2
14.5
127
606
L76
ICPC
Fracture: other
3.1
14.4
60
198
S29
ICPC
Skin symptom/complaint other
1.7
14.4
309
1981
R33
ICD-10 Finland
Retention of urine
2.3
14.4
111
501
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
12.7
14.4
25
20
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
14.4
1053
8988
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.5
14.3
49
143
R49.08
ICD-10 Finland
Other specified dysphonia
3.5
14.3
50
148
UJD02
NOMESCO Finland
Gastroscopy
2.6
14.3
81
317
N04BC06
ATC
cabergoline; oral
27.5
14.3
19
7
S01
ICPC
Pain/tenderness of skin
2.6
14.3
83
329
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
14.2
205
1170
QDB10, ,
SPAT
3.3
14.2
54
169
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
5.7
14.2
26
46
G62.8
ICD-10 Finland
Other specified polyneuropathies
5.7
14.2
26
46
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.8
14.2
73
272
SPAT1304
SPAT
Counselling and guidance related to ageing
2.3
14.1
108
486
J01DA01
ATC
[U] cefalexin
1.5
14.1
882
7247
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
6.5
14.1
23
36
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
6.5
14.1
23
36
M54.6
ICD-10 Finland
Pain in thoracic spine
2.2
14.1
130
633
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
5.5
14.0
27
50
G72.9
ICD-10 Finland
Myopathy, unspecified
5.9
14.0
25
43
N05CF02
ATC
zolpidem; oral
1.7
14.0
266
1649
C08DA01
ATC
verapamil; systemic
2.7
13.9
74
280
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
13.9
586
4419
E28.3
ICD-10 Finland
Primary ovarian failure
30.3
13.9
18
6
3028
Kela drug reimbursment
Mepolizumab
30.3
13.9
18
6
E000006, ,
ATC
2.3
13.9
114
529
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
6.1
13.9
24
40
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
13.9
206
1186
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
17.7
13.8
21
12
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.8
13.8
68
247
K29.7
ICD-10 Finland
Gastritis, unspecified
2.9
13.8
66
236
K76.9
ICD-10 Finland
Liver disease, unspecified
4.7
13.8
32
70
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.7
13.8
43
118
SPAT1252
SPAT
Overall medication plan or its review
2.3
13.8
105
472
Z2446
NOMESCO Finland
Social worker
2.2
13.8
114
531
E83.51
ICD-10 Finland
Hypocalcemia
10.6
13.7
26
25
R05CB01
ATC
acetylcysteine; inhalant, oral
5.4
13.7
27
51
R52.0
ICD-10 Finland
Acute pain
2.8
13.7
68
248
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
13.7
200
1144
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
13.7
163
871
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
6.6
13.7
22
34
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.2
13.6
53
168
XW000
NOMESCO Finland
Bone marrow biopsy
2.8
13.6
69
255
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
13.6
13
*
E23.2
ICD-10 Finland
Diabetes insipidus
+∞
13.6
13
*
R81
ICPC
Pneumonia
2.8
13.5
68
250
ZYC01, ,
SPAT
1.9
13.5
170
926
SPAT1240
SPAT
Therapeutic discussion
2.0
13.5
164
883
N05AA02
ATC
levomepromazine; systemic
2.8
13.5
69
256
E21.0
ICD-10 Finland
Primary hyperparathyroidism
16.4
13.5
21
13
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
5.3
13.5
27
52
R03BB07
ATC
umeclidinium bromide; inhalant
6.1
13.4
23
38
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.6
13.4
394
2733
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.2
13.4
114
537
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
26.0
13.4
18
7
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.4
13.4
91
389
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.7
13.3
42
116
L01BB02
ATC
mercaptopurine; oral
4.5
13.3
32
72
K50.8
ICD-10 Finland
Other Crohn disease
4.1
13.3
36
89
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.2
13.3
121
585
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.5
13.3
83
341
W19
ICD-10 Finland
Unspecified fall
2.0
13.2
152
803
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.5
13.2
83
342
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.7
13.2
71
271
OAB43, ,
SPAT
0.6
13.2
211
3366
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.9
13.1
167
913
C09CA01
ATC
losartan; oral
1.6
13.1
355
2411
K51.8
ICD-10 Finland
Other ulcerative colitis
4.1
13.1
36
90
N19
ICD-10 Finland
Unspecified kidney failure
2.9
13.1
61
215
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
13.1
89
380
XQ820
NOMESCO Finland
Exposure to medicinal substance
12.3
13.1
23
19
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
13.1
98
437
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
13.1
513
3795
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
4.6
13.1
31
69
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
4.6
13.1
31
69
RS222, ,
NOMESCO Finland
4.7
13.1
30
65
L29
ICPC
Musculoskeletal sympt/complt other
2.0
13.1
146
763
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
13.1
253
1574
M01AB55
ATC
diclofenac, combinations; oral
2.3
13.1
105
483
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.4
13.0
93
407
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.7
13.0
72
279
297, ,
Kela drug reimbursment
28.6
13.0
17
6
R49.01
ICD-10 Finland
Functional dysphonia
2.9
13.0
60
211
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.6
12.9
75
297
R06AX22
ATC
ebastine; oral
1.7
12.9
261
1643
M01AH02
ATC
rofecoxib; oral
1.9
12.9
184
1045
M03AX01
ATC
botulinum toxin; parenteral
4.8
12.9
29
62
M03BX01
ATC
baclofen; systemic
3.5
12.8
43
124
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.4
12.8
46
139
T90
ICPC
Diabetes non-insulin dependent
1.6
12.8
332
2231
F05.9
ICD-10 Finland
Delirium, unspecified
3.8
12.8
38
101
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.4
12.8
85
360
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.9
12.8
58
202
S21
ICPC
Skin texture symptom/complaint
1.8
12.7
232
1418
R4120
NOMESCO Finland
Occupational therapy
2.2
12.7
108
508
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.4
12.7
87
373
M43.1
ICD-10 Finland
Spondylolisthesis
2.6
12.7
72
282
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.9
12.7
59
208
N04BC05
ATC
pramipexole; oral
2.1
12.7
123
610
SBB10
NOMESCO Finland
Dental impressions
2.1
12.7
119
583
I50.0
ICD-10 Finland
Congestive heart failure
2.3
12.7
101
463
D86.0
ICD-10 Finland
Sarcoidosis of lung
5.0
12.7
27
55
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
4.8
12.6
28
59
N06AX18
ATC
reboxetine; oral
4.7
12.6
29
63
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
3.0
12.6
55
187
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.0
12.6
22
37
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
6.0
12.6
22
37
R03DX10
ATC
benralizumab; systemic
70.5
12.6
14
*
3027
Kela drug reimbursment
Benralizumab
70.5
12.6
14
*
M05BA06
ATC
ibandronic acid; systemic
3.6
12.6
41
116
V04CD01
ATC
metyrapone; oral
+∞
12.5
12
*
E31.08
ICD-10 Finland
Autoimmune polyglandular failure
+∞
12.5
12
*
J01CF05
ATC
flucloxacillin; systemic
2.1
12.5
118
579
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
12.5
98
446
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.3
12.4
21
16
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.5
12.4
30
68
P03
ICPC
Feeling depressed
1.9
12.4
160
879
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.7
12.4
68
262
N06AB03
ATC
fluoxetine; oral
1.8
12.4
191
1111
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.1
12.3
50
163
H3601, E103,
ICD-10 Finland
5.9
12.3
22
38
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
5.9
12.3
22
38
K90.0
ICD-10 Finland
Coeliac disease
3.0
12.3
55
190
RD211, ,
NOMESCO Finland
2.6
12.3
73
293
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
12.2
54
185
A01AB10
ATC
natamycin; local oral
3.1
12.2
51
169
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.7
12.2
68
264
J20
ICD-10 Finland
Acute bronchitis
1.9
12.2
164
913
SPAT1360
SPAT
Extensive global examination
2.2
12.2
100
464
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
4.4
12.2
30
69
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.4
12.2
85
368
NHQ40
NOMESCO Finland
Amputation of toe
4.5
12.2
29
65
D07AD01
ATC
clobetasol; topical
1.7
12.1
252
1596
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
16.0
12.1
19
12
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.9
12.1
35
91
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.1
12.1
51
170
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.2
12.1
32
78
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.2
12.1
32
78
R1250
NOMESCO Finland
Evaluation of functional capability
3.1
12.1
50
165
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.6
12.1
294
1942
R03DX09
ATC
mepolizumab; parenteral
26.9
12.1
16
6
A10AE06
ATC
insulin degludec; parenteral
2.7
12.0
67
260
R06AX27
ATC
desloratadine; oral
1.5
12.0
436
3160
M79.1
ICD-10 Finland
Myalgia
1.7
12.0
237
1480
R01AD11
ATC
triamcinolone; nasal
2.0
12.0
136
714
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.2
12.0
48
155
S19
ICPC
Skin injury other
2.6
12.0
71
284
R01AD12
ATC
fluticasone furoate; nasal
1.5
12.0
466
3427
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
12.0
167
940
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.1
12.0
23
23
K59.0
ICD-10 Finland
Constipation
2.3
12.0
94
428
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
5.7
12.0
22
39
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
5.1
12.0
25
50
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.3
12.0
44
135
M54.1
ICD-10 Finland
Radiculopathy
2.6
12.0
67
261
D11
ICPC
Diarrhoea
1.8
12.0
187
1092
C01DA14
ATC
isosorbide mononitrate; oral
1.8
11.9
192
1131
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.7
11.9
38
106
R4110, ,
SPAT
1.8
11.9
207
1247
D07AC13
ATC
mometasone; topical
1.5
11.9
412
2954
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.6
11.9
28
62
D84.18
ICD-10 Finland
Other specified defect in the complement system
47.1
11.9
14
*
XQ802
NOMESCO Finland
Epicutan test
2.5
11.9
73
298
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
5.4
11.8
23
43
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.4
11.8
23
43
N05BA12
ATC
alprazolam; oral
1.9
11.8
151
828
I45.9
ICD-10 Finland
Conduction disorder, unspecified
5.2
11.8
24
47
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
3.2
11.7
45
142
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.1
11.7
118
594
R05
ICD-10 Finland
Cough
1.6
11.7
325
2215
N06AX26
ATC
vortioxetine; oral
2.0
11.7
122
622
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.6
11.7
68
270
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.9
11.7
56
201
B34.9
ICD-10 Finland
Viral infection, unspecified
2.9
11.7
54
190
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
11.6
192
1139
D02AX
ATC
Other emollients and protectives
2.7
11.6
60
224
251, ,
Kela drug reimbursment
65.5
11.6
13
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.5
11.6
71
289
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
11.2
11.5
21
19
J05AB01
ATC
aciclovir; systemic
1.6
11.5
324
2213
PAW37
NOMESCO Finland
Biopsy of temporal artery
8.7
11.5
24
28
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
11.5
326
2231
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
4.0
11.5
32
81
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.1
11.5
47
154
L52
ICD-10 Finland
Erythema nodosum
5.7
11.5
21
37
E23.06
ICD-10 Finland
Empty sella
+∞
11.5
11
*
E25.0
ICD-10 Finland
Congenital adrenogenital disorders associated with enzyme deficiency
+∞
11.5
11
*
301
Kela drug reimbursment
Growth hormone
+∞
11.5
11
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.7
11.4
26
56
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
4.7
11.4
26
56
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
11.4
111
551
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
11.4
163
925
S81.0
ICD-10 Finland
Open wound of knee
3.7
11.4
36
100
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
11.4
99
471
XQ848
NOMESCO Finland
Dermatological photography
2.9
11.4
52
182
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.9
11.3
142
772
WX720
NOMESCO Finland
Own respiration
2.3
11.3
83
367
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.8
11.3
58
216
N06AA12
ATC
doxepin; systemic
2.4
11.3
81
355
BC1AD
NOMESCO Finland
CT of adrenal glands
5.2
11.3
23
45
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
9.7
11.3
22
23
R01AD58
ATC
fluticasone, combinations; nasal
1.6
11.2
369
2611
SBA00
NOMESCO Finland
Microbiological examinations
3.1
11.2
46
151
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
11.2
58
217
D68.8
ICD-10 Finland
Other specified coagulation defects
4.8
11.2
25
53
AN1
HP
Coronary angiography
1.9
11.2
141
768
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.7
11.2
59
223
UJG02
NOMESCO Finland
Proctoscopy
3.4
11.1
39
116
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.4
11.1
40
121
J01DA09
ATC
[U] cefadroxil
1.5
11.1
370
2624
K92.1
ICD-10 Finland
Melaena
2.4
11.1
80
351
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
11.1
266
1747
A08
ICPC
Swelling
2.2
11.1
95
449
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
5.3
11.1
22
42
A29
ICPC
General symptom/complaint other
1.7
11.1
204
1249
L60.0
ICD-10 Finland
Ingrowing nail
2.3
11.1
83
371
S22.3
ICD-10 Finland
Fracture of rib
2.1
11.1
110
551
A06AH03
ATC
naloxegol; oral
4.0
11.0
31
79
TQW40
NOMESCO Finland
Remowal of suture of skin
2.1
11.0
107
531
H3603, E103,
ICD-10 Finland
5.8
11.0
20
35
S01XA18
ATC
ciclosporin; ophthalmic
5.1
11.0
23
46
D72.1
ICD-10 Finland
Eosinophilia
10.1
11.0
21
21
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
11.0
318
2184
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.4
11.0
27
62
N18.8
ICD-10 Finland
Other chronic renal failure
3.7
11.0
34
93
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
4.5
11.0
26
58
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
4.1
11.0
30
75
C07AA05
ATC
propranolol; systemic
1.6
11.0
292
1967
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.6
10.9
63
249
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
10.9
44
143
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.6
10.9
36
103
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.6
10.9
36
103
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
5.4
10.9
21
39
I95.1
ICD-10 Finland
Orthostatic hypotension
2.6
10.9
61
238
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.5
10.9
69
286
B01AF02
ATC
apixaban; oral
1.8
10.8
183
1093
N03AF02
ATC
oxcarbazepine; oral
2.8
10.8
55
204
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.6
10.8
35
99
C09CA06
ATC
candesartan; oral
1.6
10.8
345
2424
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.5
10.7
37
109
A11CC02
ATC
dihydrotachysterol; oral
28.2
10.7
14
5
M10.9
ICD-10 Finland
Gout, unspecified
2.2
10.7
95
455
L29.9
ICD-10 Finland
Pruritus, unspecified
2.8
10.7
52
188
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
3.9
10.7
31
81
RS221, ,
NOMESCO Finland
3.9
10.7
31
81
N02AJ13
ATC
tramadol and paracetamol; systemic
3.1
10.6
43
140
N06AG02
ATC
moclobemide; oral
2.4
10.6
70
295
L16
ICPC
Ankle symptom/complaint
1.7
10.6
188
1137
Z08
ICPC
Social welfare problem
4.2
10.6
28
68
J37.0
ICD-10 Finland
Chronic laryngitis
2.6
10.6
59
229
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
60.4
10.6
12
*
ZZA00
NOMESCO Finland
Split skin graft
2.9
10.6
48
167
A02BA04
ATC
nizatidine; systemic
2.1
10.6
107
539
WYA10
NOMESCO Finland
Emergency care or similar visit
2.0
10.6
117
609
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.4
10.6
37
110
J01CA08
ATC
pivmecillinam; oral
1.5
10.6
592
4658
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
4.3
10.6
27
64
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
10.6
290
1966
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
11.3
10.6
19
17
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.3
10.6
19
17
D09
ICPC
Nausea
2.3
10.5
79
353
K86.2
ICD-10 Finland
Cyst of pancreas
4.9
10.5
23
48
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.2
10.5
88
413
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
110.8
10.4
11
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
+∞
10.4
10
*
SPAT1125
SPAT
Stoma care and guidance
3.9
10.4
30
78
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
3.9
10.4
30
78
K51.5
ICD-10 Finland
Left sided colitis
2.8
10.4
50
180
XKC03
NOMESCO Finland
Water cystometry
2.8
10.4
50
180
R03BC01
ATC
cromoglicic acid; inhalant
3.6
10.4
33
92
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
4.2
10.4
27
65
ZX120, ,
SPAT
4.2
10.4
27
65
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.4
10.4
71
305
N06AX03
ATC
mianserin; oral
2.3
10.4
77
343
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
10.4
806
6730
R06.4
ICD-10 Finland
Hyperventilation
3.8
10.3
31
83
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
4.0
10.3
29
74
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
4.0
10.3
29
74
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.2
10.3
40
127
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.5
10.3
35
102
R04.0
ICD-10 Finland
Epistaxis
2.0
10.3
109
559
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.4
10.3
25
57
M81.8
ICD-10 Finland
Other osteoporosis
4.9
10.3
22
45
B35.3
ICD-10 Finland
Tinea pedis
2.4
10.2
72
313
WX780
NOMESCO Finland
Remote monitoring CPAP
2.3
10.2
75
332
C08CA05
ATC
nifedipine; systemic
2.2
10.2
83
384
ZXC95
NOMESCO Finland
Use of surgical navigator
4.1
10.2
27
66
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.3
10.2
37
113
QXB99, ,
SPAT
2.8
10.2
51
188
Z50.1
ICD-10 Finland
Other physical therapy
2.2
10.2
83
385
R05
ICPC
Cough
1.5
10.1
365
2627
N03AX18
ATC
lacosamide; systemic
5.3
10.1
20
38
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
5.3
10.1
20
38
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.3
10.1
20
38
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
10.1
93
453
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
4.0
10.1
28
71
137
Kela drug reimbursment
Uraemia requiring dialysis
8.5
10.1
21
25
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
8.5
10.1
21
25
R5110, ,
SPAT
1.9
10.0
132
729
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
10.0
69
297
J05AB11
ATC
valaciclovir; oral
1.7
10.0
215
1370
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.4
10.0
66
279
C08CA02
ATC
felodipine; oral
1.9
10.0
123
665
JFH10
NOMESCO Finland
Total colectomy and ileostomy
40.3
10.0
12
*
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.2
10.0
83
388
Z3226
NOMESCO Finland
Physiotherapist
1.6
10.0
253
1682
L99
ICPC
Musculoskeletal disease other
3.0
9.9
43
146
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.8
9.9
49
179
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.5
9.9
33
95
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
9.9
170
1019
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.8
9.9
30
81
SCA02
NOMESCO Finland
Preventive oral health care
1.8
9.9
162
958
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.4
9.9
35
105
N06AX22
ATC
agomelatine; oral
3.0
9.9
44
152
A10AA01, ,
ATC
3.0
9.9
44
152
J01DA08
ATC
[U] cefaclor
1.8
9.8
148
853
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
4.4
9.8
24
55
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
4.9
9.8
21
43
ZXA05
NOMESCO Finland
Left side
1.5
9.8
317
2228
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
10.7
9.8
18
17
RJ410, ,
NOMESCO Finland
10.7
9.8
18
17
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.7
9.8
22
47
SPAT1202
SPAT
Intra-articular injection
2.8
9.8
48
175
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
9.6
9.8
19
20
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
9.6
9.8
19
20
XF404
NOMESCO Finland
Ambulatory ECG
1.9
9.8
118
634
SPAT1131
SPAT
Colonoscopy
2.7
9.7
53
204
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
9.7
158
932
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.8
9.7
47
170
C10AX09
ATC
ezetimibe; oral
1.6
9.7
225
1462
D01
ICPC
Abdominal pain/cramps general
1.7
9.7
185
1142
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
9.7
206
1309
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.6
9.7
31
87
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.1
9.7
39
127
L13
ICPC
Hip symptom/complaint
1.6
9.7
276
1885
197
Kela drug reimbursment
Sunitinib
13.5
9.7
16
12
N97.0
ICD-10 Finland
Female infertility associated with anovulation
4.2
9.7
25
60
B37.0
ICD-10 Finland
Candidal stomatitis
4.2
9.7
25
60
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
5.3
9.6
19
36
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.9
9.6
115
615
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
9.6
37
117
N03AF01
ATC
carbamazepine; oral, rectal
2.2
9.6
78
361
J01DC02
ATC
cefuroxime; systemic
2.2
9.6
83
394
TPH04, ,
SPAT
4.3
9.6
24
56
XA402
NOMESCO Finland
ENMG
2.9
9.6
43
149
F34.1
ICD-10 Finland
Dysthymia
2.4
9.6
63
266
XX1VW
NOMESCO Finland
Written report from radiologist
4.8
9.5
21
44
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.1
9.5
38
123
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
3.6
9.5
31
88
C08CA13
ATC
lercanidipine; oral
1.7
9.5
197
1243
M01AX01
ATC
nabumetone; oral
2.4
9.4
65
280
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.9
9.4
27
70
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
100.7
9.4
10
*
R68.2
ICD-10 Finland
Dry mouth, unspecified
7.6
9.4
21
28
R06.2
ICD-10 Finland
Wheezing
2.3
9.4
72
325
S20.2
ICD-10 Finland
Contusion of thorax
2.2
9.4
79
371
2581B
ICD-9 Finland
Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]
+∞
9.4
9
*
NG1DA
NOMESCO Finland
X-ray of knees
3.2
9.4
37
119
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.5
9.4
59
244
DPA30
NOMESCO Finland
Sphenotomy
5.2
9.4
19
37
K12.18
ICD-10 Finland
Other forms of stomatitis
5.2
9.4
19
37
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.2
9.4
80
378
SPAT1139
SPAT
Nutrition survey
2.6
9.4
54
214
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
9.4
342
2464
WVA20
NOMESCO Finland
Medicine administration
2.7
9.3
49
185
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.5
9.3
32
94
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
8.1
9.3
20
25
K83.0
ICD-10 Finland
Cholangitis
4.0
9.3
26
66
K30
ICD-10 Finland
Functional dyspepsia
1.7
9.3
168
1021
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
4.5
9.3
22
49
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.1
9.3
39
130
WX872
NOMESCO Finland
Intensive care
2.3
9.3
70
314
J01FA01
ATC
erythromycin; systemic
1.7
9.3
190
1196
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.9
9.2
27
71
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.2
9.2
36
115
L20
ICPC
Joint symptom/complaint NOS
2.4
9.2
64
277
R06.5
ICD-10 Finland
Mouth breathing
1.9
9.2
127
714
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.1
9.1
37
121
JF1AD
NOMESCO Finland
Small bowel CT
5.1
9.1
19
38
F40.2
ICD-10 Finland
Specific (isolated) phobias
5.1
9.1
19
38
R40.2
ICD-10 Finland
Coma, unspecified
5.1
9.1
19
38
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.4
9.1
61
260
N29
ICPC
Neurological sympt/complt other
3.2
9.1
35
111
S76
ICPC
Skin infection other
2.2
9.1
80
383
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.7
9.1
49
188
HAHOM, ,
NOMESCO Finland
4.0
9.1
25
63
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
11.5
9.1
16
14
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
3.4
9.1
32
96
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
9.1
183
1147
RS142, ,
NOMESCO Finland
15.7
9.0
14
9
Z49.2
ICD-10 Finland
Other dialysis
9.1
9.0
18
20
Z01.2
ICD-10 Finland
Dental examination
1.4
9.0
659
5393
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
4.1
9.0
24
59
ZXA00
NOMESCO Finland
Right side
1.5
9.0
342
2483
B01AC04
ATC
clopidogrel; oral
1.6
8.9
203
1311
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
18.7
8.9
13
7
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
18.7
8.9
13
7
N05CD02
ATC
nitrazepam; oral
3.4
8.9
31
92
NF1DA
NOMESCO Finland
X-ray of hips
3.0
8.9
38
128
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
24.2
8.9
12
5
N06AX12
ATC
bupropion; oral
1.9
8.9
108
581
UJK02
NOMESCO Finland
ERCP
2.9
8.9
42
150
Z93
ICD-10 Finland
Artificial opening status
12.6
8.9
15
12
B01AB04
ATC
dalteparin; parenteral
2.2
8.9
73
340
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.0
8.9
19
24
D01AE15
ATC
terbinafine; topical
2.0
8.8
98
511
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
4.5
8.8
21
47
N18.0
ICD-10 Finland
End-stage renal disease
6.9
8.8
21
31
205
Kela drug reimbursment
Chronic hypertension
1.5
8.8
311
2220
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.1
8.8
85
421
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.2
8.8
34
108
G44.0
ICD-10 Finland
Cluster headache syndrome
4.0
8.8
24
60
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.5
8.8
56
233
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.4
8.8
61
264
M01AE51
ATC
ibuprofen, combinations; systemic
3.7
8.7
27
74
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
3.1
8.7
36
119
K02.1
ICD-10 Finland
Caries of dentine
1.4
8.7
822
7004
M03BX02
ATC
tizanidine; oral
1.4
8.7
865
7434
M02AA10
ATC
ketoprofen; topical
1.6
8.7
211
1384
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
8.7
74
349
SPAT1234
SPAT
Support of social functional capacity
2.2
8.7
74
349
JAH01
NOMESCO Finland
Laparoscopy
2.2
8.7
72
336
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.5
8.7
54
222
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
14.1
8.7
14
10
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
8.7
135
786
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
50.3
8.7
10
*
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.0
8.7
96
501
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
8.7
122
2045
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.3
8.7
61
266
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
7.7
8.6
19
25
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
7.7
8.6
19
25
M54.3
ICD-10 Finland
Sciatica
2.0
8.6
91
466
WX704
NOMESCO Finland
Intubation
1.9
8.6
115
638
R1250, ,
SPAT
2.5
8.6
54
223
N17.8
ICD-10 Finland
Other acute renal failure
4.0
8.6
24
61
E66.00
ICD-10 Finland
Metabolic syndrome
2.1
8.6
86
432
L50.9
ICD-10 Finland
Urticaria, unspecified
2.3
8.6
62
273
K93
ICPC
Pulmonary embolism
4.6
8.6
20
44
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
4.6
8.6
20
44
R07.3
ICD-10 Finland
Other chest pain
1.7
8.6
155
942
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.0
8.6
38
131
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.4
8.6
57
242
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.9
8.6
105
567
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
7.0
8.6
20
29
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.5
8.5
53
218
J02AC02
ATC
itraconazole; systemic
1.6
8.5
241
1639
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
9.0
8.5
17
19
M05BA01
ATC
etidronic acid; systemic
9.0
8.5
17
19
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.1
8.5
23
57
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.1
8.5
23
57
K20
ICD-10 Finland
Oesophagitis
3.3
8.5
31
95
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.8
8.5
119
671
JAH00
NOMESCO Finland
Laparotomy
2.7
8.5
46
177
S06.0
ICD-10 Finland
Concussion
1.7
8.5
157
961
ND2CG
NOMESCO Finland
Extensive MRI of hand
20.1
8.5
12
6
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
20.1
8.5
12
6
L50.3
ICD-10 Finland
Dermatographic urticaria
3.1
8.5
35
116
XCK00
NOMESCO Finland
Perimetry
2.1
8.4
81
401
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
3.9
8.4
24
62
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
90.6
8.4
9
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
8.4
78
381
H26.02
ICD-10 Finland
Presenil cataract
2.8
8.4
42
155
N06AB06
ATC
sertraline; oral
1.7
8.4
170
1066
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.2
8.4
32
101
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.9
8.4
18
37
N02CC03
ATC
zolmitriptan; nasal, oral
2.0
8.4
85
430
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
8.4
109
601
2554X
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[HYPOFUNCTIO CORTICOADRENALIS ALIA]
+∞
8.3
8
*
2533
FHL
Unilateral removal of additional egg
+∞
8.3
8
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
8.3
8
*
E31.0
ICD-10 Finland
Autoimmune polyglandular failure
+∞
8.3
8
*
25800
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Cushing's syndrome
+∞
8.3
8
*
A12AA06
ATC
calcium lactate gluconate; oral
+∞
8.3
8
*
E23.3
ICD-10 Finland
Hypothalamic dysfunction, not elsewhere classified
+∞
8.3
8
*
WX212
NOMESCO Finland
Femoral plexus blockade
2.8
8.3
41
150
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
8.3
244
1673
WX308
NOMESCO Finland
Sacral anesthesy
8.6
8.3
17
20
R30.0
ICD-10 Finland
Dysuria
2.2
8.3
72
343
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
9.5
8.3
16
17
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
8.3
1017
9021
P76
ICPC
Depressive disorder
1.9
8.3
101
545
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.6
8.3
27
77
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
7.1
8.3
19
27
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
8.3
32
102
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.2
8.3
32
102
R09
ICPC
Sinus symptom/complaint
1.8
8.2
124
715
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
8.2
102
553
-54
ICPC
Repair/fix-suture/cast/prosth device
3.0
8.2
35
118
H02AB02
ATC
dexamethasone; systemic
1.7
8.2
158
977
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.5
8.2
52
216
QDA10
NOMESCO Finland
Incision of skin of lower limb
6.5
8.2
20
31
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
6.5
8.2
20
31
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
8.2
75
365
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
8.2
942
8256
Z2445
NOMESCO Finland
Psychologist
2.3
8.1
60
267
L50.0
ICD-10 Finland
Allergic urticaria
2.6
8.1
45
175
JG1JB
NOMESCO Finland
Defekography with X-ray
4.6
8.1
19
42
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
4.6
8.1
19
42
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.2
8.1
31
98
H57.1
ICD-10 Finland
Ocular pain
2.2
8.1
65
300
N02AA01
ATC
morphine; systemic, rectal
3.3
8.1
30
93
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.2
8.1
70
333
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.2
8.1
17
21
L26
ICD-10 Finland
Exfoliative dermatitis
17.3
8.1
12
7
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
8.1
338
2495
A02BC04
ATC
rabeprazole; oral
1.8
8.0
132
781
L04AC07
ATC
tocilizumab; parenteral
10.1
8.0
15
15
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.1
8.0
74
361
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.1
8.0
74
361
E000007, ,
ATC
2.0
8.0
82
416
N05AB04
ATC
prochlorperazine; systemic, rectal
3.1
8.0
32
104
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
3.9
8.0
23
60
-1, ,
NOMESCO Finland
1.4
8.0
455
3551
XX2RW, ,
NOMESCO Finland
3.5
8.0
27
79
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
7.9
124
723
G03DB01
ATC
dydrogesterone; oral
1.6
7.9
175
1122
J01DA06
ATC
[U] cefuroxime
1.6
7.9
192
1260
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.4
7.9
51
214
H3600, E103,
ICD-10 Finland
4.0
7.9
22
56
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.6
7.9
19
29
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
6.6
7.9
19
29
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.8
7.9
37
132
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
13.1
7.9
13
10
ZXD00
NOMESCO Finland
Emergency procedure
2.6
7.9
45
178
R01AC01
ATC
cromoglicic acid; nasal
2.2
7.9
62
284
L14
ICPC
Leg/thigh symptom/complaint
1.8
7.9
120
695
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.0
7.9
87
454
B03XA01
ATC
erythropoietin; parenteral
6.1
7.9
20
33
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
6.1
7.9
20
33
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
6.1
7.9
20
33
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
7.8
56
246
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
3.4
7.8
27
80
ZX100
NOMESCO Finland
Oral
3.4
7.8
27
80
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.4
7.8
50
209
XF402
NOMESCO Finland
ECG with work load test
1.7
7.8
135
811
N05AH03
ATC
olanzapine; systemic
1.9
7.8
93
498
XG466
NOMESCO Finland
Sleep oxymetry
2.6
7.8
45
179
R75
ICPC
Sinusitis acute/chronic
2.1
7.8
76
379
OAB42
NOMESCO Finland
Guidance related to known health problem
9.5
7.8
15
16
M89.0
ICD-10 Finland
Algoneurodystrophy
4.2
7.7
20
48
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.0
7.7
34
117
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
2.9
7.7
36
128
J05AH02
ATC
oseltamivir; oral
6.4
7.7
19
30
R61.9
ICD-10 Finland
Hyperhidrosis, unspecified
3.6
7.7
25
71
R15
ICD-10 Finland
Faecal incontinence
2.5
7.7
46
186
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.2
7.7
30
96
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
7.7
56
248
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
4.4
7.7
19
44
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.7
7.7
153
955
G03DC03
ATC
lynestrenol; oral
2.8
7.7
37
134
K22.1
ICD-10 Finland
Ulcer of oesophagus
3.4
7.7
27
81
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
7.7
84
437
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
7.7
82
423
T28
ICPC
Limited function/disability (T)
4.5
7.7
18
40
N06AX05
ATC
trazodone; oral
2.6
7.6
42
163
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.0
7.6
32
107
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.0
7.6
32
107
M01AG01
ATC
mefenamic acid; oral
2.5
7.6
45
181
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
2.9
7.6
34
118
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
7.6
752
6399
RJ630, ,
NOMESCO Finland
18.5
7.6
11
6
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
11.9
7.6
13
11
J01GB01
ATC
tobramycin; inhalant, parenteral
25.1
7.6
10
*
L12
ICPC
Hand/finger symptom/complaint
1.5
7.6
250
1757
F61.0
ICD-10 Finland
Mixed personality disorders
3.2
7.6
29
92
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.5
7.5
47
194
D99
ICPC
Disease digestive system other
4.1
7.5
20
49
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.3
7.5
28
87
XG405
NOMESCO Finland
Education on PEF monitoring
3.3
7.5
28
87
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
10.1
7.5
14
14
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
10.1
7.5
14
14
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
7.5
126
750
G04CA02
ATC
tamsulosin; oral
1.5
7.5
236
1641
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
7.5
106
600
K11.2
ICD-10 Finland
Sialoadenitis
2.4
7.5
49
207
K81.9
ICD-10 Finland
Cholecystitis, unspecified
4.3
7.5
19
45
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.8
7.5
37
136
130
Kela drug reimbursment
Malignant tumour
1.8
7.5
109
623
H53.2
ICD-10 Finland
Diplopia
2.3
7.5
52
226
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
2.9
7.5
33
114
D06
ICPC
Abdominal pain localized other
1.7
7.5
123
729
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.9
7.4
21
54
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.9
7.4
21
54
A10BK03
ATC
empagliflozin; oral
1.7
7.4
140
861
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.2
7.4
60
278
R03DX11
ATC
tezepelumab; systemic
80.5
7.4
8
*
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
80.5
7.4
8
*
C05AA08
ATC
fluocortolone; rectal, topical
1.6
7.4
174
1132
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.5
7.4
25
73
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.1
7.4
71
352
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.4
7.4
47
196
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
7.7
7.4
16
21
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
13.4
7.4
12
9
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.0
7.4
19
32
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
6.0
7.4
19
32
K08.3
ICD-10 Finland
Retained dental root
1.8
7.4
108
618
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
7.4
145
902
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.9
7.3
91
494
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
7.3
112
649
R74
ICPC
Upper respiratory infection acute
1.4
7.3
465
3684
K07
ICPC
Swollen ankles/oedema
2.1
7.3
68
333
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
8.4
7.3
15
18
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.3
7.3
51
222
K13.78
ICD-10 Finland
Other change in the oral mucosa
2.6
7.3
41
161
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
3.0
7.3
32
110
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
10.9
7.3
13
12
256, ,
Kela drug reimbursment
10.9
7.3
13
12
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
7.3
363
2759
E24.1
ICD-10 Finland
Nelson syndrome
+∞
7.3
7
*
E24.3
ICD-10 Finland
Ectopic ACTH syndrome
+∞
7.3
7
*
2552A
ICD-9 Finland
Disorders of adrenal glands, Adrenogenital disorders[SYNDROMA ADRENOGENITALE CONGENITUM]
+∞
7.3
7
*
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
7.3
7
*
BCA40
NOMESCO Finland
Bilateral adrenalectomy
+∞
7.3
7
*
M45
ICD-10 Finland
Ankylosing spondylitis
2.7
7.3
37
138
NH1AD
NOMESCO Finland
Ankle and foot CT
2.7
7.3
37
138
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
4.2
7.3
19
46
G72.8
ICD-10 Finland
Other specified myopathies
3.3
7.3
27
84
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.3
7.3
27
84
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.9
7.3
21
55
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.4
7.3
25
74
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.8
7.3
35
127
H53.4
ICD-10 Finland
Visual field defects
2.9
7.2
33
116
159
Kela drug reimbursment
Pazopanib
15.8
7.2
11
7
L88
ICD-10 Finland
Pyoderma gangrenosum
15.8
7.2
11
7
U05
ICPC
Urination problems other
2.0
7.2
73
369
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.4
7.2
46
192
ED1AA
NOMESCO Finland
Mandibular X-ray examination
5.8
7.2
19
33
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.5
7.2
45
186
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.5
7.2
42
168
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.5
7.2
42
168
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.5
7.2
43
174
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
4.5
7.2
17
38
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
4.5
7.2
17
38
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
4.5
7.2
17
38
H16.0
ICD-10 Finland
Corneal ulcer
2.0
7.2
75
384
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
7.1
70
350
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.9
7.1
33
117
Z51.5
ICD-10 Finland
Palliative care
1.8
7.1
111
647
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
3.5
7.1
24
70
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.5
7.1
43
175
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.1
7.1
66
323
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
7.1
87
470
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.6
7.1
108
1780
M02AA07
ATC
piroxicam; topical
1.4
7.1
451
3570
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
8.0
7.1
15
19
B05DB
ATC
Hypertonic solutions
8.0
7.1
15
19
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
3.0
7.1
30
101
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
4.1
7.1
19
47
ZZH40
NOMESCO Finland
Substitute of bone
4.1
7.1
19
47
Z94.4
ICD-10 Finland
Liver transplant status
12.1
7.1
12
10
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.9
7.1
32
112
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
6.1
7.1
18
30
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
10.1
7.0
13
13
H26.4
ICD-10 Finland
After-cataract
1.7
7.0
128
780
J01CF02
ATC
cloxacillin; systemic
2.9
7.0
31
107
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.1
7.0
28
91
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
4.2
7.0
18
43
K80.4
ICD-10 Finland
Calculus of bile duct with cholecystitis
4.2
7.0
18
43
N06AA04
ATC
clomipramine; systemic
3.2
7.0
27
86
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
7.0
7.0
16
23
R04
ICPC
Breathing problem other
2.2
7.0
60
285
J01DC04
ATC
cefaclor; oral
3.2
7.0
26
81
WX204
NOMESCO Finland
Axillary plexus blockaced
2.3
7.0
52
233
S06
ICPC
Rash localized
2.0
7.0
77
402
J33.0
ICD-10 Finland
Polyp of nasal cavity
2.5
7.0
43
177
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.4
7.0
17
39
J12.8
ICD-10 Finland
Other viral pneumonia
4.4
7.0
17
39
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
4.4
7.0
17
39
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
7.0
344
2609
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
6.4
6.9
17
27
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.7
6.9
21
57
N02CD03
ATC
fremanezumab; systemic
3.7
6.9
21
57
J01XX08
ATC
linezolid; systemic
5.9
6.9
18
31
WX702
NOMESCO Finland
Supraglottic ventilation device
1.9
6.9
83
446
ZXC50
NOMESCO Finland
Cryotherapy
2.4
6.9
44
184
J33.8
ICD-10 Finland
Other polyp of sinus
2.8
6.9
34
125
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.4
6.9
47
203
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.6
6.9
153
983
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.2
6.9
26
82
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
6.8
316
2367
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.3
6.8
25
77
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
3.3
6.8
25
77
W10
ICD-10 Finland
Fall on and from stairs and steps
1.9
6.8
79
419
SFA10
NOMESCO Finland
One-surface restoration
1.3
6.8
753
6471
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.4
6.8
45
191
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.8
153
2293
TPX15
NOMESCO Finland
Removal of vascular injection port
8.3
6.8
14
17
G04BD04
ATC
oxybutynin; oral, transdermal
2.0
6.8
73
377
Z11
ICPC
Compliance/being ill problem
4.1
6.8
18
44
A02BB01
ATC
misoprostol; oral
6.7
6.8
16
24
A10BH01
ATC
sitagliptin; oral
1.7
6.8
117
702
NDG71
NOMESCO Finland
Arthrodes of first MP joint
11.0
6.8
12
11
KAC00
NOMESCO Finland
Nephrectomy
11.0
6.8
12
11
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
11.0
6.8
12
11
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.0
6.8
68
343
R5130, ,
SPAT
9.4
6.8
13
14
KAC10
NOMESCO Finland
Total nephrectomy with capsule
6.1
6.8
17
28
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.8
6.8
32
115
SPAT1057
SPAT
Peak expiratory flow measurement
2.7
6.8
35
132
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.9
6.8
30
104
R5599
NOMESCO Finland
Other rehabilitation service
2.4
6.8
45
192
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
4.3
6.8
17
40
R4110
NOMESCO Finland
Physiotherapy
1.4
6.8
365
2810
SFA30
NOMESCO Finland
Three-surface restoration
1.3
6.7
564
4654
XJH00
NOMESCO Finland
Transanal ultrasonography
2.1
6.7
63
310
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
2.2
6.7
54
250
L08
ICPC
Shoulder symptom/complaint
1.4
6.7
317
2383
SXC05
NOMESCO Finland
Other oral or dental procedure
1.8
6.7
103
598
SPAT1151
SPAT
Treatment of major wounds
3.9
6.7
19
49
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.5
6.7
40
162
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
3.0
6.7
29
99
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.9
6.7
31
110
R4120, ,
SPAT
3.3
6.7
24
73
R4180, ,
SPAT
3.3
6.7
24
73
L30.3
ICD-10 Finland
Infective dermatitis
2.2
6.7
53
244
A10AA02, ,
ATC
2.4
6.7
45
193
L18
ICPC
Muscle pain
2.1
6.7
62
304
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
6.7
218
1527
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.7
6.6
20
54
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.7
6.6
20
54
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
6.5
6.6
16
25
S41.1
ICD-10 Finland
Open wound of upper arm
6.5
6.6
16
25
L04AC05
ATC
ustekinumab; parenteral
6.5
6.6
16
25
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.1
6.6
27
89
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.5
6.6
39
157
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.6
6.6
137
864
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
6.6
624
5235
J15.8
ICD-10 Finland
Other bacterial pneumonia
5.9
6.6
17
29
D09AB01
ATC
zinc bandage without supplements; topical
2.9
6.6
29
100
JFB00
NOMESCO Finland
Partial resection of small intestine
3.6
6.6
21
59
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.6
6.6
21
59
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.0
6.6
67
340
L01XE04
ATC
[U] sunitinib
12.3
6.6
11
9
Z56.5
ICD-10 Finland
Uncongenial work
12.3
6.6
11
9
-56
ICPC
Dressing/pressure/compress/tamponade
3.2
6.6
25
79
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.4
6.6
42
176
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.4
6.6
36
831
NC2AA
NOMESCO Finland
Forearm X-ray examination
3.0
6.6
28
95
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
8.7
6.6
13
15
K63.5
ICD-10 Finland
Polyp of colon
2.6
6.6
37
146
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
6.5
81
440
EMAK, ,
NOMESCO Finland
2.2
6.5
54
253
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
6.5
99
573
J01
ICD-10 Finland
Acute sinusitis
1.9
6.5
83
455
N07BC02
ATC
methadone; systemic
6.9
6.5
15
22
EBA00
NOMESCO Finland
Extraction of tooth
1.3
6.5
485
3927
EB1VA, ,
NOMESCO Finland
1.5
6.5
242
1740
F50.0
ICD-10 Finland
Anorexia nervosa
6.2
6.5
16
26
M01CB03
ATC
auranofin; oral
5.3
6.5
18
34
M01AX17
ATC
nimesulide; oral
1.4
6.5
300
2248
SPAT1251
SPAT
Organisation of medication
2.3
6.4
47
209
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
6.4
167
1112
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.1
6.4
59
288
R28
ICPC
Limited function/disability (R)
3.4
6.4
22
65
R04.2
ICD-10 Finland
Haemoptysis
2.3
6.4
46
203
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.6
6.4
144
927
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
6.4
58
282
S86.0
ICD-10 Finland
Injury of Achilles tendon
2.6
6.4
35
136
NF3AA
NOMESCO Finland
Femur X-ray examination
2.6
6.4
35
136
344
Kela drug reimbursment
Omalizumab
14.4
6.4
10
7
SFA20
NOMESCO Finland
Two-surface restoration
1.3
6.4
795
6925
81
HP
Angiography of the heart and coronary arteries
2.0
6.4
67
344
S01GX04
ATC
nedocromil; ophthalmic
2.9
6.4
29
102
L04AB06
ATC
golimumab; parenteral
3.8
6.4
19
51
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
3.8
6.4
19
51
IHZ05, ,
SPAT
2.1
6.4
61
303
R09.3
ICD-10 Finland
Abnormal sputum
4.1
6.4
17
42
BEF00, ,
SPAT
4.1
6.4
17
42
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
4.1
6.4
17
42
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.1
6.4
26
86
C03AA03
ATC
hydrochlorothiazide; oral
1.7
6.3
110
662
ZXC86
NOMESCO Finland
Use of endoscopic device
8.2
6.3
13
16
D11AH05
ATC
dupilumab; topical
8.2
6.3
13
16
A08.3
ICD-10 Finland
Other viral enteritis
8.2
6.3
13
16
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
8.2
6.3
13
16
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.9
6.3
28
97
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.9
6.3
28
97
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.6
6.3
34
131
-69
ICPC
Other reason for encounter NEC
2.2
6.3
53
250
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
6.3
74
395
GX2D5
NOMESCO Finland
Sleep oximetry
6.0
6.3
16
27
GX1K5
NOMESCO Finland
Diffusion capacity
6.0
6.3
16
27
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.0
6.3
16
27
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
6.0
6.3
16
27
ZY000
NOMESCO Finland
Hospital inpatient
3.2
6.3
24
76
H03BB01
ATC
carbimazole; oral
2.0
6.3
62
311
D94
ICPC
Chronic enteritis/ulcerative colitis
5.5
6.3
17
31
J96.9
ICD-10 Finland
Respiratory failure, unspecified
5.5
6.3
17
31
J01MA06
ATC
norfloxacin; oral
1.6
6.3
168
1126
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.8
6.3
31
114
349
Kela drug reimbursment
Febuxostat
11.1
6.3
11
10
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
11.1
6.3
11
10
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
6.3
510
4177
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
9.3
6.3
12
13
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
9.3
6.3
12
13
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
6.3
209
1469
N02CC04
ATC
rizatriptan; oral
1.8
6.3
86
483
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.7
6.3
32
120
TJF80
NOMESCO Finland
Ostomy education
3.9
6.3
18
47
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.1
6.3
60
298
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
18.1
6.3
9
5
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
18.1
6.3
9
5
Z31.5
ICD-10 Finland
Genetic counselling
1.9
6.3
78
425
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
6.3
116
711
E23.0
ICD-10 Finland
Hypopituitarism
+∞
6.3
6
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
6.3
6
*
JK3MN
NOMESCO Finland
Bile absorbtion isotope examination
+∞
6.3
6
*
3089, ,
Kela drug reimbursment
+∞
6.3
6
*
25508
ICD-8 Finland
Diseases of adrenal glands, Hyperfunctio adrenocorticalis alia
+∞
6.3
6
*
2581A
ICD-9 Finland
Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[SYNDROMA SCHMIDT]
+∞
6.3
6
*
25598
ICD-8 Finland
Diseases of adrenal glands, Alii definiti
+∞
6.3
6
*
E31.01
ICD-10 Finland
Schmidt's syndrome
+∞
6.3
6
*
2550X
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]
+∞
6.3
6
*
2542
FHL
Transasal hypophysectomy
+∞
6.3
6
*
25219
ICD-8 Finland
Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD
+∞
6.3
6
*
25810
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction
+∞
6.3
6
*
E25.9
ICD-10 Finland
Adrenogenital disorder, unspecified
+∞
6.3
6
*
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
6.3
6
*
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
6.3
6
*
H05BX01
ATC
cinacalcet; oral
26.8
6.2
8
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
26.8
6.2
8
*
D07XC01
ATC
betamethasone; topical
1.6
6.2
150
982
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
7.1
6.2
14
20
R1420, ,
SPAT
7.1
6.2
14
20
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.5
6.2
37
150
A10AB06
ATC
insulin glulisine; parenteral
3.7
6.2
19
52
SPAT1059
SPAT
Spirometry at the office
1.9
6.2
70
369
R10.0
ICD-10 Finland
Acute abdomen
2.3
6.2
45
200
WYA20, ,
SPAT
5.0
6.2
18
36
OAB50
NOMESCO Finland
Delivery of care equipment and instruction on their use
3.2
6.2
24
77
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
2.9
6.2
27
93
A10BJ02
ATC
liraglutide; parenteral
2.3
6.2
44
194
M16.7
ICD-10 Finland
Other secondary coxarthrosis
5.4
6.2
17
32
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.4
6.1
21
62
QCB10, ,
SPAT
3.4
6.1
21
62
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.4
6.1
21
62
GD1UN
NOMESCO Finland
Lung circulation SPECT
5.8
6.1
16
28
B02.9
ICD-10 Finland
Zoster without complication
1.8
6.1
89
509
A07EA01
ATC
prednisolone; oral, rectal
7.7
6.1
13
17
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
7.7
6.1
13
17
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
7.7
6.1
13
17
A10BK01
ATC
dapagliflozin; oral
1.7
6.1
100
592
S10
ICPC
Boil/carbuncle
1.8
6.1
82
458
D11AH01
ATC
tacrolimus; topical
3.8
6.1
18
48
183
Kela drug reimbursment
Lamotrigin and topiramate
4.1
6.1
16
39
PA2AD
NOMESCO Finland
CT angiography of brain
4.1
6.1
16
39
D01AE16
ATC
amorolfine; topical
1.6
6.1
147
963
ELB10
NOMESCO Finland
Excision of minor salivary gland
12.6
6.1
10
8
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
6.1
115
709
I50.1
ICD-10 Finland
Left ventricular failure
2.1
6.1
58
288
U04
ICPC
Incontinence urine
1.8
6.1
80
444
H01
ICPC
Ear pain/earache
1.5
6.1
165
1111
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.9
6.1
27
94
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.9
6.1
27
94
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.9
6.1
27
94
395
Kela drug reimbursment
Dupilumab
8.6
6.1
12
14
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.5
6.1
37
152
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
3.6
6.0
19
53
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.7
6.0
30
111
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.8
6.0
83
467
U14
ICPC
Kidney symptom/complaint
3.2
6.0
23
73
A10BJ06
ATC
semaglutide; parenteral
1.9
6.0
76
416
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
2.4
6.0
40
171
K29.6
ICD-10 Finland
Other gastritis
3.3
6.0
22
68
J04AB02
ATC
rifampicin; systemic
3.4
6.0
21
63
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.3
6.0
43
190

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
hydrocortisone; oral, parenteral
H02AB09 [21602737]
2.7e+00
4.7e+00
5.9e+00
1.0e+50
6.8e+00
6.6e+00
5.0e+00
cases:16.86%
controls:1.38%
cases:32.97%
controls:0.45%
cases:19.91%
controls:0.07%
cases:10.87%
controls:0.00%
cases:43.09%
controls:0.08%
cases:70.17%
controls:0.32%
cases:65.94%
controls:1.32%
231
188
1139
13456
452
61
919
13593
273
9
1098
13645
149
0
1222
13654
589
11
778
13607
908
42
386
13189
691
146
357
10884
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
2.7e+00
4.0e+00
6.1e+00
—
5.7e+00
4.5e+00
3.3e+00
cases:16.86%
controls:1.32%
cases:25.16%
controls:0.62%
cases:28.30%
controls:0.09%
—
—
cases:17.12%
controls:0.07%
cases:35.94%
controls:0.63%
cases:37.31%
controls:2.13%
231
180
1139
13464
345
85
1026
13569
388
12
983
13642
—
234
9
1133
13609
465
83
829
13148
391
235
657
10795
Internal Medicine
11 [38004456]
1.3e+00
1.8e+00
2.5e+00
6.4e+00
2.7e+00
2.0e+00
1.7e+00
cases:47.01%
controls:19.66%
cases:33.41%
controls:7.45%
cases:13.06%
controls:1.17%
cases:29.18%
controls:0.07%
cases:15.36%
controls:1.20%
cases:36.01%
controls:6.95%
cases:52.48%
controls:16.87%
644
2683
726
10961
458
1017
913
12637
179
160
1192
13494
400
9
971
13645
210
163
1157
13455
466
919
828
12312
550
1861
498
9169
Endocrinology
46 [38004485]
1.8e+00
2.4e+00
3.1e+00
—
3.9e+00
3.9e+00
3.1e+00
cases:17.15%
controls:3.22%
cases:17.21%
controls:1.86%
cases:8.68%
controls:0.43%
—
—
cases:19.09%
controls:0.47%
cases:48.53%
controls:1.88%
cases:47.04%
controls:3.89%
235
439
1135
13205
236
254
1135
13400
119
59
1252
13595
—
261
64
1106
13554
628
249
666
12982
493
429
555
10601
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
3.3e+00
4.7e+00
—
1.0e+50
—
5.2e+00
4.5e+00
cases:3.43%
controls:0.12%
cases:6.35%
controls:0.06%
—
—
cases:1.82%
controls:0.00%
—
—
cases:11.05%
controls:0.07%
cases:10.69%
controls:0.14%
47
17
1323
13627
87
8
1284
13646
—
25
0
1346
13654
—
143
9
1151
13222
112
15
936
11015
Pulmonary Disease
29 [38004472]
1.7e+00
2.0e+00
2.5e+00
4.9e+00
2.5e+00
2.1e+00
1.9e+00
cases:32.92%
controls:8.16%
cases:26.26%
controls:4.47%
cases:8.83%
controls:0.81%
cases:6.27%
controls:0.05%
cases:7.90%
controls:0.70%
cases:26.89%
controls:4.19%
cases:38.45%
controls:8.75%
451
1113
919
12531
360
611
1011
13043
121
111
1250
13543
86
7
1285
13647
108
96
1259
13522
348
554
946
12677
403
965
645
10065
Inpatient Hospital
21 [8717]
1.1e+00
1.6e+00
2.6e+00
6.2e+00
2.5e+00
1.5e+00
1.1e+00
cases:54.60%
controls:28.91%
cases:32.24%
controls:8.41%
cases:12.69%
controls:1.05%
cases:19.62%
controls:0.05%
cases:11.34%
controls:1.03%
cases:25.81%
controls:7.38%
cases:40.46%
controls:18.99%
748
3945
622
9699
442
1148
929
12506
174
143
1197
13511
269
7
1102
13647
155
140
1212
13478
334
976
960
12255
424
2095
624
8935
Predominantly allergic asthma
J45.0 [45557624]
2.3e+00
2.6e+00
2.9e+00
1.0e+50
3.1e+00
2.7e+00
2.3e+00
cases:9.85%
controls:1.14%
cases:8.10%
controls:0.66%
cases:2.84%
controls:0.17%
cases:2.92%
controls:0.00%
cases:2.78%
controls:0.12%
cases:8.11%
controls:0.58%
cases:12.69%
controls:1.40%
135
155
1235
13489
111
90
1260
13564
39
23
1332
13631
40
0
1331
13654
38
17
1329
13601
105
77
1189
13154
133
154
915
10876
Nonallergic asthma
J45.1 [45557625]
2.3e+00
2.7e+00
2.9e+00
1.0e+50
2.9e+00
2.5e+00
2.4e+00
cases:9.56%
controls:1.02%
cases:6.20%
controls:0.45%
cases:3.21%
controls:0.18%
cases:2.99%
controls:0.00%
cases:2.05%
controls:0.11%
cases:6.49%
controls:0.54%
cases:10.11%
controls:1.04%
131
139
1239
13505
85
61
1286
13593
44
24
1327
13630
41
0
1330
13654
28
15
1339
13603
84
72
1210
13159
106
115
942
10915
Emergency Room Visit
ER [9203]
1.2e+00
1.6e+00
2.4e+00
5.8e+00
1.9e+00
1.5e+00
1.2e+00
cases:62.41%
controls:32.89%
cases:36.69%
controls:10.19%
cases:12.33%
controls:1.25%
cases:19.11%
controls:0.07%
cases:7.75%
controls:1.19%
cases:32.38%
controls:9.66%
cases:53.82%
controls:25.74%
855
4488
515
9156
503
1391
868
12263
169
170
1202
13484
262
10
1109
13644
106
162
1261
13456
419
1278
875
11953
564
2839
484
8191
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
9.7e-01
1.6e+00
2.6e+00
4.6e+00
2.8e+00
1.6e+00
1.4e+00
cases:22.63%
controls:9.98%
cases:20.06%
controls:5.02%
cases:9.85%
controls:0.79%
cases:4.81%
controls:0.05%
cases:10.02%
controls:0.66%
cases:21.72%
controls:5.08%
cases:37.98%
controls:13.34%
310
1362
1060
12282
275
686
1096
12968
135
108
1236
13546
66
7
1305
13647
137
90
1230
13528
281
672
1013
12559
398
1471
650
9559
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.0e+00
1.6e+00
2.6e+00
4.3e+00
2.8e+00
1.7e+00
1.4e+00
cases:25.33%
controls:11.10%
cases:23.05%
controls:5.65%
cases:11.74%
controls:0.94%
cases:4.60%
controls:0.07%
cases:11.19%
controls:0.76%
cases:26.04%
controls:5.84%
cases:43.32%
controls:15.85%
347
1514
1023
12130
316
772
1055
12882
161
129
1210
13525
63
9
1308
13645
153
104
1214
13514
337
773
957
12458
454
1748
594
9282
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
2.6e+00
3.1e+00
2.6e+00
—
2.8e+00
2.3e+00
2.0e+00
cases:1.61%
controls:0.12%
cases:1.75%
controls:0.08%
cases:0.58%
controls:0.04%
—
—
cases:0.73%
controls:0.04%
cases:1.62%
controls:0.17%
cases:2.67%
controls:0.38%
22
17
1348
13627
24
11
1347
13643
8
6
1363
13648
—
10
6
1357
13612
21
22
1273
13209
28
42
1020
10988
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.6e+00
2.3e+00
3.2e+00
1.0e+50
3.6e+00
2.3e+00
1.9e+00
cases:7.30%
controls:1.52%
cases:6.56%
controls:0.68%
cases:3.43%
controls:0.14%
cases:0.66%
controls:0.00%
cases:2.71%
controls:0.07%
cases:6.80%
controls:0.71%
cases:12.40%
controls:2.01%
100
208
1270
13436
90
93
1281
13561
47
19
1324
13635
9
0
1362
13654
37
10
1330
13608
88
94
1206
13137
130
222
918
10808
Renin [Units/volume] in Plasma
30895-7 [3011985]
2.5e+00
3.6e+00
—
—
—
4.8e+00
4.1e+00
cases:2.19%
controls:0.18%
cases:2.70%
controls:0.07%
—
—
—
—
—
—
cases:7.73%
controls:0.07%
cases:11.55%
controls:0.22%
30
25
1340
13619
37
10
1334
13644
—
—
—
100
9
1194
13222
121
24
927
11006
androstanolone
G03BB02 [21602513]
2.5e+00
2.6e+00
—
—
2.9e+00
3.3e+00
3.6e+00
cases:1.90%
controls:0.15%
cases:1.53%
controls:0.11%
—
—
—
—
cases:0.66%
controls:0.04%
cases:2.24%
controls:0.08%
cases:2.67%
controls:0.07%
26
21
1344
13623
21
15
1350
13639
—
—
9
5
1358
13613
29
11
1265
13220
28
8
1020
11022
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2.0e+00
2.3e+00
2.9e+00
—
3.6e+00
2.1e+00
1.9e+00
cases:9.20%
controls:1.41%
cases:6.64%
controls:0.74%
cases:2.04%
controls:0.11%
—
—
cases:1.90%
controls:0.05%
cases:5.49%
controls:0.70%
cases:10.50%
controls:1.77%
126
192
1244
13452
91
101
1280
13553
28
15
1343
13639
—
26
7
1341
13611
71
92
1223
13139
110
195
938
10835
pH of Venous blood
2746-6 [3012544]
1.2e+00
1.6e+00
2.7e+00
3.8e+00
2.6e+00
1.7e+00
1.2e+00
cases:5.04%
controls:1.65%
cases:4.30%
controls:0.93%
cases:1.68%
controls:0.11%
cases:1.90%
controls:0.04%
cases:2.12%
controls:0.16%
cases:5.33%
controls:1.01%
cases:9.64%
controls:3.10%
69
225
1301
13419
59
127
1312
13527
23
15
1348
13639
26
6
1345
13648
29
22
1338
13596
69
134
1225
13097
101
342
947
10688
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
2.0e+00
2.2e+00
3.4e+00
—
2.9e+00
2.3e+00
1.9e+00
cases:7.01%
controls:1.00%
cases:5.98%
controls:0.69%
cases:3.06%
controls:0.11%
—
—
cases:1.90%
controls:0.11%
cases:7.26%
controls:0.77%
cases:14.12%
controls:2.33%
96
136
1274
13508
82
94
1289
13560
42
15
1329
13639
—
26
15
1341
13603
94
102
1200
13129
148
257
900
10773
Nausea and vomiting
R11 [45539317]
1.6e+00
2.2e+00
3.7e+00
1.0e+50
3.2e+00
2.3e+00
1.8e+00
cases:3.72%
controls:0.81%
cases:2.48%
controls:0.28%
cases:1.68%
controls:0.04%
cases:1.60%
controls:0.00%
cases:1.10%
controls:0.04%
cases:3.17%
controls:0.34%
cases:5.73%
controls:1.02%
51
110
1319
13534
34
38
1337
13616
23
6
1348
13648
22
0
1349
13654
15
6
1352
13612
41
45
1253
13186
60
113
988
10917
Bacterial infection, unspecified
A49.9 [45590816]
1.8e+00
2.3e+00
3.2e+00
1.0e+50
3.2e+00
2.4e+00
1.9e+00
cases:5.04%
controls:0.85%
cases:3.50%
controls:0.37%
cases:1.02%
controls:0.04%
cases:1.75%
controls:0.00%
cases:1.02%
controls:0.04%
cases:3.63%
controls:0.36%
cases:6.58%
controls:1.07%
69
116
1301
13528
48
50
1323
13604
14
6
1357
13648
24
0
1347
13654
14
6
1353
13612
47
47
1247
13184
69
118
979
10912
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.2e+00
1.5e+00
2.7e+00
3.7e+00
2.6e+00
1.7e+00
1.2e+00
cases:4.96%
controls:1.61%
cases:4.23%
controls:0.93%
cases:1.60%
controls:0.11%
cases:1.75%
controls:0.04%
cases:1.98%
controls:0.15%
cases:5.26%
controls:1.01%
cases:9.83%
controls:3.15%
68
220
1302
13424
58
127
1313
13527
22
15
1349
13639
24
6
1347
13648
27
21
1340
13597
68
133
1226
13098
103
347
945
10683
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
2.8e+00
3.8e+00
—
1.0e+50
1.0e+50
4.6e+00
3.3e+00
cases:2.85%
controls:0.18%
cases:2.92%
controls:0.07%
—
—
cases:0.58%
controls:0.00%
cases:1.32%
controls:0.00%
cases:4.25%
controls:0.05%
cases:3.44%
controls:0.14%
39
24
1331
13620
40
9
1331
13645
—
8
0
1363
13654
18
0
1349
13618
55
6
1239
13225
36
15
1012
11015
salmeterol; inhalant
R03AC12 [21603266]
2.1e+00
2.1e+00
3.0e+00
—
2.2e+00
2.5e+00
2.5e+00
cases:3.28%
controls:0.40%
cases:1.68%
controls:0.21%
cases:0.73%
controls:0.04%
—
—
cases:0.51%
controls:0.06%
cases:1.70%
controls:0.14%
cases:2.48%
controls:0.20%
45
55
1325
13589
23
28
1348
13626
10
5
1361
13649
—
7
8
1360
13610
22
19
1272
13212
26
22
1022
11008
Base excess in Venous blood by calculation
1927-3 [3002032]
1.2e+00
1.5e+00
2.6e+00
3.7e+00
2.5e+00
1.7e+00
1.2e+00
cases:5.04%
controls:1.60%
cases:3.94%
controls:0.91%
cases:1.53%
controls:0.11%
cases:1.68%
controls:0.04%
cases:1.83%
controls:0.15%
cases:5.26%
controls:1.01%
cases:9.54%
controls:3.03%
69
218
1301
13426
54
124
1317
13530
21
15
1350
13639
23
6
1348
13648
25
21
1342
13597
68
133
1226
13098
100
334
948
10696
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.1e+00
1.5e+00
2.5e+00
3.7e+00
2.7e+00
1.5e+00
1.2e+00
cases:23.87%
controls:9.76%
cases:20.71%
controls:5.43%
cases:10.65%
controls:0.92%
cases:1.53%
controls:0.04%
cases:7.97%
controls:0.57%
cases:20.48%
controls:5.50%
cases:34.92%
controls:13.51%
327
1332
1043
12312
284
741
1087
12913
146
126
1225
13528
21
5
1350
13649
109
78
1258
13540
265
728
1029
12503
366
1490
682
9540
Benign neoplasm: Pituitary gland
D35.2 [45581304]
3.0e+00
3.1e+00
—
1.0e+50
—
4.2e+00
4.0e+00
cases:1.46%
controls:0.07%
cases:1.17%
controls:0.05%
—
—
cases:0.58%
controls:0.00%
—
—
cases:2.40%
controls:0.04%
cases:2.86%
controls:0.05%
20
10
1350
13634
16
7
1355
13647
—
8
0
1363
13654
—
31
5
1263
13226
30
6
1018
11024
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
9.6e-01
1.5e+00
2.2e+00
4.8e+00
2.3e+00
1.4e+00
1.1e+00
cases:25.69%
controls:11.67%
cases:23.56%
controls:6.72%
cases:11.67%
controls:1.43%
cases:4.45%
controls:0.04%
cases:10.31%
controls:1.19%
cases:22.49%
controls:6.70%
cases:38.45%
controls:16.57%
352
1592
1018
12052
323
918
1048
12736
160
195
1211
13459
61
5
1310
13649
141
162
1226
13456
291
887
1003
12344
403
1828
645
9202
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
2.0e+00
2.2e+00
3.2e+00
—
2.8e+00
2.2e+00
1.9e+00
cases:7.81%
controls:1.14%
cases:6.42%
controls:0.79%
cases:3.06%
controls:0.13%
—
—
cases:1.98%
controls:0.12%
cases:7.34%
controls:0.84%
cases:14.79%
controls:2.53%
107
155
1263
13489
88
108
1283
13546
42
18
1329
13636
—
27
17
1340
13601
95
111
1199
13120
155
279
893
10751
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
1.9e+00
2.2e+00
3.2e+00
—
2.9e+00
2.2e+00
1.9e+00
cases:6.93%
controls:1.07%
cases:6.05%
controls:0.74%
cases:2.92%
controls:0.12%
—
—
cases:1.90%
controls:0.11%
cases:6.96%
controls:0.81%
cases:14.41%
controls:2.48%
95
146
1275
13498
83
101
1288
13553
40
17
1331
13637
—
26
15
1341
13603
90
107
1204
13124
151
274
897
10756
ciclosporin; oral, parenteral
L04AD01 [21603924]
2.0e+00
2.6e+00
2.8e+00
—
2.5e+00
2.1e+00
2.2e+00
cases:2.55%
controls:0.34%
cases:2.48%
controls:0.20%
cases:0.95%
controls:0.06%
—
—
cases:0.73%
controls:0.06%
cases:1.78%
controls:0.22%
cases:1.62%
controls:0.18%
35
46
1335
13598
34
27
1337
13627
13
8
1358
13646
—
10
8
1357
13610
23
29
1271
13202
17
20
1031
11010
Blasts/Leukocytes in Blood
26446-5 [3025159]
2.0e+00
2.2e+00
3.2e+00
—
2.6e+00
2.2e+00
1.9e+00
cases:6.64%
controls:0.93%
cases:6.27%
controls:0.74%
cases:3.06%
controls:0.12%
—
—
cases:1.76%
controls:0.13%
cases:7.42%
controls:0.90%
cases:14.69%
controls:2.47%
91
127
1279
13517
86
101
1285
13553
42
17
1329
13637
—
24
18
1343
13600
96
119
1198
13112
154
272
894
10758
Infectious Disease
44 [38004484]
1.6e+00
2.0e+00
2.6e+00
1.0e+50
3.6e+00
2.2e+00
2.0e+00
cases:8.91%
controls:1.90%
cases:5.91%
controls:0.83%
cases:1.60%
controls:0.12%
cases:2.19%
controls:0.00%
cases:2.56%
controls:0.07%
cases:5.95%
controls:0.70%
cases:12.12%
controls:1.77%
122
259
1248
13385
81
114
1290
13540
22
16
1349
13638
30
0
1341
13654
35
10
1332
13608
77
93
1217
13138
127
195
921
10835
Emergency Medicine
93 [38004510]
8.8e-01
1.4e+00
2.2e+00
5.8e+00
1.6e+00
1.2e+00
9.6e-01
cases:30.22%
controls:15.27%
cases:25.24%
controls:8.02%
cases:10.21%
controls:1.25%
cases:10.80%
controls:0.04%
cases:6.00%
controls:1.21%
cases:25.73%
controls:9.27%
cases:45.42%
controls:24.13%
414
2083
956
11561
346
1095
1025
12559
140
171
1231
13483
148
5
1223
13649
82
165
1285
13453
333
1226
961
12005
476
2662
572
8368
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
2.1e+00
2.3e+00
1.9e+00
—
2.3e+00
2.6e+00
2.7e+00
cases:2.55%
controls:0.32%
cases:2.19%
controls:0.23%
cases:0.51%
controls:0.07%
—
—
cases:0.73%
controls:0.07%
cases:3.01%
controls:0.22%
cases:4.01%
controls:0.28%
35
43
1335
13601
30
31
1341
13623
7
10
1364
13644
—
10
10
1357
13608
39
29
1255
13202
42
31
1006
10999
Other malignant neoplasm of kidney, except renal pelvis
C64.88 [2000501096]
1.9e+00
2.2e+00
3.1e+00
—
2.9e+00
2.3e+00
1.7e+00
cases:1.68%
controls:0.26%
cases:1.97%
controls:0.22%
cases:1.60%
controls:0.07%
—
—
cases:1.54%
controls:0.09%
cases:1.85%
controls:0.20%
cases:1.43%
controls:0.27%
23
36
1347
13608
27
30
1344
13624
22
10
1349
13644
—
21
12
1346
13606
24
26
1270
13205
15
30
1033
11000
androstanolone
A14AA01 [21600917]
2.4e+00
2.4e+00
—
—
2.7e+00
3.1e+00
3.3e+00
cases:1.90%
controls:0.18%
cases:1.53%
controls:0.14%
—
—
—
—
cases:0.66%
controls:0.04%
cases:2.24%
controls:0.11%
cases:2.86%
controls:0.11%
26
24
1344
13620
21
19
1350
13635
—
—
9
6
1358
13612
29
14
1265
13217
30
12
1018
11018
Outpatient Hospital
22 [8756]
1.0e+00
1.4e+00
2.2e+00
5.0e+00
1.9e+00
1.4e+00
1.0e+00
cases:46.28%
controls:23.27%
cases:20.35%
controls:6.03%
cases:5.47%
controls:0.66%
cases:6.78%
controls:0.05%
cases:4.68%
controls:0.71%
cases:16.85%
controls:4.91%
cases:31.97%
controls:14.13%
634
3175
736
10469
279
823
1092
12831
75
90
1296
13564
93
7
1278
13647
64
97
1303
13521
218
649
1076
12582
335
1559
713
9471
FEV1/FVC
19926-5 [3011505]
1.5e+00
2.2e+00
2.7e+00
1.0e+50
2.9e+00
2.3e+00
2.1e+00
cases:9.56%
controls:2.21%
cases:5.76%
controls:0.66%
cases:1.02%
controls:0.07%
cases:0.51%
controls:0.00%
cases:0.95%
controls:0.05%
cases:5.64%
controls:0.60%
cases:10.50%
controls:1.41%
131
301
1239
13343
79
90
1292
13564
14
9
1357
13645
7
0
1364
13654
13
7
1354
13611
73
79
1221
13152
110
156
938
10874
FEV1
20150-9 [3024653]
1.5e+00
2.2e+00
2.7e+00
1.0e+50
2.9e+00
2.3e+00
2.1e+00
cases:9.56%
controls:2.21%
cases:5.76%
controls:0.66%
cases:1.02%
controls:0.07%
cases:0.51%
controls:0.00%
cases:0.95%
controls:0.05%
cases:5.64%
controls:0.60%
cases:10.50%
controls:1.41%
131
301
1239
13343
79
90
1292
13564
14
9
1357
13645
7
0
1364
13654
13
7
1354
13611
73
79
1221
13152
110
156
938
10874
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.5e+00
2.2e+00
2.7e+00
1.0e+50
2.9e+00
2.3e+00
2.1e+00
cases:9.56%
controls:2.21%
cases:5.76%
controls:0.66%
cases:1.02%
controls:0.07%
cases:0.51%
controls:0.00%
cases:0.95%
controls:0.05%
cases:5.64%
controls:0.60%
cases:10.50%
controls:1.41%
131
301
1239
13343
79
90
1292
13564
14
9
1357
13645
7
0
1364
13654
13
7
1354
13611
73
79
1221
13152
110
156
938
10874
Asthma, unspecified
J45.9 [45562456]
1.8e+00
2.3e+00
2.6e+00
—
2.8e+00
2.3e+00
2.0e+00
cases:18.25%
controls:3.41%
cases:14.00%
controls:1.63%
cases:3.72%
controls:0.29%
—
—
cases:4.17%
controls:0.27%
cases:13.99%
controls:1.60%
cases:25.19%
controls:4.16%
250
465
1120
13179
192
222
1179
13432
51
40
1320
13614
—
57
37
1310
13581
181
212
1113
13019
264
459
784
10571
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.9e+00
2.0e+00
2.7e+00
1.0e+50
3.6e+00
1.9e+00
1.7e+00
cases:6.72%
controls:1.11%
cases:3.50%
controls:0.48%
cases:1.24%
controls:0.08%
cases:0.58%
controls:0.00%
cases:1.90%
controls:0.05%
cases:3.17%
controls:0.51%
cases:7.82%
controls:1.55%
92
152
1278
13492
48
66
1323
13588
17
11
1354
13643
8
0
1363
13654
26
7
1341
13611
41
67
1253
13164
82
171
966
10859
formoterol and fluticasone
R03AK11 [44819166]
1.8e+00
2.1e+00
2.5e+00
—
2.8e+00
2.1e+00
2.5e+00
cases:2.19%
controls:0.36%
cases:1.82%
controls:0.23%
cases:1.09%
controls:0.10%
—
—
cases:0.73%
controls:0.04%
cases:2.01%
controls:0.25%
cases:3.15%
controls:0.27%
30
49
1340
13595
25
31
1346
13623
15
13
1356
13641
—
10
6
1357
13612
26
33
1268
13198
33
30
1015
11000
salbutamol and ipratropium bromide
R03AL02 [43534844]
3.6e+00
3.1e+00
—
—
—
3.6e+00
3.4e+00
cases:3.36%
controls:0.10%
cases:2.04%
controls:0.10%
—
—
—
—
—
—
cases:2.40%
controls:0.07%
cases:4.10%
controls:0.15%
46
13
1324
13631
28
13
1343
13641
—
—
—
31
9
1263
13222
43
16
1005
11014
formoterol and beclometasone
R03AK08 [43534839]
2.2e+00
2.2e+00
2.3e+00
—
2.4e+00
2.3e+00
2.3e+00
cases:6.13%
controls:0.71%
cases:6.05%
controls:0.74%
cases:2.41%
controls:0.25%
—
—
cases:2.78%
controls:0.27%
cases:8.19%
controls:0.87%
cases:12.21%
controls:1.41%
84
97
1286
13547
83
101
1288
13553
33
34
1338
13620
—
38
37
1329
13581
106
115
1188
13116
128
155
920
10875
Eosinophils [#/volume] in Blood
26449-9 [3013115]
1.0e+00
1.6e+00
2.3e+00
3.7e+00
2.1e+00
1.6e+00
1.3e+00
cases:29.27%
controls:12.75%
cases:29.18%
controls:7.88%
cases:13.79%
controls:1.66%
cases:1.97%
controls:0.05%
cases:10.39%
controls:1.34%
cases:29.13%
controls:7.87%
cases:43.51%
controls:17.39%
401
1739
969
11905
400
1076
971
12578
189
226
1182
13428
27
7
1344
13647
142
183
1225
13435
377
1041
917
12190
456
1918
592
9112
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.0e+00
1.6e+00
2.2e+00
3.6e+00
2.2e+00
1.5e+00
1.3e+00
cases:28.25%
controls:12.24%
cases:28.01%
controls:7.57%
cases:13.27%
controls:1.63%
cases:1.90%
controls:0.05%
cases:10.24%
controls:1.30%
cases:27.67%
controls:7.63%
cases:42.65%
controls:16.75%
387
1670
983
11974
384
1033
987
12621
182
222
1189
13432
26
7
1345
13647
140
177
1227
13441
358
1010
936
12221
447
1847
601
9183
Basophils [#/volume] in Blood
26444-0 [3006315]
1.0e+00
1.6e+00
2.2e+00
3.6e+00
2.2e+00
1.5e+00
1.3e+00
cases:28.25%
controls:12.27%
cases:28.01%
controls:7.58%
cases:13.20%
controls:1.62%
cases:1.90%
controls:0.05%
cases:10.24%
controls:1.30%
cases:27.82%
controls:7.65%
cases:42.65%
controls:16.81%
387
1674
983
11970
384
1035
987
12619
181
221
1190
13433
26
7
1345
13647
140
177
1227
13441
360
1012
934
12219
447
1854
601
9176
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.0e+00
1.5e+00
2.2e+00
3.7e+00
2.3e+00
1.5e+00
1.3e+00
cases:26.35%
controls:11.58%
cases:25.16%
controls:6.79%
cases:12.11%
controls:1.57%
cases:1.68%
controls:0.04%
cases:10.31%
controls:1.18%
cases:25.66%
controls:6.87%
cases:39.03%
controls:15.37%
361
1580
1009
12064
345
927
1026
12727
166
215
1205
13439
23
6
1348
13648
141
161
1226
13457
332
909
962
12322
409
1695
639
9335
Basophils/Leukocytes in Blood
30180-4 [3022096]
1.0e+00
1.5e+00
2.2e+00
3.7e+00
2.3e+00
1.5e+00
1.2e+00
cases:26.20%
controls:11.55%
cases:25.02%
controls:6.77%
cases:12.11%
controls:1.56%
cases:1.68%
controls:0.04%
cases:10.31%
controls:1.18%
cases:25.50%
controls:6.89%
cases:38.84%
controls:15.39%
359
1576
1011
12068
343
925
1028
12729
166
213
1205
13441
23
6
1348
13648
141
161
1226
13457
330
911
964
12320
407
1698
641
9332
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
1.0e+00
1.5e+00
2.2e+00
3.7e+00
2.2e+00
1.5e+00
1.3e+00
cases:26.28%
controls:11.57%
cases:25.09%
controls:6.78%
cases:12.04%
controls:1.57%
cases:1.68%
controls:0.04%
cases:10.17%
controls:1.18%
cases:25.58%
controls:6.89%
cases:38.93%
controls:15.37%
360
1578
1010
12066
344
926
1027
12728
165
214
1206
13440
23
6
1348
13648
139
161
1228
13457
331
912
963
12319
408
1695
640
9335
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.2e+00
1.4e+00
1.9e+00
4.2e+00
1.9e+00
1.5e+00
1.2e+00
cases:20.73%
controls:7.47%
cases:12.25%
controls:3.24%
cases:4.23%
controls:0.66%
cases:2.48%
controls:0.04%
cases:3.73%
controls:0.57%
cases:12.13%
controls:3.11%
cases:22.42%
controls:7.76%
284
1019
1086
12625
168
442
1203
13212
58
90
1313
13564
34
5
1337
13649
51
77
1316
13541
157
412
1137
12819
235
856
813
10174
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
9.9e-01
1.5e+00
2.2e+00
3.7e+00
2.1e+00
1.5e+00
1.3e+00
cases:28.47%
controls:12.89%
cases:28.08%
controls:7.81%
cases:13.42%
controls:1.65%
cases:1.97%
controls:0.05%
cases:10.17%
controls:1.31%
cases:27.74%
controls:7.88%
cases:43.13%
controls:17.26%
390
1759
980
11885
385
1067
986
12587
184
225
1187
13429
27
7
1344
13647
139
178
1228
13440
359
1042
935
12189
452
1904
596
9126
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
9.6e-01
1.5e+00
2.2e+00
3.7e+00
2.3e+00
1.5e+00
1.2e+00
cases:26.35%
controls:12.01%
cases:25.38%
controls:6.97%
cases:12.25%
controls:1.60%
cases:1.75%
controls:0.04%
cases:10.39%
controls:1.20%
cases:25.73%
controls:7.11%
cases:39.60%
controls:15.92%
361
1638
1009
12006
348
952
1023
12702
168
218
1203
13436
24
6
1347
13648
142
164
1225
13454
333
941
961
12290
415
1756
633
9274
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.9e+00
2.5e+00
2.3e+00
—
2.8e+00
2.3e+00
1.4e+00
cases:9.05%
controls:1.49%
cases:6.05%
controls:0.51%
cases:0.80%
controls:0.08%
—
—
cases:0.88%
controls:0.05%
cases:4.10%
controls:0.45%
cases:5.15%
controls:1.28%
124
203
1246
13441
83
70
1288
13584
11
11
1360
13643
—
12
7
1355
13611
53
59
1241
13172
54
141
994
10889
tiotropium bromide; inhalant
R03BB04 [21603296]
2.1e+00
2.3e+00
2.2e+00
—
2.2e+00
2.2e+00
2.3e+00
cases:12.63%
controls:1.80%
cases:11.96%
controls:1.40%
cases:4.01%
controls:0.47%
—
—
cases:3.80%
controls:0.45%
cases:11.21%
controls:1.34%
cases:16.41%
controls:1.92%
173
245
1197
13399
164
191
1207
13463
55
64
1316
13590
—
52
61
1315
13557
145
177
1149
13054
172
212
876
10818
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
1.5e+00
2.1e+00
3.1e+00
—
2.5e+00
2.1e+00
1.8e+00
cases:6.20%
controls:1.39%
cases:4.81%
controls:0.63%
cases:2.26%
controls:0.10%
—
—
cases:1.61%
controls:0.14%
cases:5.72%
controls:0.70%
cases:10.40%
controls:1.87%
85
190
1285
13454
66
86
1305
13568
31
14
1340
13640
—
22
19
1345
13599
74
93
1220
13138
109
206
939
10824
Microorganisms panel - Urine sediment
58435-9 [40761536]
1.5e+00
2.0e+00
2.7e+00
—
3.1e+00
2.0e+00
1.8e+00
cases:8.61%
controls:2.07%
cases:6.78%
controls:0.97%
cases:1.90%
controls:0.13%
—
—
cases:2.27%
controls:0.10%
cases:5.87%
controls:0.81%
cases:10.69%
controls:1.95%
118
283
1252
13361
93
132
1278
13522
26
18
1345
13636
—
31
14
1336
13604
76
107
1218
13124
112
215
936
10815
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
1.4e+00
1.9e+00
2.9e+00
—
3.2e+00
2.0e+00
1.8e+00
cases:8.18%
controls:2.13%
cases:5.91%
controls:0.92%
cases:2.12%
controls:0.12%
—
—
cases:1.90%
controls:0.08%
cases:5.87%
controls:0.86%
cases:12.02%
controls:2.21%
112
291
1258
13353
81
126
1290
13528
29
17
1342
13637
—
26
11
1341
13607
76
114
1218
13117
126
244
922
10786
Normoblasts [#/volume] in Blood
715-3 [3021589]
6.9e-01
1.1e+00
2.2e+00
4.5e+00
2.1e+00
1.3e+00
1.1e+00
cases:19.12%
controls:10.58%
cases:22.17%
controls:8.33%
cases:14.73%
controls:1.79%
cases:4.52%
controls:0.05%
cases:11.12%
controls:1.48%
cases:25.19%
controls:8.39%
cases:35.69%
controls:16.24%
262
1443
1108
12201
304
1138
1067
12516
202
245
1169
13409
62
7
1309
13647
152
202
1215
13416
326
1110
968
12121
374
1791
674
9239
Hemodialysis
TK800 [2001305768]
1.5e+00
2.4e+00
3.0e+00
—
2.6e+00
2.0e+00
1.7e+00
cases:0.73%
controls:0.17%
cases:1.09%
controls:0.10%
cases:0.73%
controls:0.04%
—
—
cases:0.66%
controls:0.05%
cases:0.77%
controls:0.11%
cases:0.86%
controls:0.16%
10
23
1360
13621
15
14
1356
13640
10
5
1361
13649
—
9
7
1358
13611
10
14
1284
13217
9
18
1039
11012
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
7.7e-01
1.3e+00
2.3e+00
4.2e+00
2.0e+00
1.3e+00
1.1e+00
cases:37.66%
controls:21.90%
cases:37.64%
controls:13.86%
cases:21.37%
controls:2.64%
cases:4.89%
controls:0.07%
cases:15.00%
controls:2.36%
cases:37.87%
controls:13.70%
cases:55.06%
controls:29.24%
516
2988
854
10656
516
1893
855
11761
293
360
1078
13294
67
10
1304
13644
205
322
1162
13296
490
1813
804
11418
577
3225
471
7805
Supplier / Service Provider
OMOP5117446 [33004]
-2.6e-01
2.0e-01
9.2e-01
2.6e+00
3.7e+00
3.0e+00
3.1e+00
cases:22.26%
controls:27.14%
cases:10.80%
controls:8.98%
cases:2.12%
controls:0.86%
cases:0.51%
controls:0.04%
cases:1.98%
controls:0.05%
cases:10.90%
controls:0.60%
cases:23.76%
controls:1.41%
305
3703
1065
9941
148
1226
1223
12428
29
117
1342
13537
7
5
1364
13649
27
7
1340
13611
141
79
1153
13152
249
156
799
10874
Osteoporosis, unspecified
M81.9 [45591963]
1.7e+00
1.9e+00
2.3e+00
1.0e+50
2.9e+00
2.2e+00
2.0e+00
cases:2.48%
controls:0.45%
cases:1.53%
controls:0.23%
cases:0.58%
controls:0.06%
cases:0.58%
controls:0.00%
cases:0.66%
controls:0.04%
cases:1.78%
controls:0.20%
cases:4.29%
controls:0.60%
34
61
1336
13583
21
31
1350
13623
8
8
1363
13646
8
0
1363
13654
9
5
1358
13613
23
27
1271
13204
45
66
1003
10964
Fever, unspecified
R50.9 [45582716]
1.5e+00
1.9e+00
3.6e+00
—
2.5e+00
2.0e+00
1.6e+00
cases:7.66%
controls:1.74%
cases:3.65%
controls:0.59%
cases:1.82%
controls:0.05%
—
—
cases:0.95%
controls:0.08%
cases:3.40%
controls:0.48%
cases:8.02%
controls:1.80%
105
237
1265
13407
50
80
1321
13574
25
7
1346
13647
—
13
11
1354
13607
44
63
1250
13168
84
198
964
10832
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
2.0e+00
2.2e+00
2.2e+00
—
2.6e+00
1.9e+00
2.0e+00
cases:2.85%
controls:0.38%
cases:2.33%
controls:0.26%
cases:0.66%
controls:0.07%
—
—
cases:0.80%
controls:0.06%
cases:1.78%
controls:0.27%
cases:3.15%
controls:0.44%
39
52
1331
13592
32
35
1339
13619
9
10
1362
13644
—
11
8
1356
13610
23
36
1271
13195
33
48
1015
10982
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
9.0e-01
1.5e+00
2.1e+00
3.6e+00
2.2e+00
1.5e+00
1.2e+00
cases:24.67%
controls:11.76%
cases:24.36%
controls:6.85%
cases:11.23%
controls:1.52%
cases:1.60%
controls:0.04%
cases:9.51%
controls:1.19%
cases:24.81%
controls:7.04%
cases:38.07%
controls:15.65%
338
1604
1032
12040
334
935
1037
12719
154
207
1217
13447
22
6
1349
13648
130
162
1237
13456
321
931
973
12300
399
1726
649
9304
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
1.4e+00
1.9e+00
2.9e+00
1.0e+50
2.6e+00
2.2e+00
1.8e+00
cases:7.59%
controls:2.04%
cases:3.79%
controls:0.59%
cases:0.80%
controls:0.04%
cases:1.09%
controls:0.00%
cases:0.51%
controls:0.04%
cases:4.64%
controls:0.52%
cases:12.88%
controls:2.49%
104
278
1266
13366
52
81
1319
13573
11
6
1360
13648
15
0
1356
13654
7
5
1360
13613
60
69
1234
13162
135
275
913
10755
Outpatient Visit
OP [9202]
1.1e+00
1.2e+00
1.4e+00
4.4e+00
1.6e+00
1.6e+00
1.4e+00
cases:89.34%
controls:74.04%
cases:78.92%
controls:52.58%
cases:34.57%
controls:11.09%
cases:31.15%
controls:0.53%
cases:38.26%
controls:10.88%
cases:84.00%
controls:52.51%
cases:93.89%
controls:79.34%
1224
10102
146
3542
1082
7179
289
6475
474
1514
897
12140
427
73
944
13581
523
1481
844
12137
1087
6948
207
6283
984
8751
64
2279
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.4e+00
1.8e+00
2.7e+00
—
3.4e+00
1.8e+00
1.7e+00
cases:10.88%
controls:3.03%
cases:8.39%
controls:1.50%
cases:3.06%
controls:0.21%
—
—
cases:5.05%
controls:0.18%
cases:8.58%
controls:1.49%
cases:16.89%
controls:3.73%
149
414
1221
13230
115
205
1256
13449
42
28
1329
13626
—
69
25
1298
13593
111
197
1183
13034
177
411
871
10619
clonazepam; oral, parenteral
N03AE01 [21604415]
1.7e+00
2.0e+00
2.5e+00
—
2.4e+00
2.0e+00
2.1e+00
cases:4.89%
controls:0.92%
cases:4.01%
controls:0.55%
cases:1.60%
controls:0.14%
—
—
cases:1.24%
controls:0.12%
cases:3.63%
controls:0.51%
cases:5.63%
controls:0.73%
67
125
1303
13519
55
75
1316
13579
22
19
1349
13635
—
17
16
1350
13602
47
67
1247
13164
59
81
989
10949
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
9.3e-01
1.3e+00
2.1e+00
4.1e+00
2.1e+00
1.1e+00
8.5e-01
cases:21.09%
controls:9.56%
cases:16.92%
controls:5.17%
cases:5.03%
controls:0.63%
cases:2.26%
controls:0.04%
cases:4.83%
controls:0.63%
cases:14.53%
controls:5.22%
cases:28.82%
controls:14.76%
289
1304
1081
12340
232
706
1139
12948
69
86
1302
13568
31
5
1340
13649
66
86
1301
13532
188
691
1106
12540
302
1628
746
9402
fenoterol and ipratropium bromide
R03AL01 [43534843]
2.2e+00
2.1e+00
2.2e+00
—
2.3e+00
1.8e+00
1.9e+00
cases:3.87%
controls:0.45%
cases:2.19%
controls:0.26%
cases:0.66%
controls:0.07%
—
—
cases:0.44%
controls:0.04%
cases:1.85%
controls:0.30%
cases:3.34%
controls:0.53%
53
62
1317
13582
30
36
1341
13618
9
10
1362
13644
—
6
6
1361
13612
24
40
1270
13191
35
58
1013
10972
budesonide; oral, sublingual
A07EA06 [21600658]
2.5e+00
2.7e+00
—
—
2.7e+00
2.4e+00
2.2e+00
cases:5.26%
controls:0.47%
cases:3.06%
controls:0.22%
—
—
—
—
cases:0.88%
controls:0.06%
cases:2.55%
controls:0.23%
cases:4.20%
controls:0.47%
72
64
1298
13580
42
30
1329
13624
—
—
12
8
1355
13610
33
30
1261
13201
44
52
1004
10978
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
2.1e+00
2.0e+00
2.5e+00
—
1.9e+00
2.0e+00
2.1e+00
cases:2.19%
controls:0.29%
cases:1.90%
controls:0.26%
cases:0.88%
controls:0.07%
—
—
cases:0.51%
controls:0.08%
cases:1.93%
controls:0.26%
cases:2.10%
controls:0.26%
30
39
1340
13605
26
36
1345
13618
12
10
1359
13644
—
7
11
1360
13607
25
35
1269
13196
22
29
1026
11001
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
2.1e+00
2.1e+00
2.2e+00
—
2.4e+00
1.9e+00
1.8e+00
cases:1.39%
controls:0.18%
cases:1.90%
controls:0.23%
cases:1.17%
controls:0.13%
—
—
cases:1.39%
controls:0.12%
cases:2.01%
controls:0.31%
cases:1.53%
controls:0.26%
19
24
1351
13620
26
32
1345
13622
16
18
1355
13636
—
19
17
1348
13601
26
41
1268
13190
16
29
1032
11001
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
8.9e-01
1.8e+00
3.3e+00
—
3.2e+00
2.0e+00
1.2e+00
cases:2.85%
controls:1.19%
cases:2.99%
controls:0.52%
cases:1.60%
controls:0.06%
—
—
cases:1.10%
controls:0.04%
cases:3.40%
controls:0.47%
cases:5.63%
controls:1.75%
39
163
1331
13481
41
71
1330
13583
22
8
1349
13646
—
15
6
1352
13612
44
62
1250
13169
59
193
989
10837
Chronic maxillary sinusitis
J32.0 [45586667]
1.8e+00
2.3e+00
2.6e+00
—
1.9e+00
2.0e+00
1.8e+00
cases:4.82%
controls:0.84%
cases:2.63%
controls:0.27%
cases:0.51%
controls:0.04%
—
—
cases:0.59%
controls:0.09%
cases:2.24%
controls:0.29%
cases:4.68%
controls:0.83%
66
115
1304
13529
36
37
1335
13617
7
5
1364
13649
—
8
12
1359
13606
29
39
1265
13192
49
92
999
10938
Metastasis
OMOP4998856 [36769180]
2.0e+00
2.1e+00
2.2e+00
—
2.4e+00
1.9e+00
1.8e+00
cases:1.39%
controls:0.18%
cases:1.90%
controls:0.23%
cases:1.17%
controls:0.13%
—
—
cases:1.39%
controls:0.12%
cases:2.01%
controls:0.31%
cases:1.53%
controls:0.26%
19
25
1351
13619
26
32
1345
13622
16
18
1355
13636
—
19
17
1348
13601
26
41
1268
13190
16
29
1032
11001
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1.4e+00
2.4e+00
2.1e+00
1.0e+50
3.2e+00
1.8e+00
1.5e+00
cases:4.01%
controls:1.07%
cases:4.74%
controls:0.45%
cases:0.80%
controls:0.10%
cases:1.24%
controls:0.00%
cases:1.83%
controls:0.07%
cases:3.17%
controls:0.54%
cases:5.92%
controls:1.45%
55
146
1315
13498
65
61
1306
13593
11
13
1360
13641
17
0
1354
13654
25
10
1342
13608
41
71
1253
13160
62
160
986
10870
prednisolone
A07EA01 [21600653]
1.9e+00
2.4e+00
2.4e+00
—
2.1e+00
1.9e+00
1.6e+00
cases:46.50%
controls:11.24%
cases:37.64%
controls:4.97%
cases:7.80%
controls:0.78%
—
—
cases:6.66%
controls:0.84%
cases:24.34%
controls:4.60%
cases:38.93%
controls:11.37%
637
1533
733
12111
516
678
855
12976
107
107
1264
13547
—
91
114
1276
13504
315
609
979
12622
408
1254
640
9776
prednisolone; oral, parenteral
H02AB06 [21602734]
1.9e+00
2.4e+00
2.4e+00
—
2.1e+00
1.9e+00
1.6e+00
cases:46.50%
controls:11.18%
cases:37.56%
controls:4.95%
cases:7.73%
controls:0.78%
—
—
cases:6.66%
controls:0.84%
cases:24.27%
controls:4.60%
cases:38.65%
controls:11.31%
637
1525
733
12119
515
676
856
12978
106
107
1265
13547
—
91
114
1276
13504
314
609
980
12622
405
1248
643
9782
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
1.7e+00
1.7e+00
2.3e+00
—
2.5e+00
2.1e+00
2.1e+00
cases:0.95%
controls:0.18%
cases:1.31%
controls:0.25%
cases:0.88%
controls:0.09%
—
—
cases:1.24%
controls:0.10%
cases:2.55%
controls:0.31%
cases:4.29%
controls:0.57%
13
24
1357
13620
18
34
1353
13620
12
12
1359
13642
—
17
14
1350
13604
33
41
1261
13190
45
63
1003
10967
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
8.8e-01
1.2e+00
2.0e+00
4.3e+00
2.0e+00
1.0e+00
8.0e-01
cases:22.85%
controls:10.99%
cases:19.26%
controls:6.63%
cases:6.64%
controls:0.91%
cases:2.70%
controls:0.04%
cases:6.14%
controls:0.84%
cases:17.77%
controls:7.12%
cases:34.92%
controls:19.45%
313
1499
1057
12145
264
905
1107
12749
91
124
1280
13530
37
5
1334
13649
84
114
1283
13504
230
942
1064
12289
366
2145
682
8885
montelukast; oral
R03DC03 [21603356]
1.9e+00
2.2e+00
2.0e+00
—
2.1e+00
2.2e+00
2.0e+00
cases:18.76%
controls:3.47%
cases:15.54%
controls:1.98%
cases:3.36%
controls:0.48%
—
—
cases:4.24%
controls:0.55%
cases:15.22%
controls:2.00%
cases:21.47%
controls:3.43%
257
474
1113
13170
213
271
1158
13383
46
66
1325
13588
—
58
75
1309
13543
197
265
1097
12966
225
378
823
10652
pH of Capillary blood
2745-8 [3009343]
1.2e+00
1.8e+00
2.2e+00
1.0e+50
3.6e+00
2.0e+00
1.5e+00
cases:3.65%
controls:1.08%
cases:3.06%
controls:0.53%
cases:0.66%
controls:0.07%
cases:0.95%
controls:0.00%
cases:1.32%
controls:0.04%
cases:3.55%
controls:0.48%
cases:6.68%
controls:1.64%
50
148
1320
13496
42
73
1329
13581
9
10
1362
13644
13
0
1358
13654
18
5
1349
13613
46
64
1248
13167
70
181
978
10849
Status asthmaticus
J46 [45591560]
3.1e+00
3.5e+00
—
—
—
3.1e+00
2.6e+00
cases:4.45%
controls:0.21%
cases:2.26%
controls:0.07%
—
—
—
—
—
—
cases:1.55%
controls:0.07%
cases:3.44%
controls:0.27%
61
28
1309
13616
31
10
1340
13644
—
—
—
20
9
1274
13222
36
30
1012
11000
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.2e+00
1.9e+00
2.2e+00
1.0e+50
3.5e+00
2.0e+00
1.5e+00
cases:3.65%
controls:1.08%
cases:3.36%
controls:0.54%
cases:0.66%
controls:0.07%
cases:0.95%
controls:0.00%
cases:1.39%
controls:0.04%
cases:3.86%
controls:0.53%
cases:6.97%
controls:1.70%
50
148
1320
13496
46
74
1325
13580
9
10
1362
13644
13
0
1358
13654
19
6
1348
13612
50
70
1244
13161
73
187
975
10843
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.2e+00
2.2e+00
2.8e+00
1.0e+50
2.3e+00
2.0e+00
1.7e+00
cases:5.91%
controls:1.80%
cases:4.67%
controls:0.53%
cases:1.09%
controls:0.07%
cases:1.82%
controls:0.00%
cases:0.73%
controls:0.07%
cases:4.33%
controls:0.61%
cases:8.21%
controls:1.69%
81
246
1289
13398
64
73
1307
13581
15
9
1356
13645
25
0
1346
13654
10
10
1357
13608
56
81
1238
13150
86
186
962
10844
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.3e+00
1.6e+00
2.6e+00
—
3.3e+00
1.7e+00
1.5e+00
cases:9.12%
controls:2.56%
cases:7.08%
controls:1.46%
cases:3.72%
controls:0.28%
—
—
cases:4.61%
controls:0.18%
cases:7.73%
controls:1.54%
cases:13.07%
controls:3.10%
125
349
1245
13295
97
200
1274
13454
51
38
1320
13616
—
63
24
1304
13594
100
204
1194
13027
137
342
911
10688
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
1.4e+00
1.9e+00
2.8e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:16.72%
controls:4.72%
cases:16.27%
controls:2.80%
cases:7.59%
controls:0.52%
—
—
cases:5.49%
controls:0.35%
cases:15.61%
controls:2.87%
cases:24.14%
controls:7.08%
229
644
1141
13000
223
382
1148
13272
104
71
1267
13583
—
75
48
1292
13570
202
380
1092
12851
253
781
795
10249
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
9.2e-01
1.4e+00
2.0e+00
3.5e+00
1.8e+00
1.4e+00
1.2e+00
cases:30.00%
controls:14.56%
cases:29.98%
controls:9.53%
cases:14.88%
controls:2.35%
cases:2.70%
controls:0.09%
cases:11.41%
controls:2.11%
cases:29.13%
controls:9.42%
cases:43.99%
controls:19.27%
411
1987
959
11657
411
1301
960
12353
204
321
1167
13333
37
12
1334
13642
156
287
1211
13331
377
1247
917
11984
461
2125
587
8905
formoterol; inhalant
R03AC13 [21603267]
2.0e+00
2.1e+00
1.9e+00
—
1.9e+00
2.2e+00
2.1e+00
cases:3.80%
controls:0.52%
cases:2.55%
controls:0.31%
cases:0.51%
controls:0.08%
—
—
cases:0.66%
controls:0.10%
cases:2.32%
controls:0.27%
cases:4.10%
controls:0.54%
52
71
1318
13573
35
43
1336
13611
7
11
1364
13643
—
9
14
1358
13604
30
36
1264
13195
43
60
1005
10970
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
8.7e-01
1.2e+00
2.0e+00
4.1e+00
2.0e+00
1.0e+00
8.0e-01
cases:23.14%
controls:11.22%
cases:19.33%
controls:6.77%
cases:6.64%
controls:0.93%
cases:2.63%
controls:0.04%
cases:6.07%
controls:0.84%
cases:17.85%
controls:7.28%
cases:35.40%
controls:19.79%
317
1531
1053
12113
265
925
1106
12729
91
127
1280
13527
36
6
1335
13648
83
115
1284
13503
231
963
1063
12268
371
2183
677
8847
oxycodone; oral, parenteral
N02AA05 [21604260]
2.0e+00
2.2e+00
2.3e+00
—
2.2e+00
1.9e+00
1.5e+00
cases:9.93%
controls:1.47%
cases:7.95%
controls:0.97%
cases:3.57%
controls:0.39%
—
—
cases:3.29%
controls:0.39%
cases:7.73%
controls:1.19%
cases:11.83%
controls:2.88%
136
201
1234
13443
109
132
1262
13522
49
53
1322
13601
—
45
53
1322
13565
100
158
1194
13073
124
318
924
10712
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
6.6e-01
1.1e+00
1.9e+00
4.8e+00
1.8e+00
9.6e-01
8.5e-01
cases:28.91%
controls:17.40%
cases:23.27%
controls:9.22%
cases:8.32%
controls:1.38%
cases:4.89%
controls:0.04%
cases:6.80%
controls:1.14%
cases:20.25%
controls:8.89%
cases:41.32%
controls:23.07%
396
2374
974
11270
319
1259
1052
12395
114
189
1257
13465
67
6
1304
13648
93
155
1274
13463
262
1176
1032
12055
433
2545
615
8485
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
8.6e-01
1.2e+00
2.0e+00
4.1e+00
2.0e+00
1.0e+00
8.0e-01
cases:23.28%
controls:11.40%
cases:19.55%
controls:6.90%
cases:6.64%
controls:0.92%
cases:2.63%
controls:0.04%
cases:6.07%
controls:0.87%
cases:18.01%
controls:7.33%
cases:35.69%
controls:19.92%
319
1556
1051
12088
268
942
1103
12712
91
126
1280
13528
36
6
1335
13648
83
118
1284
13500
233
970
1061
12261
374
2197
674
8833
Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6025-1 [3011951]
3.0e+00
3.2e+00
—
—
—
3.1e+00
2.7e+00
cases:1.75%
controls:0.09%
cases:1.46%
controls:0.06%
—
—
—
—
—
—
cases:1.00%
controls:0.05%
cases:2.29%
controls:0.16%
24
12
1346
13632
20
8
1351
13646
—
—
—
13
6
1281
13225
24
18
1024
11012
Oxygen saturation in Arterial blood
2708-6 [3016502]
1.5e+00
1.7e+00
2.7e+00
1.0e+50
3.2e+00
1.6e+00
1.3e+00
cases:5.77%
controls:1.41%
cases:3.87%
controls:0.72%
cases:1.53%
controls:0.10%
cases:1.82%
controls:0.00%
cases:1.39%
controls:0.06%
cases:3.63%
controls:0.75%
cases:9.54%
controls:2.77%
79
192
1291
13452
53
98
1318
13556
21
14
1350
13640
25
0
1346
13654
19
8
1348
13610
47
99
1247
13132
100
306
948
10724
Intravenous
ZX120 [2001311495]
1.8e+00
1.9e+00
2.2e+00
1.0e+50
2.5e+00
1.7e+00
1.8e+00
cases:6.06%
controls:1.08%
cases:3.14%
controls:0.47%
cases:0.95%
controls:0.11%
cases:0.36%
controls:0.00%
cases:1.02%
controls:0.08%
cases:2.09%
controls:0.40%
cases:4.58%
controls:0.79%
83
148
1287
13496
43
64
1328
13590
13
15
1358
13639
5
0
1366
13654
14
11
1353
13607
27
53
1267
13178
48
87
1000
10943
Measurement of expired nitric oxide
444642008 [40480257]
2.6e+00
2.7e+00
—
—
—
3.5e+00
3.0e+00
cases:3.21%
controls:0.25%
cases:1.24%
controls:0.08%
—
—
—
—
—
—
cases:1.47%
controls:0.05%
cases:3.15%
controls:0.15%
44
34
1326
13610
17
11
1354
13643
—
—
—
19
6
1275
13225
33
17
1015
11013
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
1.5e+00
1.5e+00
2.8e+00
—
3.3e+00
1.8e+00
8.8e-01
cases:3.43%
controls:0.75%
cases:2.04%
controls:0.48%
cases:0.88%
controls:0.05%
—
—
cases:1.17%
controls:0.04%
cases:2.78%
controls:0.46%
cases:4.20%
controls:1.78%
47
103
1323
13541
28
65
1343
13589
12
7
1359
13647
—
16
6
1351
13612
36
61
1258
13170
44
196
1004
10834
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
1.1e+00
1.9e+00
2.9e+00
1.0e+50
3.1e+00
1.7e+00
1.2e+00
cases:2.48%
controls:0.83%
cases:2.33%
controls:0.36%
cases:1.39%
controls:0.08%
cases:1.60%
controls:0.00%
cases:1.24%
controls:0.06%
cases:2.16%
controls:0.40%
cases:4.77%
controls:1.46%
34
113
1336
13531
32
49
1339
13605
19
11
1352
13643
22
0
1349
13654
17
8
1350
13610
28
53
1266
13178
50
161
998
10869
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
1.4e+00
1.8e+00
2.6e+00
1.0e+50
3.3e+00
1.5e+00
1.3e+00
cases:6.20%
controls:1.69%
cases:4.74%
controls:0.83%
cases:1.75%
controls:0.13%
cases:2.26%
controls:0.00%
cases:1.76%
controls:0.07%
cases:4.02%
controls:0.89%
cases:10.02%
controls:2.99%
85
230
1285
13414
65
114
1306
13540
24
18
1347
13636
31
0
1340
13654
24
9
1343
13609
52
118
1242
13113
105
330
943
10700
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
1.3e+00
1.8e+00
2.6e+00
1.0e+50
3.3e+00
1.5e+00
1.3e+00
cases:6.20%
controls:1.69%
cases:4.74%
controls:0.83%
cases:1.75%
controls:0.13%
cases:2.26%
controls:0.00%
cases:1.76%
controls:0.07%
cases:4.02%
controls:0.89%
cases:10.02%
controls:2.99%
85
231
1285
13413
65
114
1306
13540
24
18
1347
13636
31
0
1340
13654
24
9
1343
13609
52
118
1242
13113
105
330
943
10700
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
5.1e-01
1.2e+00
2.2e+00
4.1e+00
2.0e+00
1.1e+00
6.9e-01
cases:45.84%
controls:33.60%
cases:47.48%
controls:21.72%
cases:28.23%
controls:4.10%
cases:14.81%
controls:0.28%
cases:23.77%
controls:4.08%
cases:46.45%
controls:22.21%
cases:62.79%
controls:45.78%
628
4584
742
9060
651
2965
720
10689
387
560
984
13094
203
38
1168
13616
325
556
1042
13062
601
2939
693
10292
658
5049
390
5981
pH of Arterial blood
2744-1 [3019977]
1.3e+00
1.8e+00
2.6e+00
1.0e+50
3.3e+00
1.6e+00
1.3e+00
cases:6.06%
controls:1.70%
cases:4.67%
controls:0.83%
cases:1.68%
controls:0.13%
cases:2.26%
controls:0.00%
cases:1.83%
controls:0.07%
cases:4.10%
controls:0.88%
cases:10.02%
controls:3.06%
83
232
1287
13412
64
114
1307
13540
23
18
1348
13636
31
0
1340
13654
25
9
1342
13609
53
117
1241
13114
105
338
943
10692
epinephrine
S01EA01 [21603673]
1.7e+00
2.0e+00
2.1e+00
—
2.1e+00
1.9e+00
1.8e+00
cases:6.06%
controls:1.13%
cases:3.36%
controls:0.46%
cases:0.44%
controls:0.05%
—
—
cases:0.44%
controls:0.05%
cases:3.55%
controls:0.53%
cases:6.49%
controls:1.13%
83
154
1287
13490
46
63
1325
13591
6
7
1365
13647
—
6
7
1361
13611
46
70
1248
13161
68
125
980
10905
epinephrine; parenteral
C01CA24 [21600303]
1.7e+00
2.0e+00
2.1e+00
—
2.1e+00
1.9e+00
1.8e+00
cases:6.06%
controls:1.13%
cases:3.36%
controls:0.46%
cases:0.44%
controls:0.05%
—
—
cases:0.44%
controls:0.05%
cases:3.55%
controls:0.53%
cases:6.49%
controls:1.13%
83
154
1287
13490
46
63
1325
13591
6
7
1365
13647
—
6
7
1361
13611
46
70
1248
13161
68
125
980
10905
Arthritis, unspecified
M13.9 [45567463]
1.2e+00
1.9e+00
2.9e+00
1.0e+50
2.7e+00
1.9e+00
1.1e+00
cases:2.99%
controls:0.89%
cases:2.12%
controls:0.33%
cases:0.80%
controls:0.04%
cases:0.58%
controls:0.00%
cases:0.88%
controls:0.06%
cases:2.09%
controls:0.31%
cases:2.77%
controls:0.93%
41
122
1329
13522
29
45
1342
13609
11
6
1360
13648
8
0
1363
13654
12
8
1355
13610
27
41
1267
13190
29
103
1019
10927
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
1.4e+00
1.8e+00
2.6e+00
1.0e+50
3.1e+00
1.7e+00
1.2e+00
cases:4.82%
controls:1.29%
cases:3.94%
controls:0.69%
cases:1.46%
controls:0.11%
cases:2.12%
controls:0.00%
cases:1.32%
controls:0.06%
cases:3.63%
controls:0.70%
cases:8.49%
controls:2.67%
66
176
1304
13468
54
94
1317
13560
20
15
1351
13639
29
0
1342
13654
18
8
1349
13610
47
92
1247
13139
89
295
959
10735
Base excess in Arterial blood by calculation
1925-7 [3003396]
1.4e+00
1.7e+00
2.7e+00
1.0e+50
3.2e+00
1.5e+00
1.2e+00
cases:6.28%
controls:1.67%
cases:4.52%
controls:0.82%
cases:1.75%
controls:0.12%
cases:2.04%
controls:0.00%
cases:1.61%
controls:0.07%
cases:4.02%
controls:0.88%
cases:9.54%
controls:3.03%
86
228
1284
13416
62
112
1309
13542
24
17
1347
13637
28
0
1343
13654
22
9
1345
13609
52
117
1242
13114
100
334
948
10696
salmeterol and fluticasone
R03AK06 [21603280]
1.9e+00
2.2e+00
2.1e+00
—
2.1e+00
1.8e+00
1.7e+00
cases:16.79%
controls:2.94%
cases:14.22%
controls:1.88%
cases:4.38%
controls:0.58%
—
—
cases:3.73%
controls:0.48%
cases:11.59%
controls:2.03%
cases:13.65%
controls:2.86%
230
401
1140
13243
195
257
1176
13397
60
79
1311
13575
—
51
66
1316
13552
150
268
1144
12963
143
316
905
10714
Thorax X-ray examination
GD1AA [2001303617]
1.4e+00
1.8e+00
2.7e+00
—
2.3e+00
1.8e+00
1.6e+00
cases:29.20%
controls:8.88%
cases:17.80%
controls:3.40%
cases:4.45%
controls:0.31%
—
—
cases:3.07%
controls:0.32%
cases:16.31%
controls:3.08%
cases:33.11%
controls:8.98%
400
1212
970
12432
244
464
1127
13190
61
42
1310
13612
—
42
43
1325
13575
211
408
1083
12823
347
990
701
10040
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
2.0e+00
2.0e+00
1.9e+00
—
1.8e+00
1.8e+00
2.2e+00
cases:5.04%
controls:0.73%
cases:2.33%
controls:0.31%
cases:0.66%
controls:0.10%
—
—
cases:0.51%
controls:0.09%
cases:2.09%
controls:0.34%
cases:6.11%
controls:0.73%
69
100
1301
13544
32
42
1339
13612
9
14
1362
13640
—
7
12
1360
13606
27
45
1267
13186
64
80
984
10950
Bacteria identified in Blood by Culture
600-7 [3023368]
1.2e+00
1.8e+00
2.5e+00
—
2.9e+00
1.7e+00
1.5e+00
cases:14.16%
controls:4.71%
cases:13.35%
controls:2.43%
cases:4.23%
controls:0.37%
—
—
cases:4.24%
controls:0.24%
cases:11.28%
controls:2.34%
cases:24.33%
controls:6.47%
194
643
1176
13001
183
332
1188
13322
58
51
1313
13603
—
58
33
1309
13585
146
310
1148
12921
255
714
793
10316
Aldosterone [Moles/volume] in Serum or Plasma
14586-2 [3001788]
2.3e+00
3.1e+00
—
—
—
3.6e+00
2.5e+00
cases:1.82%
controls:0.18%
cases:1.68%
controls:0.07%
—
—
—
—
—
—
cases:2.24%
controls:0.06%
cases:2.58%
controls:0.22%
25
25
1345
13619
23
10
1348
13644
—
—
—
29
8
1265
13223
27
24
1021
11006
Chronic pansinusitis
J32.4 [45581854]
2.8e+00
3.2e+00
1.0e+50
1.0e+50
—
3.0e+00
2.5e+00
cases:1.46%
controls:0.09%
cases:1.02%
controls:0.04%
cases:0.66%
controls:0.00%
cases:0.51%
controls:0.00%
—
—
cases:1.39%
controls:0.07%
cases:1.81%
controls:0.15%
20
12
1350
13632
14
6
1357
13648
9
0
1362
13654
7
0
1364
13654
—
18
9
1276
13222
19
16
1029
11014
Essential (primary) hypertension
I10 [45591453]
5.8e-01
9.7e-01
1.7e+00
5.0e+00
1.8e+00
9.4e-01
5.5e-01
cases:27.66%
controls:17.64%
cases:19.47%
controls:8.39%
cases:7.44%
controls:1.47%
cases:9.26%
controls:0.07%
cases:7.68%
controls:1.40%
cases:20.79%
controls:9.33%
cases:33.40%
controls:22.45%
379
2407
991
11237
267
1145
1104
12509
102
201
1269
13453
127
9
1244
13645
105
191
1262
13427
269
1235
1025
11996
350
2476
698
8554
Osmolality of Urine
2695-5 [3026782]
9.8e-01
1.7e+00
2.9e+00
—
2.9e+00
1.6e+00
1.4e+00
cases:12.19%
controls:4.96%
cases:9.77%
controls:1.98%
cases:4.08%
controls:0.23%
—
—
cases:3.58%
controls:0.20%
cases:8.19%
controls:1.74%
cases:16.98%
controls:4.72%
167
677
1203
12967
134
270
1237
13384
56
32
1315
13622
—
49
27
1318
13591
106
230
1188
13001
178
521
870
10509
Granulocytes [#/volume] in Blood
30394-1 [3035715]
1.8e+00
2.3e+00
2.5e+00
—
—
2.2e+00
2.7e+00
cases:3.28%
controls:0.54%
cases:1.39%
controls:0.15%
cases:0.73%
controls:0.06%
—
—
—
—
cases:1.31%
controls:0.15%
cases:4.48%
controls:0.31%
45
74
1325
13570
19
20
1352
13634
10
8
1361
13646
—
—
17
20
1277
13211
47
34
1001
10996
Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8099-4 [3027238]
7.2e-01
1.8e+00
2.9e+00
—
3.3e+00
1.7e+00
1.1e+00
cases:3.28%
controls:1.62%
cases:2.70%
controls:0.48%
cases:0.95%
controls:0.05%
—
—
cases:0.95%
controls:0.04%
cases:2.63%
controls:0.48%
cases:5.15%
controls:1.83%
45
221
1325
13423
37
65
1334
13589
13
7
1358
13647
—
13
5
1354
13613
34
63
1260
13168
54
202
994
10828
Office Visit
OMOP4822458 [581477]
1.4e+00
1.8e+00
2.5e+00
—
2.4e+00
1.8e+00
1.5e+00
cases:27.66%
controls:8.59%
cases:12.76%
controls:2.27%
cases:2.92%
controls:0.26%
—
—
cases:3.95%
controls:0.37%
cases:11.44%
controls:2.07%
cases:20.42%
controls:5.22%
379
1172
991
12472
175
310
1196
13344
40
35
1331
13619
—
54
50
1313
13568
148
274
1146
12957
214
576
834
10454
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.7e+00
1.9e+00
2.1e+00
—
1.9e+00
2.2e+00
1.6e+00
cases:9.34%
controls:1.82%
cases:6.49%
controls:1.00%
cases:2.84%
controls:0.36%
—
—
cases:2.63%
controls:0.40%
cases:7.73%
controls:0.91%
cases:11.16%
controls:2.45%
128
248
1242
13396
89
137
1282
13517
39
49
1332
13605
—
36
55
1331
13563
100
121
1194
13110
117
270
931
10760
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
5.5e-01
1.1e+00
2.4e+00
3.3e+00
2.1e+00
1.2e+00
8.1e-01
cases:34.09%
controls:22.90%
cases:29.83%
controls:12.64%
cases:15.83%
controls:1.66%
cases:1.75%
controls:0.07%
cases:13.02%
controls:1.78%
cases:32.23%
controls:12.72%
cases:52.19%
controls:32.71%
467
3125
903
10519
409
1726
962
11928
217
226
1154
13428
24
9
1347
13645
178
243
1189
13375
417
1683
877
11548
547
3608
501
7422
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
1.7e+00
1.8e+00
2.6e+00
—
2.8e+00
1.3e+00
1.2e+00
cases:6.13%
controls:1.19%
cases:3.57%
controls:0.59%
cases:1.17%
controls:0.09%
—
—
cases:1.10%
controls:0.07%
cases:2.40%
controls:0.64%
cases:5.73%
controls:1.89%
84
162
1286
13482
49
81
1322
13573
16
12
1355
13642
—
15
9
1352
13609
31
85
1263
13146
60
208
988
10822
Body CT examination
JN4AD [2001310897]
1.7e+00
1.9e+00
2.9e+00
1.0e+50
1.8e+00
1.8e+00
1.3e+00
cases:3.94%
controls:0.76%
cases:4.01%
controls:0.60%
cases:1.09%
controls:0.06%
cases:0.88%
controls:0.00%
cases:0.51%
controls:0.09%
cases:4.25%
controls:0.72%
cases:5.92%
controls:1.70%
54
104
1316
13540
55
82
1316
13572
15
8
1356
13646
12
0
1359
13654
7
12
1360
13606
55
95
1239
13136
62
188
986
10842
Abdominal ultrasound examination
JN3AE [2001305555]
1.6e+00
1.6e+00
2.2e+00
—
2.5e+00
1.9e+00
1.6e+00
cases:7.66%
controls:1.64%
cases:2.77%
controls:0.56%
cases:0.51%
controls:0.06%
—
—
cases:0.44%
controls:0.04%
cases:2.63%
controls:0.39%
cases:6.49%
controls:1.41%
105
224
1265
13420
38
76
1333
13578
7
8
1364
13646
—
6
5
1361
13613
34
51
1260
13180
68
155
980
10875
Pneumonia, unspecified
J18.9 [45601123]
1.6e+00
2.1e+00
2.5e+00
1.0e+50
2.1e+00
1.8e+00
1.4e+00
cases:12.26%
controls:2.87%
cases:8.53%
controls:1.15%
cases:1.68%
controls:0.15%
cases:1.75%
controls:0.00%
cases:1.17%
controls:0.14%
cases:6.65%
controls:1.20%
cases:14.22%
controls:4.06%
168
391
1202
13253
117
157
1254
13497
23
20
1348
13634
24
0
1347
13654
16
19
1351
13599
86
159
1208
13072
149
448
899
10582
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.9e-01
8.8e-01
2.3e+00
4.1e+00
2.0e+00
1.0e+00
5.6e-01
cases:46.06%
controls:36.52%
cases:48.87%
controls:28.36%
cases:35.67%
controls:5.10%
cases:16.48%
controls:0.32%
cases:28.75%
controls:5.05%
cases:53.55%
controls:29.05%
cases:65.94%
controls:52.42%
631
4983
739
8661
670
3872
701
9782
489
696
882
12958
226
44
1145
13610
393
688
974
12930
693
3843
601
9388
691
5782
357
5248
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
2.4e+00
2.6e+00
1.3e+00
—
1.9e+00
2.2e+00
2.3e+00
cases:4.89%
controls:0.48%
cases:3.36%
controls:0.26%
cases:0.36%
controls:0.10%
—
—
cases:0.59%
controls:0.09%
cases:2.32%
controls:0.27%
cases:3.63%
controls:0.37%
67
66
1303
13578
46
36
1325
13618
5
13
1366
13641
—
8
12
1359
13606
30
36
1264
13195
38
41
1010
10989
INR in Blood by Coagulation assay
34714-6 [3032080]
9.4e-01
1.4e+00
1.5e+00
3.6e+00
1.4e+00
1.2e+00
1.2e+00
cases:24.09%
controls:11.02%
cases:21.01%
controls:6.28%
cases:9.70%
controls:2.24%
cases:5.18%
controls:0.15%
cases:7.83%
controls:2.00%
cases:18.16%
controls:6.22%
cases:33.78%
controls:13.56%
330
1504
1040
12140
288
858
1083
12796
133
306
1238
13348
71
20
1300
13634
107
273
1260
13345
235
823
1059
12408
354
1496
694
9534
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.9e-01
8.7e-01
2.3e+00
4.1e+00
2.0e+00
1.0e+00
5.5e-01
cases:46.28%
controls:36.87%
cases:49.09%
controls:28.68%
cases:35.67%
controls:5.17%
cases:16.48%
controls:0.32%
cases:28.60%
controls:5.16%
cases:53.71%
controls:29.36%
cases:65.84%
controls:52.70%
634
5031
736
8613
673
3916
698
9738
489
706
882
12948
226
44
1145
13610
391
703
976
12915
695
3885
599
9346
690
5813
358
5217
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
1.2e+00
1.6e+00
2.6e+00
—
3.1e+00
1.6e+00
1.1e+00
cases:5.99%
controls:1.96%
cases:4.89%
controls:0.99%
cases:2.19%
controls:0.16%
—
—
cases:2.19%
controls:0.10%
cases:4.71%
controls:0.94%
cases:10.40%
controls:3.69%
82
267
1288
13377
67
135
1304
13519
30
22
1341
13632
—
30
14
1337
13604
61
125
1233
13106
109
407
939
10623
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
5.9e-01
1.0e+00
1.8e+00
4.3e+00
1.6e+00
1.1e+00
8.3e-01
cases:9.12%
controls:5.28%
cases:7.44%
controls:2.81%
cases:2.92%
controls:0.51%
cases:3.28%
controls:0.04%
cases:2.49%
controls:0.51%
cases:8.42%
controls:3.01%
cases:14.22%
controls:6.75%
125
721
1245
12923
102
384
1269
13270
40
69
1331
13585
45
6
1326
13648
34
69
1333
13549
109
398
1185
12833
149
745
899
10285
calcium (different salts in combination); oral
A12AA20 [21600872]
1.4e+00
1.5e+00
1.2e+00
2.5e+00
1.4e+00
1.6e+00
1.6e+00
cases:30.51%
controls:9.78%
cases:27.72%
controls:7.78%
cases:6.93%
controls:2.22%
cases:0.73%
controls:0.06%
cases:8.27%
controls:2.17%
cases:29.60%
controls:7.97%
cases:39.22%
controls:11.13%
418
1335
952
12309
380
1062
991
12592
95
303
1276
13351
10
8
1361
13646
113
295
1254
13323
383
1054
911
12177
411
1228
637
9802
Hypothyroidism, unspecified
E03.9 [45537945]
8.5e-01
1.5e+00
2.4e+00
1.0e+50
3.0e+00
1.9e+00
1.5e+00
cases:4.96%
controls:2.18%
cases:4.60%
controls:1.02%
cases:1.60%
controls:0.15%
cases:4.60%
controls:0.00%
cases:2.71%
controls:0.13%
cases:6.96%
controls:1.10%
cases:13.36%
controls:3.21%
68
298
1302
13346
63
139
1308
13515
22
21
1349
13633
63
0
1308
13654
37
18
1330
13600
90
145
1204
13086
140
354
908
10676
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
1.7e+00
2.3e+00
2.7e+00
—
—
2.1e+00
2.5e+00
cases:3.50%
controls:0.66%
cases:1.39%
controls:0.15%
cases:0.88%
controls:0.06%
—
—
—
—
cases:1.47%
controls:0.19%
cases:4.77%
controls:0.41%
48
90
1322
13554
19
20
1352
13634
12
8
1359
13646
—
—
19
25
1275
13206
50
45
998
10985
Rheumatology
66 [38004491]
1.6e+00
1.9e+00
2.4e+00
—
1.8e+00
1.9e+00
1.7e+00
cases:15.91%
controls:3.71%
cases:12.84%
controls:2.26%
cases:3.57%
controls:0.34%
—
—
cases:2.85%
controls:0.50%
cases:12.52%
controls:2.09%
cases:16.03%
controls:3.29%
218
506
1152
13138
176
308
1195
13346
49
46
1322
13608
—
39
68
1328
13550
162
276
1132
12955
168
363
880
10667
Otolaryngic Allergy Physician
207YX0602X [38003921]
2.9e+00
3.1e+00
—
—
—
2.3e+00
2.9e+00
cases:0.95%
controls:0.05%
cases:0.80%
controls:0.04%
—
—
—
—
—
—
cases:0.62%
controls:0.06%
cases:0.95%
controls:0.05%
13
7
1357
13637
11
5
1360
13649
—
—
—
8
8
1286
13223
10
6
1038
11024
Fibromyalgia
M79.7 [45553272]
1.7e+00
2.1e+00
1.8e+00
—
2.1e+00
1.8e+00
1.8e+00
cases:2.77%
controls:0.51%
cases:2.12%
controls:0.26%
cases:0.51%
controls:0.09%
—
—
cases:0.59%
controls:0.07%
cases:1.70%
controls:0.29%
cases:3.82%
controls:0.68%
38
69
1332
13575
29
35
1342
13619
7
12
1364
13642
—
8
10
1359
13608
22
39
1272
13192
40
75
1008
10955
pH of Serum or Plasma
2753-2 [3018418]
1.1e+00
1.6e+00
2.5e+00
—
2.9e+00
1.6e+00
1.5e+00
cases:17.15%
controls:6.32%
cases:14.08%
controls:3.22%
cases:6.49%
controls:0.56%
—
—
cases:7.02%
controls:0.43%
cases:15.07%
controls:3.34%
cases:30.15%
controls:8.70%
235
862
1135
12782
193
440
1178
13214
89
77
1282
13577
—
96
59
1271
13559
195
442
1099
12789
316
960
732
10070
Sleep apnoea
G47.3 [45562094]
8.9e-01
1.2e+00
1.5e+00
3.3e+00
1.7e+00
1.3e+00
1.2e+00
cases:10.07%
controls:4.40%
cases:9.04%
controls:2.86%
cases:2.84%
controls:0.62%
cases:1.82%
controls:0.07%
cases:3.29%
controls:0.61%
cases:9.51%
controls:2.83%
cases:16.98%
controls:5.63%
138
600
1232
13044
124
391
1247
13263
39
85
1332
13569
25
9
1346
13645
45
83
1322
13535
123
375
1171
12856
178
621
870
10409
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.3e+00
1.7e+00
3.0e+00
—
2.6e+00
1.5e+00
1.2e+00
cases:20.15%
controls:6.43%
cases:13.79%
controls:2.94%
cases:6.42%
controls:0.35%
—
—
cases:4.32%
controls:0.35%
cases:11.75%
controls:2.84%
cases:24.14%
controls:9.05%
276
877
1094
12767
189
402
1182
13252
88
48
1283
13606
—
59
47
1308
13571
152
376
1142
12855
253
998
795
10032
moxifloxacin; oral, parenteral
J01MA14 [21603021]
1.9e+00
2.3e+00
2.3e+00
—
2.5e+00
2.5e+00
2.1e+00
cases:5.62%
controls:0.92%
cases:2.12%
controls:0.22%
cases:0.36%
controls:0.04%
—
—
cases:0.44%
controls:0.04%
cases:2.16%
controls:0.19%
cases:4.29%
controls:0.56%
77
126
1293
13518
29
30
1342
13624
5
5
1366
13649
—
6
5
1361
13613
28
25
1266
13206
45
62
1003
10968
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.2e+00
1.7e+00
2.5e+00
—
2.9e+00
1.5e+00
1.2e+00
cases:5.69%
controls:1.73%
cases:5.18%
controls:0.98%
cases:2.26%
controls:0.19%
—
—
cases:2.56%
controls:0.14%
cases:4.71%
controls:1.08%
cases:7.06%
controls:2.20%
78
236
1292
13408
71
134
1300
13520
31
26
1340
13628
—
35
19
1332
13599
61
143
1233
13088
74
243
974
10787
Gastroenterology
10 [38004455]
1.5e+00
1.7e+00
2.1e+00
—
2.5e+00
1.8e+00
1.5e+00
cases:20.51%
controls:5.56%
cases:12.55%
controls:2.63%
cases:4.23%
controls:0.52%
—
—
cases:4.02%
controls:0.35%
cases:13.83%
controls:2.47%
cases:22.90%
controls:6.28%
281
759
1089
12885
172
359
1199
13295
58
71
1313
13583
—
55
48
1312
13570
179
327
1115
12904
240
693
808
10337
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
1.7e+00
2.2e+00
3.2e+00
—
—
2.2e+00
1.8e+00
cases:5.91%
controls:1.16%
cases:4.60%
controls:0.51%
cases:0.88%
controls:0.04%
—
—
—
—
cases:3.40%
controls:0.39%
cases:9.16%
controls:1.66%
81
158
1289
13486
63
69
1308
13585
12
5
1359
13649
—
—
44
52
1250
13179
96
183
952
10847
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
7.3e-01
1.3e+00
2.3e+00
2.7e+00
1.9e+00
1.1e+00
9.4e-01
cases:36.42%
controls:21.70%
cases:31.80%
controls:11.03%
cases:13.06%
controls:1.44%
cases:0.95%
controls:0.07%
cases:8.71%
controls:1.34%
cases:27.51%
controls:10.78%
cases:49.24%
controls:27.57%
499
2961
871
10683
436
1506
935
12148
179
197
1192
13457
13
9
1358
13645
119
183
1248
13435
356
1426
938
11805
516
3041
532
7989
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.4e+00
1.7e+00
2.6e+00
—
2.6e+00
1.5e+00
1.1e+00
cases:7.81%
controls:1.96%
cases:6.05%
controls:1.11%
cases:2.77%
controls:0.21%
—
—
cases:2.19%
controls:0.16%
cases:4.87%
controls:1.15%
cases:8.49%
controls:2.92%
107
267
1263
13377
83
152
1288
13502
38
28
1333
13626
—
30
22
1337
13596
63
152
1231
13079
89
322
959
10708
Cathetrisation of vein
TPH04 [2001309597]
1.3e+00
1.8e+00
2.3e+00
—
2.4e+00
1.9e+00
1.4e+00
cases:10.15%
controls:3.02%
cases:5.62%
controls:1.00%
cases:1.53%
controls:0.16%
—
—
cases:1.46%
controls:0.13%
cases:6.03%
controls:1.00%
cases:11.74%
controls:3.18%
139
412
1231
13232
77
136
1294
13518
21
22
1350
13632
—
20
18
1347
13600
78
132
1216
13099
123
351
925
10679
Bacteria identified in Sputum by Culture
6460-0 [3023419]
2.5e+00
3.2e+00
—
—
—
2.5e+00
2.8e+00
cases:2.12%
controls:0.18%
cases:1.75%
controls:0.07%
—
—
—
—
—
—
cases:1.55%
controls:0.13%
cases:4.01%
controls:0.25%
29
24
1341
13620
24
10
1347
13644
—
—
—
20
17
1274
13214
42
28
1006
11002
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 [3032699]
2.0e+00
3.3e+00
—
—
—
2.7e+00
3.1e+00
cases:0.73%
controls:0.10%
cases:0.95%
controls:0.04%
—
—
—
—
—
—
cases:0.77%
controls:0.05%
cases:1.34%
controls:0.06%
10
14
1360
13630
13
5
1358
13649
—
—
—
10
7
1284
13224
14
7
1034
11023
Teaching
WZC30 [2001310891]
1.4e+00
1.8e+00
2.6e+00
—
1.8e+00
1.9e+00
1.4e+00
cases:7.74%
controls:2.00%
cases:5.84%
controls:1.01%
cases:2.04%
controls:0.15%
—
—
cases:0.95%
controls:0.16%
cases:6.49%
controls:0.99%
cases:11.35%
controls:2.98%
106
273
1264
13371
80
138
1291
13516
28
21
1343
13633
—
13
22
1354
13596
84
131
1210
13100
119
329
929
10701
Chronic kidney disease, unspecified
N18.9 [45553438]
1.5e+00
1.9e+00
2.3e+00
—
2.5e+00
1.6e+00
1.1e+00
cases:2.12%
controls:0.48%
cases:2.19%
controls:0.32%
cases:0.88%
controls:0.09%
—
—
cases:0.80%
controls:0.07%
cases:2.24%
controls:0.44%
cases:2.77%
controls:0.96%
29
66
1341
13578
30
44
1341
13610
12
12
1359
13642
—
11
9
1356
13609
29
58
1265
13173
29
106
1019
10924
Malaise and fatigue
R53 [45553741]
1.3e+00
1.7e+00
3.0e+00
—
2.4e+00
1.4e+00
1.1e+00
cases:10.07%
controls:3.00%
cases:6.78%
controls:1.27%
cases:3.57%
controls:0.18%
—
—
cases:1.46%
controls:0.13%
cases:5.49%
controls:1.46%
cases:14.60%
controls:5.38%
138
410
1232
13234
93
174
1278
13480
49
24
1322
13630
—
20
18
1347
13600
71
193
1223
13038
153
593
895
10437
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
2.7e+00
2.4e+00
2.3e+00
—
—
2.6e+00
3.2e+00
cases:1.97%
controls:0.13%
cases:1.02%
controls:0.10%
cases:0.36%
controls:0.04%
—
—
—
—
cases:0.93%
controls:0.07%
cases:2.19%
controls:0.09%
27
18
1343
13626
14
13
1357
13641
5
5
1366
13649
—
—
12
9
1282
13222
23
10
1025
11020
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2.0e+00
2.1e+00
2.8e+00
—
—
2.2e+00
1.8e+00
cases:7.59%
controls:1.10%
cases:3.94%
controls:0.48%
cases:0.80%
controls:0.05%
—
—
—
—
cases:3.40%
controls:0.40%
cases:6.77%
controls:1.21%
104
150
1266
13494
54
65
1317
13589
11
7
1360
13647
—
—
44
53
1250
13178
71
133
977
10897
Crohn disease of small intestine
K50.0 [45596324]
2.0e+00
2.3e+00
2.5e+00
—
2.3e+00
2.2e+00
1.8e+00
cases:1.75%
controls:0.24%
cases:1.31%
controls:0.13%
cases:0.44%
controls:0.04%
—
—
cases:0.37%
controls:0.04%
cases:1.31%
controls:0.14%
cases:1.34%
controls:0.22%
24
33
1346
13611
18
18
1353
13636
6
5
1365
13649
—
5
5
1362
13613
17
19
1277
13212
14
24
1034
11006
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
1.4e+00
1.4e+00
2.7e+00
—
2.8e+00
1.7e+00
7.9e-01
cases:3.50%
controls:0.85%
cases:2.19%
controls:0.53%
cases:0.95%
controls:0.07%
—
—
cases:1.10%
controls:0.07%
cases:3.09%
controls:0.59%
cases:4.87%
controls:2.28%
48
116
1322
13528
30
73
1341
13581
13
9
1358
13645
—
15
9
1352
13609
40
78
1254
13153
51
251
997
10779
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.1e+00
1.5e+00
2.6e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:3.80%
controls:1.35%
cases:3.28%
controls:0.73%
cases:1.02%
controls:0.07%
—
—
cases:1.46%
controls:0.09%
cases:4.10%
controls:0.83%
cases:8.02%
controls:2.69%
52
184
1318
13460
45
100
1326
13554
14
10
1357
13644
—
20
12
1347
13606
53
110
1241
13121
84
297
964
10733
Other Crohn disease
K50.8 [45533599]
2.1e+00
2.3e+00
1.9e+00
1.0e+50
2.4e+00
2.0e+00
1.9e+00
cases:1.82%
controls:0.23%
cases:1.60%
controls:0.16%
cases:0.44%
controls:0.07%
cases:0.66%
controls:0.00%
cases:0.66%
controls:0.06%
cases:1.39%
controls:0.18%
cases:1.72%
controls:0.25%
25
31
1345
13613
22
22
1349
13632
6
9
1365
13645
9
0
1362
13654
9
8
1358
13610
18
24
1276
13207
18
28
1030
11002
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
1.5e+00
1.4e+00
2.8e+00
—
2.9e+00
1.4e+00
8.1e-01
cases:2.55%
controls:0.59%
cases:1.53%
controls:0.39%
cases:0.58%
controls:0.04%
—
—
cases:1.10%
controls:0.06%
cases:1.78%
controls:0.45%
cases:3.82%
controls:1.73%
35
81
1335
13563
21
53
1350
13601
8
5
1363
13649
—
15
8
1352
13610
23
59
1271
13172
40
191
1008
10839
vancomycin; oral
A07AA09 [21600611]
2.6e+00
2.7e+00
—
—
—
3.0e+00
2.5e+00
cases:0.95%
controls:0.07%
cases:0.66%
controls:0.04%
—
—
—
—
—
—
cases:0.77%
controls:0.04%
cases:0.86%
controls:0.07%
13
10
1357
13634
9
6
1362
13648
—
—
—
10
5
1284
13226
9
8
1039
11022
Psoriasis vulgaris
L40.0 [45543370]
1.2e+00
1.5e+00
2.6e+00
1.0e+50
2.4e+00
1.4e+00
1.5e+00
cases:1.68%
controls:0.49%
cases:1.31%
controls:0.29%
cases:0.80%
controls:0.06%
cases:0.36%
controls:0.00%
cases:0.73%
controls:0.07%
cases:1.39%
controls:0.33%
cases:2.77%
controls:0.61%
23
67
1347
13577
18
40
1353
13614
11
8
1360
13646
5
0
1366
13654
10
9
1357
13609
18
44
1276
13187
29
67
1019
10963
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
1.4e+00
1.4e+00
2.8e+00
—
2.9e+00
1.4e+00
8.4e-01
cases:2.41%
controls:0.59%
cases:1.53%
controls:0.39%
cases:0.58%
controls:0.04%
—
—
cases:1.02%
controls:0.06%
cases:1.78%
controls:0.42%
cases:3.91%
controls:1.72%
33
80
1337
13564
21
53
1350
13601
8
5
1363
13649
—
14
8
1353
13610
23
56
1271
13175
41
190
1007
10840
potassium chloride; oral
A12BA01 [21600877]
1.5e+00
1.9e+00
1.7e+00
—
2.3e+00
1.8e+00
1.6e+00
cases:7.15%
controls:1.73%
cases:6.20%
controls:1.02%
cases:1.68%
controls:0.31%
—
—
cases:2.27%
controls:0.24%
cases:5.95%
controls:1.04%
cases:10.21%
controls:2.15%
98
236
1272
13408
85
139
1286
13515
23
42
1348
13612
—
31
33
1336
13585
77
137
1217
13094
107
237
941
10793
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
2.0e+00
2.5e+00
2.8e+00
1.0e+50
—
1.8e+00
1.8e+00
cases:2.85%
controls:0.41%
cases:2.92%
controls:0.26%
cases:0.80%
controls:0.05%
cases:0.44%
controls:0.00%
—
—
cases:1.70%
controls:0.29%
cases:5.25%
controls:0.93%
39
56
1331
13588
40
35
1331
13619
11
7
1360
13647
6
0
1365
13654
—
22
38
1272
13193
55
103
993
10927
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.3e+00
1.6e+00
2.0e+00
—
2.9e+00
1.6e+00
1.4e+00
cases:8.54%
controls:2.58%
cases:6.35%
controls:1.34%
cases:1.75%
controls:0.24%
—
—
cases:3.00%
controls:0.17%
cases:7.26%
controls:1.54%
cases:15.94%
controls:4.66%
117
352
1253
13292
87
183
1284
13471
24
33
1347
13621
—
41
23
1326
13595
94
204
1200
13027
167
514
881
10516
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.3e+00
1.6e+00
1.9e+00
—
2.9e+00
1.6e+00
1.4e+00
cases:8.39%
controls:2.37%
cases:5.98%
controls:1.22%
cases:1.46%
controls:0.23%
—
—
cases:2.63%
controls:0.15%
cases:7.03%
controls:1.47%
cases:14.50%
controls:4.11%
115
324
1255
13320
82
167
1289
13487
20
31
1351
13623
—
36
21
1331
13597
91
194
1203
13037
152
453
896
10577
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
2.1e+00
3.8e+00
—
—
—
2.7e+00
2.0e+00
cases:2.77%
controls:0.35%
cases:4.23%
controls:0.10%
—
—
—
—
—
—
cases:2.70%
controls:0.18%
cases:3.34%
controls:0.44%
38
48
1332
13596
58
13
1313
13641
—
—
—
35
24
1259
13207
35
49
1013
10981
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.1e+00
1.5e+00
2.8e+00
—
2.8e+00
1.5e+00
1.0e+00
cases:3.58%
controls:1.20%
cases:2.70%
controls:0.64%
cases:1.31%
controls:0.08%
—
—
cases:1.83%
controls:0.11%
cases:2.70%
controls:0.62%
cases:6.20%
controls:2.36%
49
164
1321
13480
37
88
1334
13566
18
11
1353
13643
—
25
15
1342
13603
35
82
1259
13149
65
260
983
10770
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.3e+00
1.7e+00
1.9e+00
1.0e+50
2.5e+00
1.7e+00
1.5e+00
cases:15.26%
controls:4.49%
cases:5.91%
controls:1.16%
cases:0.95%
controls:0.14%
cases:0.36%
controls:0.00%
cases:1.54%
controls:0.13%
cases:6.34%
controls:1.18%
cases:16.70%
controls:4.13%
209
612
1161
13032
81
159
1290
13495
13
19
1358
13635
5
0
1366
13654
21
18
1346
13600
82
156
1212
13075
175
456
873
10574
Mixed asthma
J45.8 [45548118]
2.7e+00
2.7e+00
—
1.0e+50
—
2.9e+00
2.4e+00
cases:3.65%
controls:0.25%
cases:2.04%
controls:0.14%
—
—
cases:0.51%
controls:0.00%
—
—
cases:2.24%
controls:0.13%
cases:3.91%
controls:0.38%
50
34
1320
13610
28
19
1343
13635
—
7
0
1364
13654
—
29
17
1265
13214
41
42
1007
10988
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.1e+00
1.8e+00
2.2e+00
—
2.5e+00
1.5e+00
1.4e+00
cases:4.74%
controls:1.55%
cases:4.30%
controls:0.73%
cases:1.17%
controls:0.12%
—
—
cases:1.02%
controls:0.08%
cases:3.48%
controls:0.78%
cases:7.73%
controls:2.09%
65
212
1305
13432
59
99
1312
13555
16
17
1355
13637
—
14
11
1353
13607
45
103
1249
13128
81
230
967
10800
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.4e+00
1.9e+00
2.2e+00
—
2.2e+00
1.3e+00
1.6e+00
cases:8.76%
controls:2.21%
cases:6.93%
controls:1.15%
cases:1.46%
controls:0.17%
—
—
cases:1.46%
controls:0.16%
cases:5.33%
controls:1.44%
cases:16.79%
controls:4.00%
120
302
1250
13342
95
157
1276
13497
20
23
1351
13631
—
20
22
1347
13596
69
191
1225
13040
176
441
872
10589
FEV1 --post bronchodilation
20155-8 [3023550]
1.4e+00
2.1e+00
2.8e+00
1.0e+50
—
2.2e+00
2.0e+00
cases:7.81%
controls:1.96%
cases:4.60%
controls:0.57%
cases:0.88%
controls:0.05%
cases:0.44%
controls:0.00%
—
—
cases:4.48%
controls:0.54%
cases:8.87%
controls:1.28%
107
268
1263
13376
63
78
1308
13576
12
7
1359
13647
6
0
1365
13654
—
58
71
1236
13160
93
141
955
10889
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.4e+00
2.1e+00
2.8e+00
1.0e+50
—
2.2e+00
2.0e+00
cases:7.81%
controls:1.96%
cases:4.60%
controls:0.57%
cases:0.88%
controls:0.05%
cases:0.44%
controls:0.00%
—
—
cases:4.48%
controls:0.54%
cases:8.87%
controls:1.28%
107
268
1263
13376
63
78
1308
13576
12
7
1359
13647
6
0
1365
13654
—
58
71
1236
13160
93
141
955
10889
FEV1 percent change
69983-5 [42868472]
1.4e+00
2.1e+00
2.8e+00
1.0e+50
—
2.2e+00
2.0e+00
cases:7.81%
controls:1.96%
cases:4.60%
controls:0.57%
cases:0.88%
controls:0.05%
cases:0.44%
controls:0.00%
—
—
cases:4.48%
controls:0.54%
cases:8.87%
controls:1.28%
107
268
1263
13376
63
78
1308
13576
12
7
1359
13647
6
0
1365
13654
—
58
71
1236
13160
93
141
955
10889
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.4e+00
2.1e+00
2.8e+00
1.0e+50
—
2.2e+00
2.0e+00
cases:7.81%
controls:1.96%
cases:4.60%
controls:0.57%
cases:0.88%
controls:0.05%
cases:0.44%
controls:0.00%
—
—
cases:4.48%
controls:0.54%
cases:8.87%
controls:1.28%
107
268
1263
13376
63
78
1308
13576
12
7
1359
13647
6
0
1365
13654
—
58
71
1236
13160
93
141
955
10889
FVC percent change Respiratory system
69982-7 [42868471]
1.4e+00
2.1e+00
2.8e+00
1.0e+50
—
2.2e+00
2.0e+00
cases:7.81%
controls:1.96%
cases:4.60%
controls:0.57%
cases:0.88%
controls:0.05%
cases:0.44%
controls:0.00%
—
—
cases:4.48%
controls:0.54%
cases:8.87%
controls:1.28%
107
268
1263
13376
63
78
1308
13576
12
7
1359
13647
6
0
1365
13654
—
58
71
1236
13160
93
141
955
10889
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
1.3e+00
1.6e+00
2.4e+00
1.0e+50
2.9e+00
1.5e+00
9.1e-01
cases:2.85%
controls:0.78%
cases:2.19%
controls:0.47%
cases:0.73%
controls:0.07%
cases:0.95%
controls:0.00%
cases:0.66%
controls:0.04%
cases:1.70%
controls:0.39%
cases:4.29%
controls:1.78%
39
107
1331
13537
30
64
1341
13590
10
9
1361
13645
13
0
1358
13654
9
5
1358
13613
22
51
1272
13180
45
196
1003
10834
Liver transplant status
Z94.4 [45566478]
2.6e+00
2.6e+00
—
—
—
2.8e+00
2.5e+00
cases:0.51%
controls:0.04%
cases:0.58%
controls:0.04%
—
—
—
—
—
—
cases:0.62%
controls:0.04%
cases:0.57%
controls:0.05%
7
5
1363
13639
8
6
1363
13648
—
—
—
8
5
1286
13226
6
5
1042
11025
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
2.4e+00
3.0e+00
—
1.0e+50
—
2.8e+00
2.3e+00
cases:2.63%
controls:0.23%
cases:2.48%
controls:0.12%
—
—
cases:0.51%
controls:0.00%
—
—
cases:2.32%
controls:0.15%
cases:4.10%
controls:0.42%
36
32
1334
13612
34
17
1337
13637
—
7
0
1364
13654
—
30
20
1264
13211
43
46
1005
10984
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.5e+00
2.0e+00
1.9e+00
—
1.9e+00
1.8e+00
1.3e+00
cases:3.14%
controls:0.70%
cases:2.84%
controls:0.39%
cases:0.73%
controls:0.11%
—
—
cases:0.66%
controls:0.10%
cases:2.47%
controls:0.40%
cases:3.34%
controls:0.92%
43
96
1327
13548
39
53
1332
13601
10
15
1361
13639
—
9
13
1358
13605
32
53
1262
13178
35
102
1013
10928
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
1.3e+00
1.5e+00
2.5e+00
1.0e+50
2.8e+00
1.5e+00
8.4e-01
cases:2.85%
controls:0.76%
cases:1.97%
controls:0.44%
cases:0.73%
controls:0.06%
cases:0.95%
controls:0.00%
cases:0.59%
controls:0.04%
cases:1.70%
controls:0.38%
cases:4.20%
controls:1.85%
39
104
1331
13540
27
60
1344
13594
10
8
1361
13646
13
0
1358
13654
8
5
1359
13613
22
50
1272
13181
44
204
1004
10826
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.3e+00
1.7e+00
2.2e+00
—
2.4e+00
1.7e+00
1.2e+00
cases:9.42%
controls:2.85%
cases:5.03%
controls:0.92%
cases:0.95%
controls:0.11%
—
—
cases:1.02%
controls:0.10%
cases:4.40%
controls:0.82%
cases:11.07%
controls:3.45%
129
389
1241
13255
69
125
1302
13529
13
15
1358
13639
—
14
13
1353
13605
57
109
1237
13122
116
381
932
10649
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
1.4e+00
1.9e+00
2.5e+00
—
1.9e+00
1.6e+00
1.3e+00
cases:13.21%
controls:3.73%
cases:8.90%
controls:1.41%
cases:2.12%
controls:0.18%
—
—
cases:1.54%
controls:0.23%
cases:6.57%
controls:1.43%
cases:12.21%
controls:3.83%
181
509
1189
13135
122
193
1249
13461
29
24
1342
13630
—
21
32
1346
13586
85
189
1209
13042
128
422
920
10608
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.4e+00
1.8e+00
2.4e+00
—
2.3e+00
1.3e+00
1.3e+00
cases:7.74%
controls:2.02%
cases:3.72%
controls:0.67%
cases:0.73%
controls:0.07%
—
—
cases:0.66%
controls:0.07%
cases:2.86%
controls:0.79%
cases:7.63%
controls:2.20%
106
276
1264
13368
51
91
1320
13563
10
9
1361
13645
—
9
9
1358
13609
37
105
1257
13126
80
243
968
10787
Benign neoplasm: Adrenal gland
D35.0 [45576391]
2.2e+00
3.2e+00
—
—
—
2.9e+00
2.2e+00
cases:0.66%
controls:0.07%
cases:0.88%
controls:0.04%
—
—
—
—
—
—
cases:0.70%
controls:0.04%
cases:0.86%
controls:0.10%
9
10
1361
13634
12
5
1359
13649
—
—
—
9
5
1285
13226
9
11
1039
11019
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
1.0e+00
1.4e+00
2.5e+00
—
2.8e+00
1.5e+00
1.1e+00
cases:10.95%
controls:4.14%
cases:5.84%
controls:1.52%
cases:1.46%
controls:0.12%
—
—
cases:2.19%
controls:0.13%
cases:5.72%
controls:1.29%
cases:14.12%
controls:5.10%
150
565
1220
13079
80
207
1291
13447
20
16
1351
13638
—
30
18
1337
13600
74
171
1220
13060
148
562
900
10468
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.2e-01
8.1e-01
2.2e+00
4.0e+00
1.8e+00
9.1e-01
4.4e-01
cases:47.88%
controls:40.13%
cases:52.52%
controls:33.01%
cases:38.66%
controls:6.75%
cases:16.05%
controls:0.36%
cases:30.21%
controls:6.43%
cases:56.03%
controls:33.93%
cases:67.37%
controls:57.14%
656
5475
714
8169
720
4507
651
9147
530
921
841
12733
220
49
1151
13605
413
876
954
12742
725
4489
569
8742
706
6303
342
4727
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.2e+00
1.6e+00
2.0e+00
—
2.7e+00
1.6e+00
1.3e+00
cases:8.83%
controls:2.81%
cases:6.64%
controls:1.47%
cases:1.90%
controls:0.25%
—
—
cases:2.78%
controls:0.18%
cases:7.73%
controls:1.73%
cases:16.32%
controls:5.10%
121
384
1249
13260
91
201
1280
13453
26
34
1345
13620
—
38
25
1329
13593
100
229
1194
13002
171
563
877
10467
Persistent somatoform pain disorder
F45.4 [45605498]
2.7e+00
2.3e+00
—
—
—
2.9e+00
2.5e+00
cases:1.68%
controls:0.11%
cases:1.02%
controls:0.10%
—
—
—
—
—
—
cases:1.31%
controls:0.08%
cases:1.81%
controls:0.15%
23
15
1347
13629
14
14
1357
13640
—
—
—
17
10
1277
13221
19
17
1029
11013
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
2.1e+00
1.8e+00
—
—
2.5e+00
2.4e+00
1.6e+00
cases:5.18%
controls:0.66%
cases:1.82%
controls:0.30%
—
—
—
—
cases:0.51%
controls:0.04%
cases:2.09%
controls:0.20%
cases:4.39%
controls:0.91%
71
90
1299
13554
25
41
1346
13613
—
—
7
6
1360
13612
27
26
1267
13205
46
100
1002
10930
Fractional oxyhemoglobin in Capillary blood
2715-1 [3022806]
2.2e+00
3.0e+00
—
—
—
2.7e+00
2.4e+00
cases:1.90%
controls:0.21%
cases:1.46%
controls:0.07%
—
—
—
—
—
—
cases:1.16%
controls:0.08%
cases:1.91%
controls:0.17%
26
29
1344
13615
20
10
1351
13644
—
—
—
15
10
1279
13221
20
19
1028
11011
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
2.2e+00
2.9e+00
—
1.0e+50
—
2.7e+00
2.6e+00
cases:1.90%
controls:0.22%
cases:1.97%
controls:0.11%
—
—
cases:0.36%
controls:0.00%
—
—
cases:1.70%
controls:0.11%
cases:2.96%
controls:0.24%
26
30
1344
13614
27
15
1344
13639
—
5
0
1366
13654
—
22
15
1272
13216
31
26
1017
11004
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.6e+00
1.8e+00
2.2e+00
—
2.0e+00
1.2e+00
1.6e+00
cases:6.50%
controls:1.44%
cases:4.89%
controls:0.86%
cases:1.02%
controls:0.12%
—
—
cases:0.88%
controls:0.12%
cases:3.79%
controls:1.13%
cases:11.93%
controls:2.74%
89
197
1281
13447
67
118
1304
13536
14
16
1357
13638
—
12
16
1355
13602
49
149
1245
13082
125
302
923
10728
Oxygen saturation in Capillary blood
2709-4 [3021901]
2.9e+00
3.0e+00
—
—
—
2.4e+00
2.0e+00
cases:1.90%
controls:0.10%
cases:1.68%
controls:0.09%
—
—
—
—
—
—
cases:1.70%
controls:0.15%
cases:3.05%
controls:0.43%
26
14
1344
13630
23
12
1348
13642
—
—
—
22
20
1272
13211
32
47
1016
10983
ranitidine; oral, parenteral
A02BA02 [21600083]
1.3e+00
1.6e+00
1.9e+00
—
2.3e+00
1.8e+00
1.5e+00
cases:4.96%
controls:1.43%
cases:2.19%
controls:0.45%
cases:0.66%
controls:0.10%
—
—
cases:0.80%
controls:0.08%
cases:2.16%
controls:0.38%
cases:4.01%
controls:0.90%
68
195
1302
13449
30
62
1341
13592
9
14
1362
13640
—
11
11
1356
13607
28
50
1266
13181
42
99
1006
10931
ranitidine bismuth citrate; oral
A02BA07 [21600088]
1.3e+00
1.6e+00
1.9e+00
—
2.3e+00
1.8e+00
1.5e+00
cases:4.96%
controls:1.43%
cases:2.19%
controls:0.45%
cases:0.66%
controls:0.10%
—
—
cases:0.80%
controls:0.08%
cases:2.16%
controls:0.38%
cases:4.01%
controls:0.90%
68
195
1302
13449
30
62
1341
13592
9
14
1362
13640
—
11
11
1356
13607
28
50
1266
13181
42
99
1006
10931
Rheumatism, unspecified
M79.0 [45567658]
2.3e+00
2.8e+00
—
1.0e+50
—
2.9e+00
2.4e+00
cases:3.21%
controls:0.34%
cases:1.82%
controls:0.12%
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.70%
controls:0.10%
cases:2.67%
controls:0.24%
44
46
1326
13598
25
16
1346
13638
—
6
0
1365
13654
—
22
13
1272
13218
28
27
1020
11003
tinzaparin; parenteral
B01AB10 [21600981]
1.4e+00
1.8e+00
2.7e+00
—
2.2e+00
1.3e+00
9.3e-01
cases:3.43%
controls:0.84%
cases:2.84%
controls:0.51%
cases:0.95%
controls:0.07%
—
—
cases:0.51%
controls:0.06%
cases:2.16%
controls:0.58%
cases:3.91%
controls:1.58%
47
114
1323
13530
39
69
1332
13585
13
9
1358
13645
—
7
8
1360
13610
28
77
1266
13154
41
174
1007
10856
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
2.2e+00
3.5e+00
—
—
—
2.3e+00
2.3e+00
cases:1.75%
controls:0.20%
cases:1.17%
controls:0.04%
—
—
—
—
—
—
cases:0.54%
controls:0.05%
cases:1.81%
controls:0.19%
24
27
1346
13617
16
5
1355
13649
—
—
—
7
7
1287
13224
19
21
1029
11009
Unspecified osteoporosis with pathological fracture
M80.9 [45553292]
2.2e+00
3.3e+00
—
1.0e+50
—
2.7e+00
2.1e+00
cases:1.02%
controls:0.12%
cases:1.17%
controls:0.04%
—
—
cases:0.51%
controls:0.00%
—
—
cases:0.77%
controls:0.05%
cases:1.91%
controls:0.24%
14
16
1356
13628
16
6
1355
13648
—
7
0
1364
13654
—
10
7
1284
13224
20
26
1028
11004
Pharmacy visit
OMOP4822462 [581458]
5.8e-01
1.3e+00
1.5e+00
2.1e+00
1.9e+00
1.7e+00
1.1e+00
cases:95.91%
controls:92.91%
cases:95.55%
controls:84.85%
cases:80.45%
controls:47.99%
cases:16.92%
controls:2.38%
cases:85.30%
controls:47.42%
cases:97.06%
controls:85.60%
cases:98.38%
controls:95.14%
1314
12677
56
967
1310
11585
61
2069
1103
6552
268
7102
232
325
1139
13329
1166
6458
201
7160
1256
11326
38
1905
1031
10494
17
536
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
2.5e+00
2.2e+00
—
—
—
3.0e+00
2.6e+00
cases:1.97%
controls:0.16%
cases:0.66%
controls:0.07%
—
—
—
—
—
—
cases:1.16%
controls:0.06%
cases:1.62%
controls:0.13%
27
22
1343
13622
9
10
1362
13644
—
—
—
15
8
1279
13223
17
14
1031
11016
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
7.3e-01
1.2e+00
1.8e+00
3.3e+00
1.4e+00
9.5e-01
8.1e-01
cases:15.04%
controls:7.83%
cases:11.31%
controls:3.76%
cases:3.72%
controls:0.61%
cases:1.02%
controls:0.04%
cases:2.05%
controls:0.52%
cases:9.35%
controls:3.84%
cases:20.61%
controls:10.40%
206
1068
1164
12576
155
514
1216
13140
51
83
1320
13571
14
5
1357
13649
28
71
1339
13547
121
508
1173
12723
216
1147
832
9883
Medical Oncology
90 [38004507]
7.9e-01
1.1e+00
1.5e+00
3.5e+00
1.6e+00
1.2e+00
6.2e-01
cases:9.05%
controls:4.33%
cases:8.90%
controls:3.10%
cases:4.74%
controls:1.12%
cases:2.55%
controls:0.08%
cases:4.54%
controls:0.97%
cases:8.58%
controls:2.85%
cases:8.02%
controls:4.50%
124
591
1246
13053
122
423
1249
13231
65
153
1306
13501
35
11
1336
13643
62
132
1305
13486
111
377
1183
12854
84
496
964
10534
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
1.3e+00
1.5e+00
2.3e+00
1.0e+50
2.8e+00
1.5e+00
7.9e-01
cases:2.85%
controls:0.77%
cases:1.97%
controls:0.43%
cases:0.66%
controls:0.07%
cases:0.95%
controls:0.00%
cases:0.59%
controls:0.04%
cases:1.62%
controls:0.37%
cases:3.82%
controls:1.77%
39
105
1331
13539
27
59
1344
13595
9
9
1362
13645
13
0
1358
13654
8
5
1359
13613
21
49
1273
13182
40
195
1008
10835
Psychiatry
26 [38004469]
1.1e+00
1.2e+00
1.2e+00
2.3e+00
1.6e+00
1.5e+00
1.3e+00
cases:15.26%
controls:5.62%
cases:9.19%
controls:2.94%
cases:3.43%
controls:1.09%
cases:0.66%
controls:0.07%
cases:5.27%
controls:1.07%
cases:10.82%
controls:2.76%
cases:17.27%
controls:5.22%
209
767
1161
12877
126
401
1245
13253
47
149
1324
13505
9
9
1362
13645
72
146
1295
13472
140
365
1154
12866
181
576
867
10454
Differential panel, method unspecified - Blood
69738-3 [42870588]
1.2e+00
1.6e+00
2.2e+00
—
2.4e+00
1.5e+00
1.3e+00
cases:21.24%
controls:7.64%
cases:19.26%
controls:4.78%
cases:9.70%
controls:1.14%
—
—
cases:8.05%
controls:0.82%
cases:19.32%
controls:4.94%
cases:29.87%
controls:10.09%
291
1043
1079
12601
264
652
1107
13002
133
156
1238
13498
—
110
111
1257
13507
250
653
1044
12578
313
1113
735
9917
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.4e-01
7.3e-01
2.0e+00
4.2e+00
1.8e+00
8.1e-01
5.1e-01
cases:32.55%
controls:27.57%
cases:37.86%
controls:22.67%
cases:26.33%
controls:4.74%
cases:11.38%
controls:0.20%
cases:20.99%
controls:4.35%
cases:41.42%
controls:23.88%
cases:55.63%
controls:43.05%
446
3762
924
9882
519
3096
852
10558
361
647
1010
13007
156
27
1215
13627
287
592
1080
13026
536
3160
758
10071
583
4748
465
6282
Nephrology
39 [38004479]
1.4e+00
1.5e+00
2.0e+00
—
2.2e+00
1.7e+00
1.5e+00
cases:3.28%
controls:0.86%
cases:2.70%
controls:0.64%
cases:1.60%
controls:0.23%
—
—
cases:1.76%
controls:0.19%
cases:3.71%
controls:0.71%
cases:4.10%
controls:0.96%
45
118
1325
13526
37
88
1334
13566
22
31
1349
13623
—
24
26
1343
13592
48
94
1246
13137
43
106
1005
10924
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.5e+00
1.8e+00
2.0e+00
—
2.1e+00
1.2e+00
1.5e+00
cases:6.06%
controls:1.42%
cases:5.03%
controls:0.86%
cases:0.95%
controls:0.13%
—
—
cases:0.95%
controls:0.12%
cases:3.86%
controls:1.14%
cases:12.40%
controls:2.92%
83
194
1287
13450
69
118
1302
13536
13
18
1358
13636
—
13
16
1354
13602
50
151
1244
13080
130
322
918
10708
CBC panel - Blood by Automated count
58410-2 [40761511]
3.4e-01
8.7e-01
2.1e+00
3.7e+00
1.8e+00
9.1e-01
4.7e-01
cases:45.69%
controls:37.53%
cases:44.06%
controls:24.77%
cases:26.11%
controls:4.21%
cases:10.50%
controls:0.28%
cases:20.99%
controls:4.35%
cases:44.59%
controls:24.53%
cases:60.50%
controls:48.88%
626
5121
744
8523
604
3382
767
10272
358
575
1013
13079
144
38
1227
13616
287
592
1080
13026
577
3246
717
9985
634
5391
414
5639
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
7.8e-01
1.5e+00
2.2e+00
—
2.9e+00
1.5e+00
1.3e+00
cases:4.31%
controls:2.02%
cases:3.50%
controls:0.82%
cases:0.95%
controls:0.11%
—
—
cases:1.10%
controls:0.06%
cases:3.25%
controls:0.73%
cases:6.30%
controls:1.80%
59
276
1311
13368
48
112
1323
13542
13
15
1358
13639
—
15
8
1352
13610
42
97
1252
13134
66
198
982
10832
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
1.8e+00
3.4e+00
—
—
—
2.6e+00
2.4e+00
cases:1.53%
controls:0.26%
cases:1.46%
controls:0.05%
—
—
—
—
—
—
cases:1.08%
controls:0.08%
cases:2.19%
controls:0.20%
21
36
1349
13608
20
7
1351
13647
—
—
—
14
11
1280
13220
23
22
1025
11008
Gas panel - Venous blood
24339-4 [3000991]
1.0e+00
1.6e+00
2.4e+00
—
2.5e+00
1.5e+00
1.1e+00
cases:3.65%
controls:1.33%
cases:3.21%
controls:0.66%
cases:1.02%
controls:0.10%
—
—
cases:1.68%
controls:0.14%
cases:3.09%
controls:0.72%
cases:6.87%
controls:2.37%
50
182
1320
13462
44
90
1327
13564
14
13
1357
13641
—
23
19
1344
13599
40
95
1254
13136
72
261
976
10769
loperamide; oral
A07DA03 [21600646]
1.6e+00
1.8e+00
2.0e+00
—
1.8e+00
1.7e+00
1.3e+00
cases:5.40%
controls:1.16%
cases:3.28%
controls:0.59%
cases:0.88%
controls:0.12%
—
—
cases:0.73%
controls:0.12%
cases:2.78%
controls:0.50%
cases:4.87%
controls:1.37%
74
158
1296
13486
45
80
1326
13574
12
17
1359
13637
—
10
17
1357
13601
36
66
1258
13165
51
151
997
10879
loperamide oxide; oral
A07DA05 [21600648]
1.6e+00
1.8e+00
2.0e+00
—
1.8e+00
1.7e+00
1.3e+00
cases:5.40%
controls:1.16%
cases:3.28%
controls:0.59%
cases:0.88%
controls:0.12%
—
—
cases:0.73%
controls:0.12%
cases:2.78%
controls:0.50%
cases:4.87%
controls:1.37%
74
158
1296
13486
45
80
1326
13574
12
17
1359
13637
—
10
17
1357
13601
36
66
1258
13165
51
151
997
10879
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.4e+00
1.8e+00
1.9e+00
—
2.4e+00
1.6e+00
9.9e-01
cases:4.89%
controls:1.20%
cases:3.72%
controls:0.64%
cases:0.51%
controls:0.08%
—
—
cases:1.76%
controls:0.15%
cases:3.63%
controls:0.78%
cases:6.49%
controls:2.51%
67
164
1303
13480
51
88
1320
13566
7
11
1364
13643
—
24
21
1343
13597
47
103
1247
13128
68
277
980
10753
Bronchiectasis
J47 [45605889]
2.1e+00
2.7e+00
—
1.0e+50
—
2.8e+00
2.5e+00
cases:1.68%
controls:0.21%
cases:1.68%
controls:0.12%
—
—
cases:0.66%
controls:0.00%
—
—
cases:1.78%
controls:0.11%
cases:3.15%
controls:0.25%
23
29
1347
13615
23
16
1348
13638
—
9
0
1362
13654
—
23
15
1271
13216
33
28
1015
11002
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
1.5e+00
3.0e+00
—
—
—
3.2e+00
2.4e+00
cases:2.34%
controls:0.53%
cases:2.55%
controls:0.13%
—
—
—
—
—
—
cases:3.55%
controls:0.15%
cases:5.15%
controls:0.51%
32
72
1338
13572
35
18
1336
13636
—
—
—
46
20
1248
13211
54
56
994
10974
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
8.3e-01
1.8e+00
2.3e+00
1.0e+50
2.8e+00
1.3e+00
9.6e-01
cases:1.61%
controls:0.70%
cases:1.82%
controls:0.31%
cases:0.66%
controls:0.07%
cases:1.02%
controls:0.00%
cases:0.73%
controls:0.04%
cases:1.31%
controls:0.35%
cases:3.53%
controls:1.39%
22
96
1348
13548
25
42
1346
13612
9
9
1362
13645
14
0
1357
13654
10
6
1357
13612
17
46
1277
13185
37
153
1011
10877
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
2.0e+00
2.5e+00
1.0e+50
1.0e+50
—
2.6e+00
2.9e+00
cases:5.33%
controls:0.74%
cases:2.55%
controls:0.21%
cases:0.58%
controls:0.00%
cases:0.95%
controls:0.00%
—
—
cases:2.16%
controls:0.16%
cases:8.30%
controls:0.51%
73
101
1297
13543
35
29
1336
13625
8
0
1363
13654
13
0
1358
13654
—
28
21
1266
13210
87
56
961
10974
hydrocortisone
S01BA02 [21603619]
1.6e+00
1.8e+00
1.0e+50
—
—
3.8e+00
2.8e+00
cases:1.53%
controls:0.30%
cases:1.09%
controls:0.18%
cases:0.88%
controls:0.00%
—
—
—
—
cases:4.87%
controls:0.11%
cases:8.87%
controls:0.60%
21
41
1349
13603
15
25
1356
13629
12
0
1359
13654
—
—
63
15
1231
13216
93
66
955
10964
hydrocortisone
S01CB03 [21603666]
1.6e+00
1.8e+00
1.0e+50
—
—
3.8e+00
2.8e+00
cases:1.53%
controls:0.30%
cases:1.09%
controls:0.18%
cases:0.88%
controls:0.00%
—
—
—
—
cases:4.87%
controls:0.11%
cases:8.87%
controls:0.60%
21
41
1349
13603
15
25
1356
13629
12
0
1359
13654
—
—
63
15
1231
13216
93
66
955
10964
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
1.3e+00
2.1e+00
3.2e+00
1.0e+50
—
1.9e+00
1.5e+00
cases:2.48%
controls:0.66%
cases:2.33%
controls:0.29%
cases:1.24%
controls:0.05%
cases:1.53%
controls:0.00%
—
—
cases:2.40%
controls:0.36%
cases:5.34%
controls:1.31%
34
90
1336
13554
32
40
1339
13614
17
7
1354
13647
21
0
1350
13654
—
31
47
1263
13184
56
144
992
10886
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
1.6e+00
1.8e+00
1.5e+00
-1.0e+50
2.0e+00
1.5e+00
1.6e+00
cases:7.81%
controls:1.77%
cases:3.36%
controls:0.56%
cases:0.73%
controls:0.16%
cases:0.00%
controls:0.04%
cases:0.95%
controls:0.12%
cases:2.40%
controls:0.54%
cases:8.11%
controls:1.79%
107
241
1263
13403
46
77
1325
13577
10
22
1361
13632
0
5
1371
13649
13
17
1354
13601
31
71
1263
13160
85
197
963
10833
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
2.4e+00
1.9e+00
—
—
—
3.2e+00
2.4e+00
cases:1.82%
controls:0.16%
cases:0.51%
controls:0.07%
—
—
—
—
—
—
cases:1.08%
controls:0.05%
cases:1.53%
controls:0.14%
25
22
1345
13622
7
10
1364
13644
—
—
—
14
6
1280
13225
16
15
1032
11015
Bacteria identified in Isolate by Culture
43409-2 [3042936]
1.3e+00
1.7e+00
1.9e+00
—
2.5e+00
1.4e+00
1.2e+00
cases:9.12%
controls:2.64%
cases:5.62%
controls:1.08%
cases:0.66%
controls:0.10%
—
—
cases:1.17%
controls:0.10%
cases:3.94%
controls:1.02%
cases:9.92%
controls:3.16%
125
360
1245
13284
77
147
1294
13507
9
14
1362
13640
—
16
13
1351
13605
51
135
1243
13096
104
348
944
10682
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
1.9e+00
2.8e+00
—
—
—
2.4e+00
2.8e+00
cases:1.97%
controls:0.29%
cases:1.24%
controls:0.07%
—
—
—
—
—
—
cases:1.08%
controls:0.10%
cases:2.19%
controls:0.14%
27
40
1343
13604
17
10
1354
13644
—
—
—
14
13
1280
13218
23
15
1025
11015
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
2.6e+00
2.4e+00
—
—
—
2.7e+00
2.2e+00
cases:3.58%
controls:0.26%
cases:1.02%
controls:0.10%
—
—
—
—
—
—
cases:1.55%
controls:0.11%
cases:2.77%
controls:0.30%
49
36
1321
13608
14
13
1357
13641
—
—
—
20
14
1274
13217
29
33
1019
10997
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.1e+00
1.4e+00
2.3e+00
—
2.6e+00
1.4e+00
1.2e+00
cases:13.80%
controls:5.17%
cases:9.99%
controls:2.65%
cases:2.63%
controls:0.26%
—
—
cases:3.22%
controls:0.26%
cases:9.97%
controls:2.60%
cases:21.85%
controls:8.00%
189
705
1181
12939
137
362
1234
13292
36
36
1335
13618
—
44
35
1323
13583
129
344
1165
12887
229
882
819
10148
esomeprazole; oral, parenteral
A02BC05 [21600100]
1.1e+00
1.3e+00
1.5e+00
2.3e+00
1.3e+00
1.3e+00
1.1e+00
cases:21.53%
controls:8.47%
cases:14.88%
controls:4.39%
cases:4.38%
controls:0.98%
cases:0.51%
controls:0.05%
cases:3.73%
controls:1.06%
cases:14.14%
controls:4.30%
cases:20.99%
controls:8.10%
295
1155
1075
12489
204
599
1167
13055
60
134
1311
13520
7
7
1364
13647
51
144
1316
13474
183
569
1111
12662
220
893
828
10137
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
1.3e+00
2.1e+00
3.2e+00
1.0e+50
—
2.0e+00
1.3e+00
cases:2.26%
controls:0.64%
cases:2.26%
controls:0.28%
cases:1.24%
controls:0.05%
cases:1.39%
controls:0.00%
—
—
cases:2.47%
controls:0.34%
cases:4.58%
controls:1.26%
31
87
1339
13557
31
38
1340
13616
17
7
1354
13647
19
0
1352
13654
—
32
45
1262
13186
48
139
1000
10891
Sicca syndrome [Sjögren]
M35.0 [45562711]
1.6e+00
1.8e+00
2.1e+00
1.0e+50
2.3e+00
2.1e+00
2.3e+00
cases:1.61%
controls:0.34%
cases:1.17%
controls:0.20%
cases:0.44%
controls:0.05%
cases:0.36%
controls:0.00%
cases:0.37%
controls:0.04%
cases:1.39%
controls:0.17%
cases:2.29%
controls:0.23%
22
47
1348
13597
16
27
1355
13627
6
7
1365
13647
5
0
1366
13654
5
5
1362
13613
18
23
1276
13208
24
25
1024
11005
furosemide; oral, parenteral
C03CA01 [21601518]
1.4e+00
1.3e+00
1.1e+00
2.2e+00
1.2e+00
1.3e+00
1.3e+00
cases:18.69%
controls:5.27%
cases:14.59%
controls:4.32%
cases:4.52%
controls:1.52%
cases:0.51%
controls:0.06%
cases:4.97%
controls:1.49%
cases:15.84%
controls:4.79%
cases:23.28%
controls:7.72%
256
719
1114
12925
200
590
1171
13064
62
208
1309
13446
7
8
1364
13646
68
203
1299
13415
205
634
1089
12597
244
851
804
10179
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
1.2e+00
1.2e+00
2.0e+00
—
2.7e+00
1.4e+00
1.3e+00
cases:4.16%
controls:1.31%
cases:2.63%
controls:0.79%
cases:1.02%
controls:0.14%
—
—
cases:1.24%
controls:0.08%
cases:3.32%
controls:0.82%
cases:6.77%
controls:1.97%
57
179
1313
13465
36
108
1335
13546
14
19
1357
13635
—
17
11
1350
13607
43
108
1251
13123
71
217
977
10813
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2.4e+00
2.2e+00
—
—
—
3.4e+00
1.9e+00
cases:2.92%
controls:0.29%
cases:1.31%
controls:0.15%
—
—
—
—
—
—
cases:1.08%
controls:0.04%
cases:2.86%
controls:0.43%
40
39
1330
13605
18
20
1353
13634
—
—
—
14
5
1280
13226
30
47
1018
10983
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
2.4e+00
1.9e+00
—
—
—
3.0e+00
2.4e+00
cases:1.82%
controls:0.16%
cases:0.51%
controls:0.07%
—
—
—
—
—
—
cases:1.08%
controls:0.05%
cases:1.53%
controls:0.14%
25
22
1345
13622
7
10
1364
13644
—
—
—
14
7
1280
13224
16
15
1032
11015
Other procedure to treat skin wound, unspecified location
QXB99 [2001310054]
2.0e+00
2.9e+00
—
—
—
2.2e+00
2.8e+00
cases:1.24%
controls:0.18%
cases:0.80%
controls:0.04%
—
—
—
—
—
—
cases:0.46%
controls:0.05%
cases:2.00%
controls:0.13%
17
24
1353
13620
11
6
1360
13648
—
—
—
6
7
1288
13224
21
14
1027
11016
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.0e-01
7.6e-01
2.0e+00
3.7e+00
1.7e+00
8.9e-01
4.8e-01
cases:34.45%
controls:28.07%
cases:38.66%
controls:22.81%
cases:28.15%
controls:4.97%
cases:10.80%
controls:0.29%
cases:20.63%
controls:4.68%
cases:42.50%
controls:23.37%
cases:53.24%
controls:41.22%
472
3830
898
9814
530
3114
841
10540
386
679
985
12975
148
40
1223
13614
282
638
1085
12980
550
3092
744
10139
558
4547
490
6483
Mycobacterium sp identified in Specimen
40699-1 [3042631]
1.9e+00
2.8e+00
—
—
—
2.7e+00
2.4e+00
cases:1.17%
controls:0.18%
cases:1.46%
controls:0.09%
—
—
—
—
—
—
cases:1.08%
controls:0.08%
cases:1.81%
controls:0.16%
16
24
1354
13620
20
12
1351
13642
—
—
—
14
10
1280
13221
19
18
1029
11012
Metanephrine [Moles/volume] in Serum or Plasma
25473-0 [3009340]
2.3e+00
2.5e+00
—
—
—
3.3e+00
1.7e+00
cases:1.82%
controls:0.19%
cases:1.39%
controls:0.11%
—
—
—
—
—
—
cases:1.00%
controls:0.04%
cases:1.34%
controls:0.24%
25
26
1345
13618
19
15
1352
13639
—
—
—
13
5
1281
13226
14
27
1034
11003
Emergency Room and Inpatient Visit
ERIP [262]
1.1e+00
1.6e+00
2.4e+00
—
2.3e+00
1.2e+00
1.2e+00
cases:14.67%
controls:5.19%
cases:12.98%
controls:3.01%
cases:4.08%
controls:0.39%
—
—
cases:3.22%
controls:0.34%
cases:11.67%
controls:3.67%
cases:26.81%
controls:10.24%
201
708
1169
12936
178
411
1193
13243
56
53
1315
13601
—
44
46
1323
13572
151
485
1143
12746
281
1129
767
9901
Intramuscular
ZX114 [2001311493]
1.8e+00
2.1e+00
—
—
—
3.1e+00
2.7e+00
cases:0.88%
controls:0.14%
cases:0.44%
controls:0.05%
—
—
—
—
—
—
cases:0.85%
controls:0.04%
cases:1.05%
controls:0.07%
12
19
1358
13625
6
7
1365
13647
—
—
—
11
5
1283
13226
11
8
1037
11022
Hypothyroidism caused by autoimmune thyroiditis
E03.80 [2000501406]
1.5e+00
1.5e+00
—
1.0e+50
3.0e+00
2.7e+00
2.5e+00
cases:1.02%
controls:0.22%
cases:0.51%
controls:0.12%
—
—
cases:0.51%
controls:0.00%
cases:0.73%
controls:0.04%
cases:2.40%
controls:0.17%
cases:4.96%
controls:0.41%
14
30
1356
13614
7
16
1364
13638
—
7
0
1364
13654
10
5
1357
13613
31
22
1263
13209
52
45
996
10985
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
1.1e+00
2.7e+00
—
—
—
3.5e+00
2.4e+00
cases:1.68%
controls:0.55%
cases:3.36%
controls:0.23%
—
—
—
—
—
—
cases:4.56%
controls:0.14%
cases:6.68%
controls:0.63%
23
75
1347
13569
46
32
1325
13622
—
—
—
59
19
1235
13212
70
69
978
10961
Sarcoidosis of other and combined sites
D86.8 [45576423]
2.2e+00
2.7e+00
—
1.0e+50
—
2.3e+00
2.5e+00
cases:0.88%
controls:0.10%
cases:1.17%
controls:0.08%
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.00%
controls:0.10%
cases:1.43%
controls:0.12%
12
13
1358
13631
16
11
1355
13643
—
6
0
1365
13654
—
13
13
1281
13218
15
13
1033
11017
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.9e+00
2.1e+00
2.6e+00
—
—
1.7e+00
1.5e+00
cases:4.09%
controls:0.65%
cases:2.33%
controls:0.30%
cases:0.58%
controls:0.04%
—
—
—
—
cases:2.01%
controls:0.37%
cases:4.01%
controls:0.92%
56
89
1314
13555
32
41
1339
13613
8
6
1363
13648
—
—
26
49
1268
13182
42
102
1006
10928
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
1.1e+00
1.6e+00
2.2e+00
—
2.5e+00
1.3e+00
1.0e+00
cases:16.50%
controls:6.19%
cases:13.20%
controls:3.11%
cases:3.65%
controls:0.42%
—
—
cases:3.88%
controls:0.32%
cases:10.90%
controls:3.17%
cases:23.00%
controls:9.55%
226
844
1144
12800
181
425
1190
13229
50
58
1321
13596
—
53
43
1314
13575
141
420
1153
12811
241
1053
807
9977
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.0e+00
1.6e+00
2.5e+00
—
2.4e+00
1.4e+00
9.4e-01
cases:18.18%
controls:7.56%
cases:14.88%
controls:3.57%
cases:5.54%
controls:0.50%
—
—
cases:4.24%
controls:0.42%
cases:13.21%
controls:3.57%
cases:25.29%
controls:11.69%
249
1031
1121
12613
204
488
1167
13166
76
68
1295
13586
—
58
57
1309
13561
171
472
1123
12759
265
1289
783
9741
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.3e+00
1.4e+00
2.1e+00
1.0e+50
2.2e+00
1.5e+00
1.2e+00
cases:2.19%
controls:0.63%
cases:1.39%
controls:0.33%
cases:0.66%
controls:0.08%
cases:0.66%
controls:0.00%
cases:0.80%
controls:0.09%
cases:1.85%
controls:0.42%
cases:3.15%
controls:0.99%
30
86
1340
13558
19
45
1352
13609
9
11
1362
13643
9
0
1362
13654
11
12
1356
13606
24
55
1270
13176
33
109
1015
10921
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
9.9e-01
1.5e+00
2.5e+00
—
2.4e+00
1.3e+00
1.0e+00
cases:14.82%
controls:6.07%
cases:10.28%
controls:2.59%
cases:3.65%
controls:0.30%
—
—
cases:3.00%
controls:0.28%
cases:8.96%
controls:2.58%
cases:19.47%
controls:8.01%
203
828
1167
12816
141
354
1230
13300
50
41
1321
13613
—
41
38
1326
13580
116
342
1178
12889
204
883
844
10147
Complicated migraine
G43.3 [45576576]
1.7e+00
2.4e+00
—
—
2.1e+00
1.8e+00
1.7e+00
cases:1.02%
controls:0.19%
cases:1.09%
controls:0.10%
—
—
—
—
cases:0.44%
controls:0.05%
cases:0.85%
controls:0.14%
cases:1.24%
controls:0.24%
14
26
1356
13618
15
14
1356
13640
—
—
6
7
1361
13611
11
19
1283
13212
13
26
1035
11004
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.2e+00
1.8e+00
1.6e+00
—
2.6e+00
1.5e+00
9.9e-01
cases:6.42%
controls:2.01%
cases:4.96%
controls:0.89%
cases:0.73%
controls:0.15%
—
—
cases:2.27%
controls:0.18%
cases:4.56%
controls:1.04%
cases:8.21%
controls:3.22%
88
274
1282
13370
68
121
1303
13533
10
20
1361
13634
—
31
24
1336
13594
59
138
1235
13093
86
355
962
10675
Physiotherapist
Z3226 [2001311560]
6.7e-01
1.6e+00
2.7e+00
1.0e+50
2.3e+00
1.4e+00
9.0e-01
cases:4.60%
controls:2.40%
cases:2.12%
controls:0.42%
cases:0.88%
controls:0.06%
cases:0.36%
controls:0.00%
cases:0.88%
controls:0.09%
cases:1.55%
controls:0.37%
cases:2.96%
controls:1.22%
63
328
1307
13316
29
58
1342
13596
12
8
1359
13646
5
0
1366
13654
12
12
1355
13606
20
49
1274
13182
31
135
1017
10895
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
8.7e-01
1.5e+00
2.3e+00
—
2.2e+00
1.6e+00
1.2e+00
cases:10.73%
controls:4.79%
cases:8.39%
controls:2.07%
cases:2.84%
controls:0.31%
—
—
cases:2.27%
controls:0.25%
cases:8.81%
controls:1.91%
cases:16.22%
controls:5.41%
147
653
1223
12991
115
283
1256
13371
39
42
1332
13612
—
31
34
1336
13584
114
253
1180
12978
170
597
878
10433
Metanephrine Free [Moles/volume] in Serum or Plasma
49700-8 [3032155]
2.4e+00
2.7e+00
—
—
—
2.9e+00
1.7e+00
cases:1.82%
controls:0.18%
cases:1.60%
controls:0.11%
—
—
—
—
—
—
cases:0.93%
controls:0.05%
cases:1.53%
controls:0.28%
25
24
1345
13620
22
15
1349
13639
—
—
—
12
7
1282
13224
16
31
1032
10999
Gas panel - Central venous blood
97535-9 [1616796]
2.1e+00
3.1e+00
—
1.0e+50
1.0e+50
2.1e+00
2.3e+00
cases:2.63%
controls:0.32%
cases:3.43%
controls:0.15%
—
—
cases:0.44%
controls:0.00%
cases:1.46%
controls:0.00%
cases:2.01%
controls:0.25%
cases:4.58%
controls:0.50%
36
44
1334
13600
47
21
1324
13633
—
6
0
1365
13654
20
0
1347
13618
26
33
1268
13198
48
55
1000
10975
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
1.9e+00
2.9e+00
—
1.0e+50
—
2.5e+00
2.2e+00
cases:1.61%
controls:0.23%
cases:1.75%
controls:0.10%
—
—
cases:0.36%
controls:0.00%
—
—
cases:1.39%
controls:0.11%
cases:2.86%
controls:0.32%
22
32
1348
13612
24
13
1347
13641
—
5
0
1366
13654
—
18
15
1276
13216
30
35
1018
10995
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
8.2e-01
1.4e+00
2.4e+00
—
2.5e+00
1.4e+00
1.2e+00
cases:26.42%
controls:13.63%
cases:22.68%
controls:6.55%
cases:9.70%
controls:0.97%
—
—
cases:8.41%
controls:0.79%
cases:21.72%
controls:6.65%
cases:42.94%
controls:19.24%
362
1859
1008
11785
311
895
1060
12759
133
133
1238
13521
—
115
107
1252
13511
281
880
1013
12351
450
2122
598
8908
Other seropositive rheumatoid arthritis
M05.8 [45538634]
1.1e+00
1.5e+00
1.9e+00
—
2.2e+00
1.6e+00
1.3e+00
cases:3.65%
controls:1.19%
cases:3.36%
controls:0.77%
cases:1.17%
controls:0.18%
—
—
cases:1.68%
controls:0.19%
cases:3.48%
controls:0.73%
cases:3.91%
controls:1.14%
50
162
1320
13482
46
105
1325
13549
16
24
1355
13630
—
23
26
1344
13592
45
97
1249
13134
41
126
1007
10904
magnesium hydroxide; oral
A02AA04 [21600052]
1.6e+00
2.2e+00
1.8e+00
—
2.4e+00
1.9e+00
1.5e+00
cases:2.41%
controls:0.51%
cases:1.90%
controls:0.22%
cases:0.44%
controls:0.07%
—
—
cases:0.88%
controls:0.08%
cases:1.85%
controls:0.27%
cases:2.29%
controls:0.52%
33
70
1337
13574
26
30
1345
13624
6
10
1365
13644
—
12
11
1355
13607
24
36
1270
13195
24
57
1024
10973
magnesium hydroxide; oral
G04BX01 [21602658]
1.6e+00
2.2e+00
1.8e+00
—
2.4e+00
1.9e+00
1.5e+00
cases:2.41%
controls:0.51%
cases:1.90%
controls:0.22%
cases:0.44%
controls:0.07%
—
—
cases:0.88%
controls:0.08%
cases:1.85%
controls:0.27%
cases:2.29%
controls:0.52%
33
70
1337
13574
26
30
1345
13624
6
10
1365
13644
—
12
11
1355
13607
24
36
1270
13195
24
57
1024
10973
Other specified noninfective gastroenteritis and colitis
K52.88 [2000502923]
2.1e+00
2.6e+00
1.0e+50
1.0e+50
—
2.3e+00
2.5e+00
cases:1.39%
controls:0.17%
cases:1.09%
controls:0.08%
cases:0.51%
controls:0.00%
cases:0.44%
controls:0.00%
—
—
cases:0.85%
controls:0.08%
cases:1.53%
controls:0.13%
19
23
1351
13621
15
11
1356
13643
7
0
1364
13654
6
0
1365
13654
—
11
11
1283
13220
16
14
1032
11016
Lactate [Moles/volume] in Blood
32693-4 [3047181]
1.5e+00
1.6e+00
3.3e+00
1.0e+50
—
1.6e+00
1.6e+00
cases:2.41%
controls:0.57%
cases:1.31%
controls:0.26%
cases:0.95%
controls:0.04%
cases:0.66%
controls:0.00%
—
—
cases:1.55%
controls:0.32%
cases:3.44%
controls:0.69%
33
78
1337
13566
18
35
1353
13619
13
5
1358
13649
9
0
1362
13654
—
20
43
1274
13188
36
76
1012
10954
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
1.8e+00
2.3e+00
—
—
2.6e+00
1.4e+00
1.4e+00
cases:2.63%
controls:0.43%
cases:1.97%
controls:0.21%
—
—
—
—
cases:0.51%
controls:0.04%
cases:1.24%
controls:0.32%
cases:2.77%
controls:0.68%
36
58
1334
13586
27
28
1344
13626
—
—
7
5
1360
13613
16
42
1278
13189
29
75
1019
10955
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
9.6e-01
1.3e+00
2.3e+00
—
2.2e+00
1.5e+00
1.3e+00
cases:20.66%
controls:9.04%
cases:15.83%
controls:4.73%
cases:5.25%
controls:0.56%
—
—
cases:3.88%
controls:0.46%
cases:20.17%
controls:5.15%
cases:39.60%
controls:15.76%
283
1233
1087
12411
217
646
1154
13008
72
76
1299
13578
—
53
62
1314
13556
261
681
1033
12550
415
1738
633
9292
Kidney transplant status
Z94.0 [45566477]
1.8e+00
1.8e+00
1.9e+00
—
2.2e+00
1.8e+00
1.3e+00
cases:1.09%
controls:0.18%
cases:1.09%
controls:0.19%
cases:0.66%
controls:0.10%
—
—
cases:0.73%
controls:0.08%
cases:1.24%
controls:0.20%
cases:0.76%
controls:0.20%
15
25
1355
13619
15
26
1356
13628
9
13
1362
13641
—
10
11
1357
13607
16
26
1278
13205
8
22
1040
11008
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
4.4e-01
8.9e-01
2.1e+00
2.8e+00
1.8e+00
9.3e-01
5.4e-01
cases:39.85%
controls:30.01%
cases:35.01%
controls:18.06%
cases:16.85%
controls:2.32%
cases:1.82%
controls:0.12%
cases:13.90%
controls:2.51%
cases:35.78%
controls:18.09%
cases:56.77%
controls:43.33%
546
4095
824
9549
480
2466
891
11188
231
317
1140
13337
25
16
1346
13638
190
342
1177
13276
463
2393
831
10838
595
4779
453
6251
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
2.0e+00
3.0e+00
—
—
—
2.4e+00
2.2e+00
cases:3.07%
controls:0.43%
cases:2.48%
controls:0.13%
—
—
—
—
—
—
cases:1.78%
controls:0.17%
cases:4.01%
controls:0.46%
42
59
1328
13585
34
18
1337
13636
—
—
—
23
22
1271
13209
42
51
1006
10979
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
1.8e+00
2.3e+00
—
—
2.6e+00
1.4e+00
1.4e+00
cases:2.63%
controls:0.43%
cases:1.97%
controls:0.21%
—
—
—
—
cases:0.51%
controls:0.04%
cases:1.24%
controls:0.32%
cases:2.67%
controls:0.68%
36
58
1334
13586
27
28
1344
13626
—
—
7
5
1360
13613
16
42
1278
13189
28
75
1020
10955
Podiatric therapy
R4180 [2001310242]
2.7e+00
2.5e+00
—
—
—
2.3e+00
2.0e+00
cases:0.95%
controls:0.07%
cases:0.51%
controls:0.04%
—
—
—
—
—
—
cases:0.62%
controls:0.06%
cases:1.24%
controls:0.16%
13
9
1357
13635
7
6
1364
13648
—
—
—
8
8
1286
13223
13
18
1035
11012
Platelets [#/volume] in Blood
26515-7 [3007461]
2.3e-01
7.3e-01
2.1e+00
3.8e+00
1.6e+00
8.1e-01
2.6e-01
cases:50.07%
controls:44.28%
cases:54.70%
controls:36.87%
cases:39.82%
controls:7.80%
cases:16.19%
controls:0.44%
cases:29.70%
controls:7.67%
cases:57.81%
controls:37.88%
cases:67.75%
controls:61.88%
686
6041
684
7603
750
5034
621
8620
546
1065
825
12589
222
60
1149
13594
406
1045
961
12573
748
5012
546
8219
710
6825
338
4205
MCH [Entitic mass]
28539-5 [3035941]
2.3e-01
7.2e-01
2.1e+00
3.8e+00
1.6e+00
8.1e-01
2.5e-01
cases:50.07%
controls:44.36%
cases:54.70%
controls:36.95%
cases:39.82%
controls:7.79%
cases:16.27%
controls:0.44%
cases:29.70%
controls:7.67%
cases:57.81%
controls:37.93%
cases:67.75%
controls:61.99%
686
6053
684
7591
750
5045
621
8609
546
1063
825
12591
223
60
1148
13594
406
1045
961
12573
748
5019
546
8212
710
6838
338
4192
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.3e-01
7.2e-01
2.1e+00
3.8e+00
1.6e+00
8.1e-01
2.5e-01
cases:50.07%
controls:44.41%
cases:54.70%
controls:36.96%
cases:39.82%
controls:7.79%
cases:16.27%
controls:0.44%
cases:29.70%
controls:7.67%
cases:57.81%
controls:37.92%
cases:67.75%
controls:62.01%
686
6059
684
7585
750
5047
621
8607
546
1063
825
12591
223
60
1148
13594
406
1045
961
12573
748
5017
546
8214
710
6840
338
4190
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
1.1e+00
1.4e+00
2.3e+00
—
2.4e+00
1.3e+00
1.1e+00
cases:16.93%
controls:6.63%
cases:14.22%
controls:3.76%
cases:4.23%
controls:0.44%
—
—
cases:4.17%
controls:0.41%
cases:12.21%
controls:3.76%
cases:24.14%
controls:10.01%
232
905
1138
12739
195
514
1176
13140
58
60
1313
13594
—
57
56
1310
13562
158
497
1136
12734
253
1104
795
9926
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.3e-01
7.3e-01
2.1e+00
3.8e+00
1.6e+00
8.1e-01
2.5e-01
cases:50.07%
controls:44.46%
cases:54.85%
controls:37.01%
cases:39.82%
controls:7.80%
cases:16.27%
controls:0.44%
cases:29.77%
controls:7.70%
cases:57.88%
controls:38.02%
cases:67.75%
controls:62.06%
686
6066
684
7578
752
5053
619
8601
546
1065
825
12589
223
60
1148
13594
407
1048
960
12570
749
5031
545
8200
710
6845
338
4185
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.2e-01
8.9e-01
1.9e+00
3.5e+00
1.6e+00
6.9e-01
4.8e-01
cases:24.38%
controls:17.47%
cases:17.43%
controls:7.98%
cases:6.05%
controls:0.97%
cases:1.17%
controls:0.04%
cases:4.54%
controls:0.91%
cases:14.99%
controls:8.10%
cases:32.73%
controls:23.23%
334
2384
1036
11260
239
1089
1132
12565
83
133
1288
13521
16
5
1355
13649
62
124
1305
13494
194
1072
1100
12159
343
2562
705
8468
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.3e-01
7.2e-01
2.1e+00
3.8e+00
1.6e+00
8.1e-01
2.5e-01
cases:50.07%
controls:44.40%
cases:54.70%
controls:36.99%
cases:39.82%
controls:7.79%
cases:16.27%
controls:0.44%
cases:29.70%
controls:7.71%
cases:57.88%
controls:38.00%
cases:67.75%
controls:62.01%
686
6058
684
7586
750
5050
621
8604
546
1064
825
12590
223
60
1148
13594
406
1050
961
12568
749
5028
545
8203
710
6840
338
4190
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.3e-01
7.2e-01
2.1e+00
3.8e+00
1.6e+00
8.1e-01
2.5e-01
cases:50.07%
controls:44.42%
cases:54.70%
controls:37.00%
cases:39.82%
controls:7.80%
cases:16.27%
controls:0.44%
cases:29.70%
controls:7.70%
cases:57.88%
controls:37.99%
cases:67.75%
controls:62.04%
686
6060
684
7584
750
5052
621
8602
546
1065
825
12589
223
60
1148
13594
406
1048
961
12570
749
5027
545
8204
710
6843
338
4187
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.5e+00
1.8e+00
—
1.7e+00
1.7e+00
1.5e+00
cases:13.07%
controls:4.21%
cases:8.90%
controls:2.07%
cases:3.65%
controls:0.60%
—
—
cases:3.95%
controls:0.76%
cases:9.81%
controls:1.97%
cases:14.79%
controls:3.78%
179
574
1191
13070
122
282
1249
13372
50
82
1321
13572
—
54
103
1313
13515
127
260
1167
12971
155
417
893
10613
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.3e-01
7.2e-01
2.1e+00
3.8e+00
1.6e+00
8.0e-01
2.5e-01
cases:50.15%
controls:44.49%
cases:54.63%
controls:37.06%
cases:39.82%
controls:7.84%
cases:16.34%
controls:0.44%
cases:29.70%
controls:7.71%
cases:57.81%
controls:38.05%
cases:67.84%
controls:62.09%
687
6070
683
7574
749
5060
622
8594
546
1071
825
12583
224
60
1147
13594
406
1050
961
12568
748
5035
546
8196
711
6849
337
4181
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
1.7e+00
2.8e+00
—
—
—
2.9e+00
2.0e+00
cases:1.09%
controls:0.20%
cases:0.73%
controls:0.04%
—
—
—
—
—
—
cases:0.93%
controls:0.05%
cases:1.15%
controls:0.15%
15
27
1355
13617
10
6
1361
13648
—
—
—
12
7
1282
13224
12
17
1036
11013
adalimumab; parenteral
L04AB04 [21603911]
1.8e+00
2.0e+00
1.5e+00
—
2.0e+00
1.8e+00
1.7e+00
cases:1.82%
controls:0.30%
cases:1.46%
controls:0.20%
cases:0.44%
controls:0.10%
—
—
cases:0.44%
controls:0.06%
cases:1.39%
controls:0.23%
cases:2.10%
controls:0.38%
25
41
1345
13603
20
27
1351
13627
6
13
1365
13641
—
6
8
1361
13610
18
30
1276
13201
22
42
1026
10988
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
1.3e+00
1.8e+00
2.7e+00
1.0e+50
—
2.0e+00
1.6e+00
cases:3.65%
controls:1.06%
cases:2.92%
controls:0.48%
cases:0.66%
controls:0.04%
cases:0.88%
controls:0.00%
—
—
cases:3.25%
controls:0.44%
cases:6.11%
controls:1.35%
50
144
1320
13500
40
66
1331
13588
9
6
1362
13648
12
0
1359
13654
—
42
58
1252
13173
64
149
984
10881
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1.6e+00
1.8e+00
2.9e+00
1.0e+50
—
1.7e+00
1.4e+00
cases:4.67%
controls:0.97%
cases:3.06%
controls:0.53%
cases:1.17%
controls:0.07%
cases:1.46%
controls:0.00%
—
—
cases:3.01%
controls:0.58%
cases:7.16%
controls:1.80%
64
133
1306
13511
42
72
1329
13582
16
9
1355
13645
20
0
1351
13654
—
39
77
1255
13154
75
198
973
10832
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.7e+00
3.0e+00
—
—
—
2.3e+00
2.4e+00
cases:2.04%
controls:0.37%
cases:1.53%
controls:0.08%
—
—
—
—
—
—
cases:1.16%
controls:0.12%
cases:2.77%
controls:0.25%
28
50
1342
13594
21
11
1350
13643
—
—
—
15
16
1279
13215
29
28
1019
11002
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
1.2e+00
1.6e+00
1.5e+00
—
2.4e+00
1.7e+00
1.0e+00
cases:4.38%
controls:1.41%
cases:3.94%
controls:0.83%
cases:1.02%
controls:0.22%
—
—
cases:1.68%
controls:0.16%
cases:3.79%
controls:0.73%
cases:5.06%
controls:1.86%
60
193
1310
13451
54
113
1317
13541
14
30
1357
13624
—
23
22
1344
13596
49
96
1245
13135
53
205
995
10825
gabapentin; oral
N02BF01 [955005]
1.4e+00
1.6e+00
1.7e+00
—
1.7e+00
1.6e+00
1.3e+00
cases:11.24%
controls:3.06%
cases:7.66%
controls:1.71%
cases:2.77%
controls:0.51%
—
—
cases:2.63%
controls:0.48%
cases:8.35%
controls:1.76%
cases:14.41%
controls:4.20%
154
417
1216
13227
105
234
1266
13420
38
69
1333
13585
—
36
66
1331
13552
108
233
1186
12998
151
463
897
10567
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
9.6e-01
1.3e+00
2.4e+00
—
2.2e+00
1.3e+00
1.1e+00
cases:16.13%
controls:6.89%
cases:11.74%
controls:3.50%
cases:5.76%
controls:0.53%
—
—
cases:3.44%
controls:0.40%
cases:11.75%
controls:3.34%
cases:24.71%
controls:9.83%
221
940
1149
12704
161
478
1210
13176
79
72
1292
13582
—
47
54
1320
13564
152
442
1142
12789
259
1084
789
9946
Cardiology
6 [38004451]
7.7e-01
9.0e-01
1.1e+00
3.3e+00
1.4e+00
1.0e+00
8.9e-01
cases:20.07%
controls:10.40%
cases:11.60%
controls:5.05%
cases:2.33%
controls:0.80%
cases:0.95%
controls:0.04%
cases:3.29%
controls:0.84%
cases:13.06%
controls:5.12%
cases:24.14%
controls:11.57%
275
1419
1095
12225
159
689
1212
12965
32
109
1339
13545
13
5
1358
13649
45
114
1322
13504
169
677
1125
12554
253
1276
795
9754
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.8e+00
2.8e+00
—
1.0e+50
—
2.4e+00
2.3e+00
cases:2.77%
controls:0.45%
cases:3.14%
controls:0.20%
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.85%
controls:0.17%
cases:3.44%
controls:0.35%
38
61
1332
13583
43
27
1328
13627
—
6
0
1365
13654
—
24
23
1270
13208
36
39
1012
10991
Diffusion capacity of lung
54715006 [4182985]
2.4e+00
2.3e+00
—
—
—
2.4e+00
2.2e+00
cases:3.21%
controls:0.30%
cases:1.02%
controls:0.10%
—
—
—
—
—
—
cases:1.47%
controls:0.13%
cases:2.58%
controls:0.30%
44
41
1326
13603
14
14
1357
13640
—
—
—
19
17
1275
13214
27
33
1021
10997
Chronic ulcer skin
S97 [2002001061]
1.9e+00
1.7e+00
1.9e+00
—
—
1.9e+00
1.8e+00
cases:3.43%
controls:0.54%
cases:1.90%
controls:0.34%
cases:0.66%
controls:0.10%
—
—
—
—
cases:2.01%
controls:0.29%
cases:4.87%
controls:0.81%
47
74
1323
13570
26
47
1345
13607
9
13
1362
13641
—
—
26
39
1268
13192
51
89
997
10941
Hypokalaemia
E87.6 [45537991]
2.2e+00
3.0e+00
—
1.0e+50
—
2.2e+00
1.9e+00
cases:1.75%
controls:0.19%
cases:1.17%
controls:0.06%
—
—
cases:0.51%
controls:0.00%
—
—
cases:0.54%
controls:0.06%
cases:1.91%
controls:0.30%
24
26
1346
13618
16
8
1355
13646
—
7
0
1364
13654
—
7
8
1287
13223
20
33
1028
10997

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1078
1243
29.40
307.65
6.8
1.9
214.01
382.54
nmol/l
68.55
1028
1157
415
165
34.59
307.65
5.2
1.2
81.87
83.54
mu/l
0.02
393
152
189
158
13.57
192.18
1.6
1.2
351.54
332.19
pmol/l
0.10
157
138
869
3468
4.66
187.42
8.1
4.2
—
—
—
0
0
640
2142
4.51
171.86
6.0
3.5
0.80
0.82
mmol/l
5.56
616
2038
459
1186
5.16
171.18
7.3
4.5
0.97
1.00
%
0.10
203
350
1211
6519
5.76
168.72
17.3
6.8
1.20
1.21
mmol/l
2.80
1034
5661
895
3878
4.32
166.90
8.7
3.7
7.40
7.40
ph
1.99
740
2749
443
1137
5.14
166.07
6.8
4.4
0.63
0.68
%
0.20
190
331
423
1057
5.21
163.49
4.7
2.9
9.32
10.67
g/l
7.48
398
982
536
1652
4.52
158.75
8.9
5.7
1.05
1.06
mmol/l
0.38
522
1540
436
1144
4.99
158.45
7.8
4.9
0.03
0.12
%
1.22
165
264
365
827
5.53
157.59
4.3
3.5
4.33
4.56
pmol/l
3.42
339
738
430
1136
4.93
154.61
7.6
4.6
0.10
0.12
%
0.15
174
299
1104
5833
4.53
149.31
16.3
6.4
1.20
1.21
mmol/l
2.68
1075
5394
256
438
6.86
147.93
2.6
1.3
345.08
287.12
mu/l
2.12
238
398
215
316
7.79
142.85
1.7
1.3
15.78
9.80
u/l
3.86
182
243
388
1005
4.88
141.90
7.3
3.3
1.22
1.23
mmol/l
1.82
372
856
1106
5983
4.38
141.27
4.7
2.4
79.49
77.16
nmol/l
2.12
1051
5439
185
239
8.71
137.04
5.4
3.6
—
—
—
0
0
566
2004
3.96
135.25
3.5
2.4
2.30
2.33
g/l
0.48
528
1873
185
243
8.56
135.14
1.7
1.4
69.78
61.48
mmol/l
1.38
165
199
535
1832
4.01
133.98
3.6
2.5
21.74
22.78
%
0.85
500
1722
639
2476
3.79
133.24
4.4
2.8
474.34
523.02
mosm/kgh2o
6.85
587
2182
341
839
4.98
132.09
2.3
1.8
1.20
1.39
g/l
0.60
325
774
581
2162
3.78
127.85
3.7
2.5
11.71
13.20
umol/l
5.37
543
2026
1048
5738
3.85
124.76
10.7
5.0
34.05
35.90
g/l
22.41
1014
5385
759
3445
3.48
120.87
3.6
2.3
3.10
2.82
mg/l
2.84
703
2963
831
4137
3.31
110.80
5.3
2.5
53.84
80.84
u/l
0.78
793
3844
159
224
7.83
108.92
6.2
4.1
2.99
2.76
mmol/l
0.33
123
146
163
237
7.61
108.59
4.1
3.4
4.87
4.23
e9/l
2.19
163
237
872
4502
3.29
108.59
12.7
6.4
—
—
—
0
0
1130
6852
3.76
106.98
14.0
6.4
0.64
0.57
e9/l
16.57
1070
5900
686
3103
3.26
106.63
11.4
4.7
—
—
—
0
0
1130
6860
3.75
106.60
13.9
6.4
0.04
0.04
e9/l
0.89
1072
5911
1197
7556
4.08
105.97
12.5
5.1
6.75
6.63
mmol/l
0.93
1173
7153
1147
7076
3.78
104.41
14.4
6.7
0.18
0.19
e9/l
2.14
1088
6193
1122
6858
3.65
102.93
12.3
6.5
9.60
11.55
umol/l
11.01
1099
6557
1137
7010
3.70
102.81
14.1
6.4
1.95
1.92
e9/l
0.12
1083
6187
123
139
9.56
100.69
1.9
1.3
—
—
—
0
0
335
989
4.09
100.50
2.4
1.3
439.88
203.88
u/ml
1.13
320
916
227
499
5.19
99.02
2.9
1.9
1.73
1.87
ug/l
0.08
208
446
1053
6292
3.35
98.08
14.4
6.6
8.63
8.72
%
0.58
1035
5907
1051
6286
3.33
97.46
14.3
6.5
2.46
2.85
%
5.98
1030
5901
120
140
9.24
95.80
1.8
1.3
2.37
3.02
g/l
2.51
65
107
120
140
9.24
95.80
1.8
1.3
0.39
0.41
g/l
0.12
64
107
120
140
9.24
95.80
1.8
1.3
6.13
7.12
g/l
1.15
66
109
1047
6285
3.29
95.70
14.5
6.5
0.63
0.69
%
2.58
1024
5893
990
5757
3.18
95.64
21.8
13.7
1.19
1.23
inr
1.34
891
4754
633
2881
3.10
94.91
4.2
2.6
6.17
6.43
e6/l
0.18
602
2629
496
1959
3.31
94.91
1.7
1.4
538.11
531.67
titre
0.02
106
418
196
393
5.60
94.69
6.4
4.9
8.48
8.52
kpa
0.09
196
385
174
313
6.17
94.30
4.4
3.1
60.39
57.58
%
1.72
174
313
120
143
9.05
94.21
1.7
1.3
272.76
278.47
mosm/kgh2o
1.23
99
109
1062
6470
3.28
93.73
14.3
6.5
25.99
28.22
%
8.68
1044
6151
306
896
4.05
92.30
7.3
4.4
5.14
5.14
kpa
0.02
300
870
622
2842
3.05
92.03
2.1
1.5
2.32
2.36
g/l
0.21
458
1760
379
1289
3.61
91.76
11.0
9.0
95.62
95.74
%
0.14
370
1252
1044
6362
3.19
90.77
13.6
6.3
59.61
56.85
%
9.96
1033
6090
403
1436
3.48
90.62
11.4
8.6
4.92
5.10
kpa
3.32
393
1387
403
1437
3.48
90.51
11.4
8.6
11.65
12.38
kpa
2.10
389
1388
300
878
4.03
90.44
7.1
4.4
7.42
7.42
ph
0.20
274
737
766
3956
2.95
90.08
3.4
2.2
173.65
201.52
u/l
0.53
742
3753
231
556
4.74
90.05
1.5
1.3
1.18
1.64
u/ml
0.15
20
40
401
1433
3.47
89.66
11.1
8.5
0.95
0.95
mmol/l
0.01
338
1179
401
1437
3.46
89.22
11.4
8.6
7.42
7.41
ph
1.58
272
794
839
4576
2.93
88.64
5.7
3.5
2.32
2.35
mmol/l
9.83
805
4176
146
235
6.78
88.20
1.8
1.6
0.59
0.76
g/l
0.89
83
192
1166
7641
3.50
88.13
18.7
9.7
4.84
4.03
e9/l
23.08
1107
6659
413
1561
3.28
83.68
2.8
1.7
—
—
—
0
0
320
1042
3.64
82.01
7.1
3.7
—
—
—
0
0
454
1847
3.11
80.79
3.3
2.0
—
—
—
0
0
770
4185
2.75
79.04
5.2
3.3
51.98
72.43
e6/l
0.24
675
3200
100
118
9.02
78.94
1.8
2.3
1343.11
1247.12
e6/l
0.33
80
100
366
1336
3.31
77.98
10.2
4.1
5.88
5.76
kpa
1.24
354
1295
220
569
4.37
77.80
1.7
1.4
3.10
16.05
iu/ml
—
7
11
286
893
3.73
77.78
4.4
3.5
75.06
79.52
ng/l
0.38
236
784
364
1330
3.30
77.37
10.3
4.2
7.38
7.38
ph
0.39
245
746
109
147
7.93
77.12
2.3
1.8
4.24
4.49
mmol/24h
0.31
96
132
323
1104
3.46
76.38
12.2
6.9
9.08
9.14
mmol/l
0.05
313
1068
99
121
8.70
75.97
2.1
1.3
1.16
2.45
u/ml
0.42
61
65
379
1450
3.17
74.27
3.0
2.9
1.94
1.81
%
1.63
332
1304
352
1291
3.27
74.05
10.2
4.2
2.03
1.75
mmol/l
0.64
316
1107
115
173
7.12
73.81
5.3
2.6
—
—
—
0
0
318
1100
3.41
73.57
2.7
2.9
75.24
71.01
e9/l
1.05
239
797
951
5899
2.72
72.61
30.5
11.1
0.00
0.00
e9/l
0.51
859
4837
681
3612
2.64
71.42
4.9
3.2
0.32
0.43
e6/l
0.83
590
2653
695
3734
2.63
70.83
4.8
3.2
1203.64
1107.47
ng/l
0.22
628
3189
698
3789
2.60
69.19
7.5
3.9
0.00
0.01
estimate
1.74
399
1336
299
1033
3.38
68.98
2.8
3.0
64.15
66.81
g/l
6.88
284
959
241
726
3.77
68.61
1.5
1.2
—
—
—
0
0
1315
9901
3.99
67.12
20.0
8.0
78.91
79.44
u/l
0.17
1301
9410
336
1265
3.14
67.03
2.9
2.3
0.22
0.21
g/l
0.23
310
1191
815
4835
2.53
65.87
6.2
3.9
47.94
92.01
e6/l
2.22
690
3382
142
296
5.20
65.07
3.1
2.1
126.10
129.10
g/l
0.75
136
240
987
6453
2.60
63.99
5.3
3.0
133.95
112.13
ug/l
2.07
940
6045
618
3260
2.54
63.81
1.7
1.3
1.23
1.47
u/ml
0.33
227
885
544
2703
2.60
63.69
2.2
1.7
28875192.51
36968519.71
pmol/l
0.14
471
2256
672
3707
2.49
62.73
2.1
1.7
20.50
20.64
nmol/l
0.08
606
3154
403
1734
2.82
62.71
3.8
3.1
4.70
4.83
e9/l
0.12
373
1523
710
4017
2.48
62.69
5.1
3.1
—
—
—
0
0
683
3798
2.49
62.62
6.8
3.2
0.06
0.05
estimate
0.09
361
1140
184
488
4.16
62.44
1.6
1.2
—
—
—
0
0
103
165
6.64
62.18
1.9
1.2
0.16
0.41
nmol/l
—
9
9
80
97
8.66
61.66
1.3
1.2
30.75
34.35
mmol/l
0.56
74
88
801
4810
2.45
61.65
7.5
3.6
29.25
72.43
ng/l
1.39
654
3269
1030
6955
2.59
60.96
7.4
3.9
0.00
4.39
estimate
1.33
419
1461
249
837
3.38
59.47
2.6
2.7
—
—
—
0
0
1030
7014
2.55
58.85
7.5
3.9
0.00
0.23
estimate
0.54
408
1380
92
139
6.99
58.66
1.9
1.2
0.30
0.30
nmol/l
0.00
54
112
570
2992
2.47
58.34
2.8
1.8
1.15
1.21
mg/l
0.18
451
2318
1014
6889
2.51
57.66
7.5
3.8
0.00
0.00
estimate
0.50
419
1433
90
136
6.98
57.36
1.9
1.2
—
—
nmol/l
—
0
0
94
149
6.67
57.28
1.8
2.4
31.20
32.40
pg
1.45
94
149
754
4508
2.37
57.21
5.8
3.2
48.75
32.31
u/l
0.72
707
4276
838
5272
2.36
56.13
7.4
3.7
0.01
0.07
estimate
1.67
366
1180
1162
8470
2.74
56.05
8.7
4.6
2848.33
1947.31
e6/l
0.17
21
122
296
1140
3.00
55.91
10.1
3.8
4.56
4.56
kpa
0.00
286
1106
48
32
15.47
54.71
2.4
1.3
433.97
70.41
nmol/24h
0.95
48
32
97
168
6.11
54.14
1.8
2.3
1.05
0.90
%
1.39
72
113
217
720
3.36
52.60
1.8
1.4
25.69
27.84
iu/l
0.40
188
612
96
170
5.97
52.36
4.0
2.5
—
—
—
0
0
139
341
4.40
52.04
2.5
2.2
9.74
11.77
mg/l
1.96
131
318
107
211
5.39
52.02
1.9
1.3
0.34
0.47
nmol/l
0.73
72
172
184
554
3.65
51.82
9.1
5.7
1.50
1.55
%
0.35
179
528
158
432
3.98
51.13
1.6
1.7
0.24
0.23
g/l
0.59
145
414
161
447
3.92
50.99
1.6
1.6
1.29
1.19
g/l
3.12
150
426
1253
9673
2.95
50.62
10.6
4.3
14.12
11.77
mm/h
7.19
1206
9075
290
1163
2.86
50.48
14.7
9.1
—
—
—
0
0
389
1810
2.56
50.43
4.2
2.5
214.98
112.13
ug/g
3.32
333
1454
171
503
3.71
49.80
9.0
6.1
0.85
0.88
%
0.30
166
476
235
850
3.10
49.17
3.7
2.1
11.74
13.37
nmol/l
1.79
207
765
1294
10244
3.12
48.27
9.7
4.5
15.32
14.72
pmol/l
13.62
1243
9473
149
407
3.96
48.22
7.7
5.3
1.66
1.43
mg/l
1.82
143
370
96
186
5.45
47.54
3.1
3.4
0.94
1.55
%
1.14
87
170
258
1007
2.89
47.00
1.4
1.2
167.19
154.02
u/ml
0.17
102
381
116
267
4.63
47.00
2.6
3.1
29.02
33.05
umol/l
1.18
103
242
357
1644
2.54
46.91
2.2
1.4
—
—
—
0
0
418
2076
2.41
46.55
2.2
1.7
1399.06
1182.22
nmol/l
3.99
323
1570
853
5680
2.19
46.24
2.7
2.1
91.78
96.81
pmol/l
2.88
534
2994
61
76
8.33
45.90
1.4
1.4
6.96
6.15
u/l
0.13
56
63
175
555
3.44
45.32
8.1
3.5
25.66
25.19
mmol/l
0.81
170
535
402
1993
2.40
44.71
3.0
2.4
29.64
29.46
s
0.23
386
1937
110
254
4.60
44.36
4.0
4.6
—
—
—
0
0
219
807
3.01
44.11
11.4
3.8
127.04
129.22
g/l
0.69
211
784
65
92
7.34
43.88
1.7
2.4
563.91
474.45
e6/l
0.56
43
73
199
700
3.13
43.43
14.1
11.6
16.01
15.85
%
0.35
194
677
141
399
3.80
43.30
3.5
4.2
40.39
59.96
mg/l
0.60
96
348
73
119
6.40
43.20
1.6
1.3
441.83
335.53
mu/l
1.26
65
89
65
94
7.19
43.04
1.8
2.4
260.64
219.67
e6/l
0.54
45
78
139
399
3.74
41.78
3.6
4.2
28.90
51.80
mg/l
1.48
93
349
369
1818
2.37
41.20
1.5
1.2
—
—
—
0
0
175
590
3.23
40.93
2.0
1.9
6.38
7.33
iu/ml
0.19
48
142
127
356
3.81
39.47
3.3
4.0
3.31
3.07
ratio
0.04
61
207
819
5589
2.04
38.92
5.6
3.4
6.30
6.23
ph
1.09
489
3191
141
434
3.49
38.09
2.4
2.2
337.41
428.19
ug/l
0.26
134
407
41
39
10.78
37.65
1.7
1.6
27.46
30.41
%
0.43
41
39
137
418
3.51
37.50
1.6
1.4
246.54
281.44
ug/g
1.09
85
249
460
2594
2.12
36.25
4.5
2.9
2.45
2.45
mmol/l
0.70
432
2336
157
536
3.16
35.82
1.8
1.9
1.66
1.51
g/l
0.98
137
479
124
365
3.62
35.82
8.9
7.1
1.32
1.35
mmol/l
0.09
108
321
548
3317
2.04
35.52
4.0
2.7
332.14
334.72
umol/l
0.21
483
2938
92
221
4.37
35.22
1.3
1.1
27.99
2563.30
iu/ml
0.52
37
51
53
77
7.10
34.92
1.4
1.3
—
—
—
0
0
102
274
3.92
33.61
1.6
1.7
—
—
—
0
0
304
1535
2.23
31.11
4.2
2.8
5.84
7.42
umol/l
1.41
248
1358
91
245
3.89
29.86
10.3
8.8
11.70
11.25
mmol/l
0.53
86
225
91
245
3.89
29.86
10.3
8.9
103.91
105.12
mmol/l
1.08
86
225
72
163
4.59
29.68
9.0
6.4
12.21
11.62
mg/l
0.42
66
153
184
758
2.63
29.52
13.4
10.5
23.95
24.23
mmol/l
0.55
178
742
55
99
5.73
29.41
1.3
1.1
—
—
—
0
0
443
2637
1.97
28.95
1.6
1.3
19.98
29.89
iu/ml
2.13
153
811
77
189
4.24
28.64
2.6
1.5
—
—
—
0
0
77
189
4.24
28.64
2.6
1.5
—
—
—
0
0
77
189
4.24
28.64
2.6
1.5
—
—
—
0
0
77
189
4.24
28.64
2.6
1.5
—
—
—
0
0
646
4363
1.85
28.57
5.5
3.4
—
0.80
—
0
15
171
701
2.63
27.64
10.7
3.7
1.30
1.24
%
0.29
171
696
63
141
4.62
26.33
2.1
1.5
57.49
57.02
%
0.03
43
91
642
4416
1.80
26.03
4.3
3.4
6.84
7.52
mmol/l
3.27
570
3766
34
42
8.26
25.69
1.5
2.2
0.34
0.31
e9/l
—
7
20
52
101
5.30
25.63
1.2
1.1
107.25
109.13
pmol/l
0.07
52
101
287
1525
2.09
25.33
1.7
1.4
—
—
—
0
0
821
6109
1.77
25.12
4.4
2.8
—
—
estimate
—
0
0
227
1116
2.22
24.37
1.7
1.4
—
—
—
0
0
34
45
7.71
24.27
1.6
1.5
14.99
15.04
pmol/l
0.02
28
37
31
37
8.54
24.06
2.4
4.2
154.27
40.34
au/ml
—
10
10
283
1530
2.05
23.70
1.9
1.5
—
—
—
0
0
108
377
3.01
23.56
1.4
1.2
182.00
97.50
titre
0.50
15
40
50
102
5.04
23.32
2.3
1.4
28.68
32.83
%
0.30
33
63
112
402
2.93
23.25
5.1
3.2
3.37
3.54
g/l
0.49
101
386
215
1055
2.21
23.12
3.5
2.3
0.51
0.56
e6/l
0.08
208
1007
403
2478
1.86
23.02
2.1
1.9
—
—
—
0
0
41
72
5.83
22.49
2.7
3.0
15.64
16.79
%
0.85
41
72
88
281
3.27
22.31
1.4
1.6
—
—
—
0
0
101
351
3.02
22.20
1.5
1.4
610.21
527.22
mg/l
0.63
96
334
43
81
5.44
21.91
2.7
2.4
41.17
41.31
%
0.01
29
41
41
74
5.67
21.87
1.2
1.3
138.40
145.28
nmol/l
0.35
41
74
83
259
3.34
21.83
1.6
1.5
—
—
—
0
0
92
306
3.14
21.80
1.5
1.6
24.06
51.78
e6/l
0.46
63
221
1083
8910
1.81
21.78
6.4
3.9
—
5051.20
—
0
20
110
407
2.84
21.59
2.2
2.0
67.25
18.34
iu/l
0.36
51
167
78
236
3.43
21.54
1.6
1.6
158.65
151.10
au/ml
0.21
22
66
93
315
3.08
21.37
1.4
1.4
3.60
3.70
mmol/l
0.34
87
295
137
570
2.55
21.36
1.5
1.2
—
—
—
0
0
192
929
2.23
21.29
6.3
3.3
110.77
190.03
ng/l
3.55
178
848
1345
11945
2.41
21.27
11.0
5.5
2.21
1.89
mu/l
0.62
1290
11130
92
311
3.09
21.21
1.5
1.6
170.79
262.80
e6/l
0.36
71
236
582
4063
1.71
21.17
4.1
3.4
49.66
45.76
mg/l
0.16
369
2571
395
2474
1.81
20.96
1.6
1.3
7.67
10.77
u/ml
0.59
178
964
83
267
3.23
20.79
1.7
1.4
275.72
240.88
u/ml
0.40
64
151
344
2091
1.84
20.01
1.9
1.6
—
—
—
0
0
72
217
3.44
20.01
1.1
1.1
—
—
—
0
0
110
430
2.68
19.43
1.5
1.2
28.17
27.23
u/ml
—
6
21
583
4148
1.67
19.27
5.0
4.1
10.58
8.35
mg/mmol
0.52
351
2572
44
95
4.74
19.23
1.1
1.1
—
—
—
0
0
144
645
2.37
19.09
9.1
4.7
—
—
—
0
0
65
190
3.53
18.93
2.0
1.3
33.33
28.78
u/l
0.42
56
152
33
57
5.90
18.42
2.0
1.4
1.57
4.92
%
—
7
13
194
1003
2.08
18.04
1.5
1.4
—
—
—
0
0
91
338
2.80
17.73
1.5
1.2
37.49
51.94
u/ml
—
10
36
36
71
5.17
17.46
1.9
1.7
—
—
—
0
0
110
455
2.53
17.33
1.6
1.3
—
—
—
0
0
28
44
6.47
17.13
1.3
1.3
171.11
157.61
mmol/24h
0.21
28
44
61
183
3.43
17.09
1.7
1.3
48.81
71.91
u/ml
—
9
11
27
17
16.15
17.04
1.4
1.0
—
—
—
0
0
101
407
2.59
16.79
1.5
1.2
2.96
2.42
u/ml
—
7
43
101
410
2.57
16.54
1.5
1.3
4.66
11.21
u/ml
0.77
12
70
1398
12860
2.63
16.48
55.0
17.5
138.97
139.64
mmol/l
13.46
1390
12617
1398
12883
2.59
15.99
55.1
17.6
3.91
3.96
mmol/l
13.79
1390
12612
83
311
2.77
15.92
2.7
1.6
53.63
42.37
nmol/l
1.34
83
297
36
78
4.71
15.68
2.1
1.5
30.58
29.66
umol/l
0.19
36
70
1049
8871
1.63
15.65
6.5
3.3
65.97
45.56
u/l
4.35
984
8392
53
155
3.51
15.45
1.4
1.8
—
—
—
0
0
39
92
4.33
15.31
1.2
1.1
390.48
237.21
mg/l
0.74
29
77
1378
12685
2.29
14.64
48.8
15.1
21.85
23.34
mg/l
1.32
1300
10399
1217
10772
1.74
14.40
52.0
18.7
14.23
13.58
%
36.96
1211
10627
39
98
4.06
14.12
1.3
1.1
56.01
35.93
mg/l
0.67
26
78
84
337
2.58
14.10
14.2
4.4
63.50
60.12
%
0.68
79
327
464
3320
1.58
13.92
7.0
4.1
91.95
91.15
%
0.27
450
3252
1307
11843
1.90
13.92
9.5
6.1
41.10
39.00
mmol/mol
10.91
1258
11145
34
80
4.33
13.41
1.6
1.2
0.85
0.50
ratio
0.53
15
45
107
497
2.24
13.00
2.7
2.6
4.15
4.25
g/l
0.69
101
463
107
497
2.24
13.00
2.7
2.6
7.48
7.42
g/l
0.11
101
463
107
497
2.24
13.00
2.7
2.6
3.32
3.76
g/l
2.36
101
463
61
217
2.89
12.91
1.0
1.1
—
—
—
0
0
559
4251
1.51
12.37
3.8
2.4
—
—
—
0
0
123
616
2.09
12.36
3.1
2.1
0.00
0.01
estimate
0.50
65
197
43
128
3.43
12.25
3.7
4.0
—
—
—
0
0
60
1448
0.39
12.23
1.6
2.0
3.15
3.44
ratio
1.40
38
1129
164
916
1.89
12.08
2.5
2.5
21.01
20.28
au/ml
—
9
94
25
29
8.75
12.02
3.1
4.4
45.44
53.21
%
0.69
25
29
25
29
8.75
12.02
1.3
1.1
377.77
315.16
pmol/l
0.18
13
19
532
4023
1.50
12.01
10.6
6.3
—
—
—
0
0
352
2441
1.58
11.77
7.5
3.9
145.72
366.86
ng/l
2.40
265
1838
307
2070
1.61
11.53
4.6
3.0
4.05
2.71
e6/l
0.92
176
1013
50
173
2.96
11.15
1.1
1.2
—
—
—
0
0
22
42
5.30
11.08
1.2
1.1
—
—
—
0
0
22
42
5.30
11.08
1.2
1.1
—
—
—
0
0
22
42
5.30
11.08
1.2
1.1
—
—
—
0
0
20
35
5.78
11.02
4.3
2.1
0.61
0.61
mmol/l
0.03
20
35
23
46
5.06
11.01
3.4
2.0
10.12
9.60
mg/l
0.14
15
39
50
1248
0.38
10.96
1.3
1.4
—
—
—
0
0
103
505
2.12
10.95
3.4
2.6
20.41
20.82
s
0.57
91
459
185
1111
1.76
10.73
1.4
1.2
—
—
—
0
0
29
72
4.09
10.70
2.6
1.4
13.17
12.90
u/l
0.05
29
67
148
833
1.86
10.63
1.3
1.3
71.34
44.99
au/ml
—
10
62
202
1251
1.71
10.50
3.5
2.4
35.10
81.50
u/l
0.62
177
1043
322
2258
1.54
10.07
4.3
2.9
1.98
1.09
e6/l
0.38
196
1204
39
125
3.18
9.92
5.2
5.3
138.35
67.55
u/ml
0.42
17
41
197
1236
1.69
9.73
2.9
2.1
0.00
0.02
estimate
0.78
79
254
43
1087
0.38
9.68
1.5
1.7
3.65
3.50
mmol/l
0.33
21
768
27
69
3.97
9.61
1.1
1.1
1.09
1.06
ratio
0.16
19
58
30
84
3.62
9.40
3.1
2.6
7.55
8.61
mmol/l
0.70
30
84
90
445
2.09
9.38
4.8
3.7
321.02
334.05
mg/l
0.06
52
196
19
22
8.73
9.29
1.2
1.6
—
—
—
0
0
204
1308
1.65
9.26
3.6
4.4
8.51
21.44
ug/l
1.05
170
1064
14
9
15.68
9.03
1.1
7.3
13.35
14.12
mmol/l
—
14
9
95
489
2.01
8.89
2.8
2.1
1243.26
6573.48
u/l
2.14
36
212
65
289
2.31
8.82
2.1
1.8
1.24
0.84
nmol/l
2.03
54
250
40
143
2.85
8.47
2.5
2.3
0.59
1.01
g/24h
1.30
18
85
22
54
4.12
8.27
1.0
1.1
161.00
49.57
ng/l
—
8
14
36
123
2.97
8.27
3.4
3.3
59.53
55.28
%
0.61
30
112
642
5286
1.38
8.22
2.5
2.1
—
—
—
0
0
30
93
3.27
8.09
1.7
1.4
—
—
—
0
0
14
12
11.76
8.08
2.9
1.4
43.71
51.50
umol/l
0.19
14
12
85
437
2.00
8.01
2.9
2.6
8.09
10.42
g/l
6.87
77
401
28
84
3.38
7.95
2.6
2.3
585.91
623.50
ml
0.20
22
54
975
10784
0.72
7.94
51.7
19.6
330.76
332.15
g/l
4.47
967
10722
105
583
1.86
7.88
1.7
1.6
0.30
0.34
mg/l
0.25
48
274
112
637
1.82
7.79
2.6
2.3
—
—
—
0
0
26
76
3.46
7.69
1.0
1.1
1647.08
1545.72
miu/ml
0.22
26
76
64
305
2.15
7.39
1.3
1.2
—
—
—
0
0
12
9
13.43
7.39
5.1
4.4
37.08
28.11
mg/l
—
12
9
37
138
2.72
7.28
1.1
1.3
—
—
—
0
0
400
3095
1.40
7.25
7.5
3.9
1.02
1.51
kg/l
0.50
283
2037
19
33
5.82
7.22
4.4
3.5
—
—
—
0
0
22
60
3.71
7.20
1.3
3.4
56.63
114.28
umol/l
—
8
36
155
994
1.62
7.00
3.1
2.4
5.03
6.99
ug/l
0.98
133
892
30
102
2.98
6.98
1.2
1.1
0.26
1.56
nmol/l
—
6
15
1293
12116
1.54
6.90
6.8
5.0
5.82
5.89
mmol/l
0.95
1236
11168
11
8
13.84
6.89
2.7
3.1
41.47
89.33
pmol/l
—
6
8
650
5465
1.34
6.87
2.4
1.9
1.59
1.34
mmol/l
7.36
542
4674
29
98
3.00
6.83
2.3
2.4
790.66
938.47
mg
0.17
29
98
67
337
2.04
6.74
1.2
1.1
0.62
2.63
u/ml
2.94
46
194
1401
13411
1.87
6.67
56.9
19.3
82.21
74.30
umol/l
7.99
1395
13274
17
41
4.18
6.55
1.4
1.4
—
—
—
0
0
1374
13087
1.72
6.55
42.3
13.4
—
—
—
0
0
471
3801
1.35
6.45
5.0
3.0
0.00
0.03
0.74
12
89
32
119
2.73
6.37
1.1
1.1
—
—
—
0
0
13
16
8.19
6.33
2.0
1.1
1.36
1.36
umol/l
—
13
7
32
120
2.70
6.27
2.9
2.3
—
—
—
0
0
68
354
1.97
6.24
4.1
3.2
1.19
2.03
index
0.97
43
180
17
43
3.99
6.17
1.6
1.3
60.55
63.67
%
0.11
11
36
54
260
2.12
6.12
2.2
3.8
560.50
1510.18
u/ml
0.42
46
244
41
176
2.37
6.10
1.1
1.2
—
—
—
0
0
29
105
2.80
6.07
2.9
2.3
1.64
2.02
u/field
0.22
14
56
47
218
2.19
5.86
1.1
1.1
4.18
4.85
u/ml
0.08
24
92
11
13
8.52
5.56
1.2
1.1
—
—
—
0
0
13
20
6.55
5.56
1.0
1.2
—
—
—
0
0
18
525
0.33
5.56
1.2
1.1
1.54
1.55
g/l
0.05
18
525
27
101
2.70
5.35
1.0
1.0
—
—
—
0
0
1386
13315
1.66
5.29
28.3
11.8
26.57
25.54
u/l
1.44
1377
12973
67
368
1.86
5.28
1.6
1.2
—
—
—
0
0
54
276
1.99
5.26
1.2
1.1
0.55
1.44
u/ml
1.63
32
146
21
70
3.03
5.11
2.4
2.5
—
34.44
—
0
10
44
211
2.12
5.09
1.2
1.2
4.44
3.49
u/ml
0.18
18
91
17
485
0.34
5.04
1.0
1.1
—
0.64
—
0
56
35
156
2.27
4.84
1.7
2.0
—
—
—
0
0
28
114
2.48
4.72
1.1
1.1
—
—
—
0
0
11
18
6.15
4.60
2.5
1.6
—
—
—
0
0
23
86
2.70
4.59
1.9
1.4
94.00
490.00
titre
—
5
9
46
234
2.00
4.58
1.2
1.1
1.33
3.44
u/ml
1.35
29
119
15
44
3.43
4.47
2.8
1.4
—
—
—
0
0
7
6
11.71
4.28
2.3
4.7
—
—
—
0
0
51
276
1.88
4.27
2.6
2.4
113.03
110.77
ug/min
0.01
36
168
13
29
4.51
4.25
1.6
1.9
—
—
—
0
0
8
10
8.04
4.06
3.6
1.0
—
—
—
0
0
59
340
1.77
4.05
2.1
1.6
10289.26
12646.40
e6/l
0.21
47
243
81
510
1.62
4.02
1.1
1.1
—
—
—
0
0
25
107
2.36
3.84
1.1
1.1
—
—
—
0
0
33
161
2.07
3.73
1.7
1.5
25.13
33.18
g/l
2.89
33
145
64
388
1.68
3.70
1.3
1.2
—
—
—
0
0
158
1168
1.39
3.64
7.1
3.8
7.38
7.36
ph
1.12
141
839
74
471
1.60
3.55
2.9
3.5
1594.27
3166.11
u/ml
0.27
64
412
14
46
3.06
3.53
1.3
1.1
0.69
18.08
u/ml
—
7
27
28
132
2.14
3.46
1.0
1.1
—
—
—
0
0
178
1356
1.36
3.42
1.7
1.5
—
—
—
0
0
33
167
2.00
3.40
1.6
2.4
8.47
7.12
umol/l
0.23
28
117
11
27
4.10
3.39
1.2
3.7
193.52
81.74
ng/l
—
6
18
27
536
0.49
3.39
2.3
1.2
0.88
0.89
g/l
0.18
27
536
221
1744
1.31
3.34
1.4
1.3
—
—
—
0
0
26
122
2.15
3.27
1.3
1.2
—
—
—
0
0
50
294
1.73
3.26
1.1
1.1
1.70
6.11
u/ml
2.01
25
171
9
19
4.76
3.24
1.0
1.2
—
—
—
0
0
9
19
4.76
3.24
1.1
1.1
—
—
—
0
0
17
67
2.56
3.13
1.2
1.2
—
—
—
0
0
14
50
2.82
3.09
2.2
2.7
—
—
—
0
0
6
8
7.53
3.05
21.2
7.4
3.83
5.70
mmol/l
—
6
8
7
12
5.85
3.02
1.1
1.0
—
—
—
0
0
33
590
0.55
3.00
1.5
1.6
1271.96
1002.79
mu/l
0.65
27
485
11
31
3.57
2.99
1.2
1.1
—
—
—
0
0
15
57
2.65
2.97
1.1
1.1
134.80
175.60
iu/ml
0.32
15
57
26
128
2.05
2.92
1.6
1.6
—
—
—
0
0
8
17
4.73
2.92
1.4
3.9
—
—
—
0
0
11
32
3.46
2.90
1.1
1.2
3.28
8.38
pmol/l
—
5
11
50
305
1.66
2.89
8.3
4.6
—
—
—
0
0
47
282
1.69
2.88
1.1
1.1
0.72
1.51
u/ml
0.57
19
135
23
109
2.13
2.85
1.3
1.1
114.29
163.33
titre
—
7
18
12
38
3.18
2.85
1.0
1.0
—
—
—
0
0
12
38
3.18
2.85
1.0
1.2
—
—
—
0
0
31
165
1.90
2.82
1.5
1.2
—
—
—
0
0
42
247
1.72
2.78
3.0
2.3
—
—
—
0
0
10
30
3.35
2.60
2.1
3.5
2.30
5.40
ug/l
—
10
30
58
379
1.55
2.57
23.8
10.2
—
—
—
0
0
85
602
1.44
2.55
2.1
2.0
—
—
—
0
0
5
7
7.16
2.55
2.8
1.9
—
—
—
0
0
6
11
5.47
2.54
1.2
1.3
—
—
—
0
0
13
50
2.61
2.53
1.5
1.8
—
—
—
0
0
14
56
2.51
2.53
1.6
1.7
4480.00
3856.00
titre
—
5
10
25
132
1.91
2.36
1.3
1.2
—
—
—
0
0
13
52
2.51
2.36
2.6
1.9
0.00
0.06
estimate
0.49
13
52
21
105
2.01
2.31
1.2
1.5
1.27
1.25
promille
0.02
13
86
43
269
1.62
2.31
1.3
1.2
—
—
—
0
0
9
28
3.23
2.31
2.0
2.0
—
—
—
0
0
16
72
2.24
2.28
9.3
7.9
3.71
258.75
ug/l
—
9
46
28
156
1.81
2.26
2.2
2.3
—
—
—
0
0
35
211
1.67
2.18
1.1
1.1
1.00
2.33
eliau/ml
—
5
92
147
1832
0.78
2.16
3.5
3.2
0.92
0.77
ug/l
0.31
111
1163
20
101
1.99
2.16
1.3
1.2
—
—
—
0
0
1227
11842
1.21
2.08
5.2
4.2
1.49
1.27
mmol/l
10.17
1144
10956
27
155
1.76
2.01
1.2
1.4
—
—
—
0
0
51
738
0.68
1.99
1.7
1.7
—
—
—
0
0
69
498
1.40
1.93
1.4
1.7
17.52
11.77
u/ml
0.17
11
112
18
92
1.97
1.90
1.2
1.2
0.35
3.13
u/ml
—
8
38
23
128
1.81
1.90
2.2
2.2
—
—
—
0
0
22
121
1.83
1.89
1.5
1.4
—
—
—
0
0
7
22
3.19
1.88
1.3
1.5
—
—
—
0
0
13
59
2.21
1.84
2.8
1.8
—
—
—
0
0
9
35
2.58
1.80
2.4
3.0
—
—
—
0
0
22
124
1.79
1.76
2.1
1.3
10826.77
187118.23
e6/l
1.28
13
79
84
638
1.34
1.74
6.0
3.5
1.02
1.02
ratio
0.13
78
581
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
61
440
1.40
1.74
1.2
1.3
233.69
226.99
miu/ml
0.05
19
213
8
30
2.68
1.72
19.9
6.6
6.58
4.90
kpa
—
8
30
14
269
0.52
1.72
1.4
1.5
—
—
—
0
0
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
36
235
1.55
1.69
2.9
3.5
0.83
0.80
nmol/l
0.15
27
196
6
19
3.17
1.66
1.0
1.2
0.05
0.02
u/ml
—
6
19
1406
13835
1.34
1.62
65.1
23.2
7.80
6.69
e9/l
26.32
1393
13542
22
128
1.73
1.60
1.7
1.4
—
—
—
0
0
8
32
2.51
1.59
1.9
1.2
136.38
138.79
mmol/l
—
8
24
14
261
0.53
1.58
1.4
1.4
—
—
—
0
0
1405
13829
1.33
1.57
65.2
23.2
271.47
254.98
e9/l
13.39
1395
13580
17
92
1.86
1.56
1.3
1.5
11.13
12.23
umol/l
0.34
17
86
1405
13831
1.32
1.55
64.8
23.1
91.21
90.91
fl
1.45
1400
13703
32
208
1.55
1.54
1.4
1.2
—
—
—
0
0
1405
13833
1.32
1.53
64.8
23.1
30.15
30.25
pg
1.18
1400
13703
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
48
341
1.42
1.52
1.4
1.4
81.36
225.36
pmol/l
1.97
48
334
1405
13834
1.32
1.52
65.0
23.1
4.37
4.48
e12/l
13.05
1395
13549
1405
13834
1.32
1.52
66.7
23.7
39.30
40.21
%
9.43
1400
13697
61
453
1.36
1.50
2.1
2.7
—
—
—
0
0
1405
13839
1.31
1.47
65.8
23.3
130.38
134.68
g/l
22.63
1400
13710
8
169
0.47
1.47
1.9
1.6
—
—
—
0
0
12
60
2.01
1.38
1.1
1.4
85.38
169.18
pmol/l
1.44
12
60
410
3747
1.13
1.32
1.7
1.5
—
—
—
0
0
550
5116
1.12
1.31
4.0
3.1
—
—
—
0
0
30
203
1.49
1.25
1.1
1.0
0.13
0.29
u/ml
0.55
14
69
48
356
1.36
1.23
2.3
1.7
—
—
—
0
0
5
20
2.50
1.15
1.0
1.3
—
—
mmol/l
—
0
0
22
144
1.54
1.09
3.1
2.3
—
—
—
0
0
7
33
2.13
1.05
3.1
1.2
55.23
55.43
%
—
7
27
5
22
2.28
1.03
2.0
1.3
42.40
66.64
ug/l
—
5
22
7
34
2.06
1.03
1.0
1.3
—
—
—
0
0
132
1528
0.85
1.01
5.9
4.8
32.48
32.54
%
0.02
105
1032
332
3044
1.12
1.01
5.7
5.4
6.46
2.87
ug/l
0.48
301
2737
1273
12490
1.14
0.97
6.2
5.0
4.61
4.68
mmol/l
1.83
1197
11728
150
1310
1.16
0.96
1.9
1.7
—
—
—
0
0
1266
12433
1.13
0.88
6.2
4.9
1.51
1.49
mmol/l
0.89
1188
11602
22
152
1.45
0.88
1.0
1.1
—
—
—
0
0
6
30
2.00
0.87
1.3
2.2
29.37
18.18
umol/l
—
6
30
8
44
1.82
0.86
1.0
1.0
—
—
—
0
0
14
90
1.56
0.78
1.7
1.4
80.64
79.47
umol/l
0.03
14
90
162
1455
1.13
0.73
1.6
1.7
—
—
—
0
0
5
25
2.00
0.72
2.0
1.4
6.50
8.39
mmol/l
—
5
25
7
41
1.71
0.70
1.1
1.3
32.86
28.07
s
—
7
41
1283
12646
1.11
0.69
6.9
5.7
2.59
2.74
mmol/l
7.40
1202
11827
11
69
1.60
0.68
2.4
1.5
—
—
—
0
0
9
59
1.53
0.68
1.3
1.2
19.33
8.63
mm/h
—
9
59
14
94
1.49
0.66
1.2
1.2
0.44
1.95
u/ml
—
8
31
56
660
0.84
0.60
1.2
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
7.0
—
7.26
—
0
23
0
23
0.00
0.58
0.0
3.5
—
45.83
—
0
23
14
98
1.43
0.56
1.9
1.6
7.20
6.72
mmol/l
—
8
69
33
272
1.22
0.47
6.0
3.6
22.51
24.91
mg/l
0.23
28
195
11
154
0.71
0.47
1.3
1.1
—
—
—
0
0
11
77
1.43
0.45
4.6
3.2
0.91
0.84
index
0.14
11
77
5
84
0.59
0.45
1.0
1.0
350.00
298.11
ng/l
—
5
57
5
85
0.59
0.45
1.0
1.0
1085.80
690.56
ng/l
—
5
57
103
937
1.11
0.43
1.3
1.2
—
—
—
0
0
5
32
1.56
0.42
1.2
1.6
0.15
2.40
u/ml
—
5
32
59
522
1.14
0.39
3.1
1.8
—
—
—
0
0
10
71
1.41
0.39
1.7
1.7
78.00
96.36
ng/l
—
10
71
6
45
1.33
0.33
1.0
1.7
40.92
40.48
g/l
—
6
45
10
133
0.75
0.33
1.9
2.5
—
—
—
0
0
112
1056
1.07
0.24
5.2
2.5
6.19
6.09
ph
0.66
83
689
6
53
1.13
0.18
4.0
3.0
27.17
30.57
umol/l
—
6
39
60
561
1.07
0.18
3.1
1.8
—
—
—
0
0
60
562
1.07
0.17
3.1
1.8
—
—
—
0
0
7
63
1.11
0.17
1.1
1.5
7.94
6.02
mmol/l
—
7
63
20
223
0.90
0.14
1.1
1.2
—
—
—
0
0
31
285
1.09
0.14
1.4
1.1
—
—
—
0
0
31
286
1.09
0.13
1.4
1.1
—
—
—
0
0
59
565
1.05
0.10
3.2
1.8
—
—
—
0
0
21
225
0.93
0.07
1.7
1.9
—
—
—
0
0
58
560
1.04
0.07
3.2
1.8
—
—
—
0
0
155
1574
0.98
0.05
1.9
1.5
—
—
—
0
0
20
188
1.06
0.05
1.1
1.2
—
—
—
0
0
36
373
0.96
0.04
1.5
1.3
—
—
—
0
0
11
113
0.97
0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
0.47
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
-0.00
1.2
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
51.57
—
0
9
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
343.67
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ADDISON and mortality.

Females

Parameter HR [95% CI] p-value
E4_ADDISON 3.11 [2.63, 3.68] < 0.001
Birth year 0.992 [0.98, 1.0] 0.064

During the follow-up period (1.1.1998 — 31.12.2019), 772 out of 3174 females with E4_ADDISON died.

Males

Parameter HR [95% CI] p-value
E4_ADDISON 3.382 [2.67, 4.29] < 0.001
Birth year 0.99 [0.98, 1.0] 0.035

During the follow-up period (1.1.1998 — 31.12.2019), 628 out of 2061 males with E4_ADDISON died.

Mortality risk

Mortality risk for people of age

years, who have E4_ADDISON.

N-year risk Females Males
1 0.367% 0.675%
5 1.877% 4.233%
10 4.403% 9.797%
15 7.805% 19.147%
20 13.146% 30.999%

Relationships between endpoints

↥

Index endpoint: E4_ADDISON – Adrenocortical insufficiency

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data